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Abstract 
 
The host-pathogen interaction is dictated by the competition for nutrients.  Iron is a 
rare, but critical component for several conserved biochemical reactions, and as 
such, is at the forefront in the competition between host and pathogen.  The obligate 
intracellular human pathogen, Chlamydia trachomatis, enters an alternative growth 
mode when iron is depleted within the host.  Termed persistence, this growth mode 
is characterized by the arrest of development until suitable conditions arise within 
the host cell, and is likely an important evolutionary mechanism for chronic 
infection that has been linked to multiple sequelae of infection in vivo.  Despite the 
relevance of persistence in human disease, the sensory and response mechanisms 
that trigger this alternative growth mode are not understood.   
 
The research presented in this report demonstrates a new, robust model for the 
iron-restriction of intracellular-dwelling C. trachomatis.  The model was used to 
elicit uniform populations of persistent Chlamydiae in vitro, which allowed accurate 
analysis of differential transcription under iron-starvation conditions.  From these 
studies, the gene ytgA, which is predicted to function as part of an ABC-metal 
transport complex, was elevated upon low-iron availability.   
 
The identification of the trans- and cis-regulatory factors responsible for the 
modulation of ytgA transcription was attempted.  Our research indicates that the 
ytgC, which exists in an operon with ytgA, encodes a genetic fusion between a 
 4 
predicted membrane channel forming polypeptide (N-terminus) and a metal-
dependent DNA binding polypeptide (C-terminus), which we have termed C-YtgC.   
C-YtgC recognized the IGR upstream of ytgA in an iron-dependent manner in vitro, 
providing a molecular mechanism for the regulation of ytgA under iron-limiting 
conditions.  Two regions containing cis-regulatory elements within the IGR of ytgA 
were identified for this binding.  Additional preliminary evidence suggests a 
mechanism for the liberation of the C-YtgC polypeptide from the membrane channel 
portion of the protein.  
 
In summary, the research presented in this report has gained significant advances in 
the field of Chlamydia iron-biology.  The search for a robust iron-restriction model 
has implicated that the chlamydial iron source may be cytosolic, rather than 
endocytic.  Furthermore, the characterization of a novel trans-regulatory factor 
suggests that Chlamydia may employ a sophisticated regulatory network for 
maintenance of iron-homeostasis.  Continued research into the mechanisms of iron 
acquisition is warranted, considering the strong link between low-iron availability 
and chronic infection. 
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1.1 The pathogenic burden of the Chlamydiacea  
 
The Chlamydiacea are obligate, intracellular pathogens that are the etiological 
agents of a variety of globally relevant human diseases.  Chlamydia trachomatis is 
both the leading cause of sexually transmitted infection (STI) (CDC, 2008; 2001) and 
infection-derived blindness (Resnikoff et al., 2004), worldwide.  The World Health 
Organization (WHO) estimated that 92 million cases of chlamydial STI are 
contracted each year (WHO, 2001).  Acute genital infection may cause urethritis in 
men and cervicitis in women.  Although infection with C. trachomatis is treatable 
with antibiotics such as tetracycline or azithromycin, genital infection is often 
asymptomatic.  If untreated, chronic genital infection can lead to pelvic 
inflammatory disease (PID), infertility, and ectopic pregnancy in women (WHO, 
2001).   In 1994, an estimated 2 billion US dollars were spent on untreated C. 
trachomatis infections and their related consequences (CDC, 1997).  
 
Trachoma caused the loss of vision in approximately 1.3 million people worldwide 
in 2002 (Resnikoff et al., 2004). Trachoma is caused, initially, by the C. trachomatis 
infection of the upper, inner eyelid.  Chronic infection leads to a host inflammatory 
response that causes scarring and trichiasis, which is the inversion of the eyelid 
such that the eyelashes of the afflicted patient scratch against the cornea.  Thus, 
blindness via corneal scratching is an indirect symptom of C. trachomatis infection.  
The disease is spread through unhygienic contact, and subsequently is endemic in 
the developing world (WHO, 2001).   
 16 
 
A separate species, Chlamydophila pneumoniae (Also referred to as Chlamydia 
pneumoniae), is the causal agent of 5-6% of all bronchitis and pneumoniae cases in 
the U.S.A. (Grayston, 2000).  C. pneumoniae is a community acquired respiratory 
pathogen and infection has been linked as a contributing factor to several chronic 
diseases, including arthrosclerosis and arthritis (Campbell & C. C. Kuo, 2002).  
Moreover, a significant percentage of the population (~20% by the age of 20) may 
be seropositive for C. pneumoniae (Grayston, 2000), although pulmonary disease is 
rare without immunocompromising factors.   
 
Clearly, the pathogenic burden that has been placed on both the developed and 
developing nations of the world provide the rationale for the continued examination 
of these microorganisms, especially in the context of human infection and pathology. 
 
1.2 Phylogeny of the Chlamydiacea indicates pathogenic speciation 
 
The order, Chlamydiales, was redefined in 1999 based on 16S and 23S rRNA 
sequence comparison such that the Chlamydiacea family currently contains nine 
species which are clustered within two genera: Chlamydia trachomatis, Chlamydia 
suis, Chlamydia muridarum, Chlamydophila pneumoniae, Chlamydophila abortus, 
Chlamydophila caviae, Chlamydophila felis, Chlamydophila pecorum, and 
Chlamydophila psittaci (Everett, Bush, & Andersen, 1999).  However, this 
redefinition is still somewhat controversial and many researchers continue to use 
 17 
the original nomenclature (i.e. Chlamydia pneumoniae).  For the purposes of this 
report, all Chlamydia or Chlamydophila genera will be abbreviated for clarity.   
 
The human pathogen, C. trachomatis, has been classified by serotype, with each 
serotype grouped based on its distinct biovar.  Serotypes A-C are ocular pathogens, 
causing trachoma, while serovars D-K cause non-invasive genital infections.  The 
members of a separate group of serovars, termed the Lymphogranuloma venerum 
(LGV) strains (L1, L2, L3) (H D Caldwell, Kromhout, & Schachter, 1981; H D Caldwell 
& Schachter, 1982), are highly invasive after genital infection, and often reach the 
regional lymph nodes of infected patients (Schachter, 1978). 
 
At least one isolate from each serovar have been sequenced and annotated, 
including serovars D (DW-3) (Stephens et al., 1998), A (HAR-13) (J H Carlson, 
Porcella, G McClarty, & H D Caldwell, 2005), and L2 (424/Bu) (Thomson et al., 
2008).  Despite the wide range of tropisms, analyses comparing the genomes have 
reported remarkable synteny among the different serovars, with the coding 
sequence identity exceeding 99% in each pair-wise comparison (J H Carlson, 
Porcella, G McClarty, & H D Caldwell, 2005; Thomson et al., 2008).  Of note, the 
serotypes of the genital and LGV biovars possess intact tryptophan biosynthesis 
operons, whereas the ocular serotypes have lost this ability (J H Carlson, Porcella, G 
McClarty, & H D Caldwell, 2005; Fehlner-Gardiner et al., 2002).   
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Several strains of C. pneumoniae have also been sequenced, e.g., strains CWL029 and 
AR39 (S. Kalman et al., 1999; Read et al., 2000).  Comparison analysis revealed that 
C. pneumoniae contains 214 extra open reading frames (ORFs) that are specific from 
trachomal strains, of which 186 were hypothetical (S. Kalman et al., 1999; Read et 
al., 2000).  Moreover, comparison revealed that C. trachomatis maintains 70 ORFs 
that are not conserved in C. pneumoniae, of which the lack a tryptophan synthesis 
operon is most notable (S. Kalman et al., 1999).  Therefore, comparisons between 
the findings in C. pneumoniae can only be extrapolated to C. trachomatis, or vis-a-
versa, on a case-by-case basis.     
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Figure 1.1- Phylogenetic comparison of Chlamydiales using 16S rRNA gene sequence.  16S 
rRNA sequences were obtained from various bacteria, including members of the family Chlamydiales, 
and a tree was constructed using Geneious (Drummond et al., 2010).  The numbers above each 
branch represent substitutions per nucleotide from the most recent node. 
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1.3 Chlamydia Biology 
 
1.3.1 The Chlamydia developmental cycle is a unique, biphasic process 
 
The Chlamydiacea are Gram negative, obligate intracellular parasites with an 
absolute requirement to establish an intracellular niche for survival (Moulder, 1985; 
1991).   Chlamydiae undergo a unique biphasic developmental cycle in which the 
bacteria alternate between an extracellular, spore-like state and an intracellular, 
vegetative form (Abdelrahman & R J Belland, 2005).  The cycle begins with an 
elementary body (EB), which is a small, electron dense particle that has evolved to 
survive the extracellular environment that is encountered between infection cycles.  
Although metabolically inert, the EB comes ‘pre-packaged’ with a variety of protein 
components that are necessary for host cell invasion, including an intact type three 
secretion system (T3SS).  Attachment to the host cell occurs in two steps.  The first 
is a reversible electrostatic interaction between the bacteria and heparin sulfate 
present on the host cell surface.  The addition of exogenous heparin sulfate reverses 
this attachment (J. P. Zhang & Stephens, 1992).  A second, irreversible step of 
invasion occurs upon the interaction between the EB and a secondary receptor (R A 
Carabeo & T Hackstadt, 2001), which was later described to be host platelet derived 
growth factor receptor-B (PDGFR-B) (Elwell, Ceesay, Kim, D. Kalman, & J. N. Engel, 
2008), although it is unclear if there are others.  Immediately upon this irreversible 
binding, an effector protein, termed translocated actin recruiting phosphoprotein 
(TARP), is translocated across the host membrane via the T3SS, where it is tyrosine 
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phosphorylated (Clifton et al., 2004) by the host kinase, Abl-1 (Elwell, Ceesay, Kim, 
D. Kalman, & J. N. Engel, 2008).  Phosphorylation of the secreted effector causes the 
recruitment of actin and pedestal formation in a ARP2/3 dependent process, which 
promotes EB invasion into the host (Rey A Carabeo, Cheryl A Dooley, Scott S 
Grieshaber, & Ted Hackstadt, 2007; B. J. Lane, Mutchler, Al Khodor, Scott S 
Grieshaber, & Rey A Carabeo, 2008). Upon internalization the EB is contained within 
a vacuole, termed an inclusion, which is originally composed of host lipids/proteins, 
but is rapidly modified in a process that requires both bacterial transcription and 
translation (Scidmore, Rockey, E R Fischer, Heinzen, & T Hackstadt, 1996).  Inside 
the inclusion, the EB differentiates into the vegetative form, the reticulate body 
(RB).  This differentiation is characterized by an increase in size, loss of DNA 
compaction, and a loss of infectivity.  In the RB form, chlamydiae undergo binary 
fission as a means of replication.  
 
Under normal in vitro growth conditions, C. trachomatis begins the asynchronous re-
differentiation back into the infectious EB from 20-40 hours post-invasion (p.i.).  
Eventually, mature inclusions exit the host cell, either by protease-dependent lysis, 
or through a process called extrusion, which involves the vacuolar exit and 
septation from the host cell, leaving both entities initially intact (Hybiske & 
Stephens, 2007).  EBs released in this process may go on to cause a secondary 
infection, restarting the cycle. 
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Figure 1.2- Schematic diagram of the biphasic chlamydial developmental cycle.  Chlamydial 
development begins with the elementary body (EB), which is a metabolically inert yet infectious 
particle that is able induce its own phagocytosis via the T3S of at least one effector protein into the 
host cell cytoplasm.  Once inside the cell, the EB is contained within a phagosome and begins to 
differentiate into the replicative, metabolically active particle, termed a reticulate body (RB).  
Metabolically active chlamydiae rapidly modify the phagosomal membrane in which they are 
contained, which is termed an inclusion.  Within the inclusion RBs undergo binary fission as a means 
of replication.  After several divisions, RBs begin to re-differentiate into the infectious, EB particle.  
Eventually, the host cell ruptures, releasing the contents of the inclusion into the extracellular 
environment, where infectious particles may be able to cause a secondary infection.  Under certain 
stress conditions, Chlamydiae enter an alternative growth mode termed persistence, which is 
characterized by aberrantly enlarged RB morphology, and a lack of re-differentiation into the 
infectious EB form.  If the stress condition is rescinded Chlamydiae may be able to re-enter the acute 
developmental cycle.  For review, see (Abdelrahman & R J Belland, 2005) 
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1.3.2 The kinetics of the chlamydial developmental cycle during in vitro 
infection 
 
The duration of the chlamydial developmental cycle ranges greatly between the 
species of Chlamydiacea.  For instance, a complete infection cycle for C. pneumoniae 
can last from 72-96 hours, while C. trachomatis serovar L2 usually completes an 
infection cycle within 40-48 hours (Siewert, Rupp, Klinger, Solbach, & Gieffers, 
2005).  Even among the C. trachomatis serotypes, diversity exists in the kinetics of 
development, which is considered a paradox due to the high level of genomic 
synteny in pair-wise comparisons (>99%) (J H Carlson, Porcella, G McClarty, & H D 
Caldwell, 2005; Thomson et al., 2008).  Miyairi et al. (2006) showed that a clear 
dichotomy in the length of developmental completion within HeLa cells existed 
between the ocular and genital biovars (Miyairi, Mahdi, Scot P Ouellette, R J Belland, 
& Gerald I Byrne, 2006).  Infectious progeny were first detected between 18-24 
hours for the genitropic serovars (D, E, L2, etc), whereas infectious progeny were 
first detected between 27-36 hours for ocular serovars (A, B, C, etc.).  This delay was 
concomitant with an overall decrease in maximum IFU output at later stages in the 
infection for the ocular strains.  Even within the genital serovars, a slight difference 
in development rate existed between the serovar D and serovar E strains.  At 24 
hours p.i., serovar D exhibited a 2-log higher IFU output than serovar E.  However, 
this difference in rate of development was transient, as recoverable infectious 
progeny was nearly identical at 30 hours p.i for both serovars (Miyairi, Mahdi, Scot 
P Ouellette, R J Belland, & Gerald I Byrne, 2006).   
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Interestingly, when the oculotropic serovar A was grown in a human conjuctival 
epithelial cell line, conversion of RB to EB occurred slightly earlier.  In contrast, 
when the genitropic serovar D was grown in the same conjuctival cell line, the 
maximum recoverable IFU output was reduced from growth in HeLa.  These results 
suggest that rates of development can be slightly influenced by the choice of 
epithelial host cell (Miyairi, Mahdi, Scot P Ouellette, R J Belland, & Gerald I Byrne, 
2006).   
 
Whether these differences in devopment rates preclude the comparison of separate 
studies that use different serovars is subject to debate.  Certainly, the comparison of 
studies that have used different biovars of C. trachomatis (e.g. serovar A and D), 
should be made tenuously, as there are distinct metabolic differences between the 
two strains (such as the capability for tryptophan biosynthesis (Fehlner-Gardiner et 
al., 2002)).  However, the comparison of serovars from within a biovar (e.g. Serovars 
D and E) may be appropriate, as long as the slight differences in growth rate are 
taken into account.  In any case, the few genotypic differences between the serovars 
that mediate this variation are not well understood and are a burgeoning focus for 
the field (Gerald I Byrne, 2010).   
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1.3.3 The role of the inclusion membrane in Chlamydia biology 
 
The function of the vacuole is essential to the survival of Chlamydia.  Inclusions 
show limited interaction with the endocytic pathway (van Ooij, Apodaca, & J. Engel, 
1997; Ouellette & R A Carabeo, 2010; M A Scidmore, E R Fischer, & T Hackstadt, 
1996; 2003), and fail to fuse with phagolysosomal compartments (Eissenberg & 
Wyrick, 1981).   The inclusion membrane also functions in the inhibition of host cell 
apoptosis, through the sequestration of PKC- at the membrane, away from its pro-
apoptotic functions at the mitochondrial and nuclear locations (Tse et al., 2005).  
This protection comes at a cost, in the form of segregation from cytoplasmic 
nutrients.  How nutrients permeate the inclusion membrane is not fully understood 
(Saka & Valdivia, 2010), and is an area of intense research interest to the field.   
 
1.3.4 The role of type 3 secretion in Chlamydia biology 
 
Interestingly, electron microscopic studies have observed the continued presence of 
the T3SS needle apparatuses that protrude the inclusion membrane (Matsumoto, 
1982).  This has led to several areas of speculation, including that the T3S 
machinery may serve as a conduit into the cytoplasm (Heinzen & T Hackstadt, 1997) 
or that contact between the T3SS and the inclusion membrane may serve as a 
regulatory factor for chlamydial development (Skilton et al., 2009; D. P. Wilson, 
Whittum-Hudson, Timms, & Bavoil, 2009).  Regardless of specific speculative 
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functions, the continued presence of T3S machinery throughout infection may 
suggest it has functions in addition to its role in host cell invasion. 
 
For instance, several effector proteins with putative functions have been described.  
Some, like IncA, localize to the inclusion membrane once secreted.  Inc proteins have 
been predicted to contain a bi-lobed N-terminal domain capable of linking the 
chlamydial cell wall to the inclusion membrane, with the C-terminal tail localizing to 
the host cell cytoplasm (Bannantine, Griffiths, Viratyosin, Brown, & Rockey, 2000; 
Toh, Miura, Shirai, & Hattori, 2003).  Fifty Inc proteins have been predicted, of which 
22 have been empirically shown as secreted (Z. Li et al., 2008).  Even fewer have 
been assigned a putative function (Betts, Wolf, & Kenneth A Fields, 2009).  The first 
Inc to be characterized (Rockey, Heinzen, & T Hackstadt, 1995), IncA, seems to 
function in the homotypic fusion of multiple chlamydial inclusions within the same 
infected host cell (Suchland, Rockey, Bannantine, & Stamm, 2000).  Other Inc 
proteins have been reported to function in the recruitment of various Rabs or 
SNAREs, which may modulate the recruitment of specific vesicles to the inclusion 
membrane (Cortes, Kimberly A Rzomp, Tvinnereim, Marci A Scidmore, & Wizel, 
2007; Delevoye et al., 2008; K A Rzomp, Moorhead, & M A Scidmore, 2006).  The 
functions of many effectors are only just beginning to be understood, but it is clear 
that T3S is not just important for invasion and is instrumental to the RB life stage, as 
well as the EB.   
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1.4. The chlamydial genome  
 
The intracellular niche and developmental cycle of Chlamydiae are unique.  This is 
reflected in the chlamydial genome, which yields little homology to other eubacteria.  
In fact, 28% of proteins from serovar D are Chlamydia-specific with unknown 
function.  Like other intracellular bacteria, the protective and nutrient rich 
intracellular niche has allowed genomic reduction in Chlamydiae.  C. trachomatis, for 
example, has lost the metabolic ability to complete the TCA cycle and the de novo 
synthesis of amino acids or nucleotides.  The presence of a several porins and 
membrane transport components, combined with the lack of complete metabolic 
pathways, suggest that most of the nutrients and metabolites required for 
chlamydial growth are acquired from the host (Stephens et al., 1998).   
 
While C. trachomatis retain a full array of DNA repair proteins, it lacks any genes 
involved in competence, DNA uptake, or transformation (Stephens et al., 1998).  
That being said, lateral gene transfer can occur between different strains and 
species of different antibiotic resistance cassettes (DeMars & Weinfurter, 2008; 
Suchland, Sandoz, Jeffrey, Stamm, & Rockey, 2009), although the mechanism for this 
process is unknown and has not yet been harnessed for the manipulation of 
chlamydial genetics.  Thus members of the Chlamydiacea are not genetically 
tractable, which precludes plasmid introduction or chromosomal deletion studies. 
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1.5 Chlamydial nutrient acquisition 
 
The protective niche derived from life within a self-contained vacuole does not come 
without cost.  This barrier also separates chlamydiae from the cytosolic nutrients 
for which they are auxotrophic.   
 
1.5.1 Nucleotides 
 
For instance, C. trachomatis possesses only the ability to modify UTP into CTP via a 
functional CTP synthetase, and must acquire ATP, GTP and UTP from the host 
(Tipples & G McClarty, 1993; Wylie, J. D. Berry, & G McClarty, 1996).   For this 
purpose, C. trachomatis employs two nucleotide membrane transport systems: Npt1 
and Npt2.  Npt1 functions in the antiport of ATP into the bacteria, expelling ADP into 
the lumen of the inclusion in the process.  Npt2 is able to import all four of the 
nucleotide triphosphates in a proton-dependent manner (Tjaden et al., 1999). 
 
1.5.2 Amino Acids 
 
The different members of the Chlamydiacea have evolved different requirements for 
amino acids.  Tryptophan is of particular interest.  IFN-γ treatment of host cells 
activates indoleamine 2,3 oxygenase (IDO), which cleaves tryptophan.  C. 
pneumoniae, C. muridarum, and C. trachomatis serovars A, B, and C are susceptible to 
IFN-γ treatment because they do not possess the metabolic ability to synthesize 
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tryptophan.  On the other hand, C. trachomatis serovars D, E, K, along with the LGV 
strains, possess, at the least, a partial metabolic pathway for the synthesis of this 
amino acid, which provides a limited protection from IFN-γ mediated inhibition 
(Fehlner-Gardiner et al., 2002).    
 
However, many of the other amino acid biosynthesis pathways are missing or 
functionally incomplete in all the Chlamydiacea.  C. trachomatis possesses an array 
of proteins involved in amino acid transporter across the bacterial membrane, 
including at least 13 ABC-transport systems and 3 integral membrane proteins 
(Saka & Valdivia, 2010; Stephens et al., 1998).   The exact functions of many of these 
putative ABC-transport systems have not been determined. 
 
1.5.3 Lipids 
 
In contrast to the acquisition of nucleotides and amino acids, in which a plethora of 
transport channels and systems have evolved, the chlamydial acquisition of lipids 
occurs via vesicle interception.  Most evidence reports that Chlamydia are able to 
acquire sphingomyelin, cholesterol, and other lipids via the interception of host 
vesicles that are in transport from the golgi to the cytoplasmic membrane (R A 
Carabeo, Mead, & T Hackstadt, 2003; T Hackstadt, Rockey, Heinzen, & M A Scidmore, 
1996; T Hackstadt, M A Scidmore, & Rockey, 1995).  Others have reported that these 
nutrients can be also be acquired from transport from multivesicular bodies (W L 
Beatty, 2006; Robertson, Gu, Rowe, & Wandy L Beatty, 2009).   Recently, the 
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intrusion of entire lipid droplets into chlamydial inclusions was observed 
(Cocchiaro, Kumar, Elizabeth R Fischer, Ted Hackstadt, & Valdivia, 2008), suggesting 
yet another mechanism for the acquisition of host lipids. 
 
Although the traffic of sphingomyelin and cholesterol from the golgi to the inclusion 
membrane has been well documented (R A Carabeo, Mead, & T Hackstadt, 2003; T 
Hackstadt, Rockey, Heinzen, & M A Scidmore, 1996; T Hackstadt, M A Scidmore, & 
Rockey, 1995; Robertson, Gu, Rowe, & Wandy L Beatty, 2009), it does not appear 
that golgi-derived proteins are delivered to the lumen of the chlamydial inclusion in 
great quantity (Saka & Valdivia, 2010).  Thus, the mechanism for vesicle 
interception is still unclear. 
 
1.6 Chlamydial transcription 
 
Interestingly, microarray analyses revealed that every ORF in the C. trachomatis 
genome is transcribed (R J Belland, G Zhong, et al., 2003), and that concomitant with 
the infection cycle there is a transcriptional program that displays a temporal 
control, in which genes are expressed at various stages, and thus classified by the 
timing of their expression (R J Belland, G Zhong, et al., 2003; Maurer, Mehlitz, 
Mollenkopf, & Meyer, 2007; Nicholson, Olinger, Chong, Schoolnik, & Stephens, 
2003).  How Chlamydia regulate this temporal expression is an area of interest in 
the field.   
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Transcription in Chlamydiacea, like all bacteria, is accomplished by RNA polymerase 
(RNAP).  It is a complex typically composed of five subunits: 2’.  Additionally, 
bacterial transcription factors (designated, ) regulate specific transcription via 
recognition of certain -35 and -10 elements upstream of particular ORFs allowing 
efficient recruitment of the core enzyme.  In E. coli, 70 is the main sigma factor, and 
is responsible for promoting transcription of general house-keeping genes.  
Alternative -factors generally dictate various transcriptional shifts from normal 
growth in response to environmental cues.   
 
C. trachomatis possesses the typical components of the bacterial RNAP core enzyme, 
except for the -subunit (Stephens et al., 1998), whose function has not yet been 
elucidated in any prokaryote. Three sigma factors have been identified in Chlamydia 
(28, 54, and 66), of which 66 has been labeled as a 70 family member via 
structure homology (J. E. Koehler, Burgess, Thompson, & Stephens, 1990).  However, 
bioinformatic analyses have revealed that promoter regions recognized by 66 are 
relatively unconserved compared to those recognized by 70 in E. coli (Grech, 
Maetschke, Mathews, & Timms, 2007; Grech, Mathews, & Timms, 2008).   
 
The function of the two alternative sigma factors is less understood.  28 has been 
shown to be heat-responsive (L. Shen, M. Li, & Y. X. Zhang, 2004), and to modulate 
the expression of hctB, a late-gene coding for a histone-like protein that has been 
hypothesized to be, in part, responsible for the RB to EB conversion (H. H. Yu & Tan, 
2003).  Even less is known about the function of 54.  The only sequence prediction 
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study to date produced just two putative promoter-binding sites, whose transcript 
expressions are indistinguishable from other mid-cycle genes (Mathews & Timms, 
2000).   Although insights into the function of these sigma factors are only just now 
becoming a reality, it is increasingly unlikely that they, by themselves, are 
responsible for the temporal transcript control that was revealed by microarray 
analysis.  Other hypotheses for this temporal control include the general 
supercoiling of DNA (Niehus, E. Cheng, & Tan, 2008) and the regulated expression of 
histone-like proteins (N. A. Grieshaber, S S Grieshaber, et al., 2006; N. A. Grieshaber, 
J. B. Sager, et al., 2006).  Both mechanisms presumably involve the modulation of 
accessibility of certain promoter elements upon changes in global DNA compaction.    
 
1.7 Chlamydial persistence 
 
Under certain stress conditions in vitro, Chlamydiae can enter an alternative growth 
mode, termed persistence, which was defined as a “viable but non-cultivatable state 
of growth” (W L Beatty, Morrison, & Byrne, 1994).  Persistent chlamydiae exhibit 
several unique phenotypic characteristics, including the accumulation of aberrantly 
enlarged RBs that fail to re-differentiate back into infectious EBs, resulting in a loss 
of recoverable infectious progeny.  However, this unique growth state is reversible, 
as the removal of the mediating stress allows the re-entry into the normal 
developmental cycle (W L Beatty, Morrison, & Byrne, 1994; R. J. Hogan, Mathews, 
Mukhopadhyay, Summersgill, & Timms, 2004; Wyrick, 2010).   
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To date, the characterized in vitro mediators of persistence in Chlamydiacea include 
IFN-γ treatment (W L Beatty, Byrne, & Morrison, 1993), -lactam antibiotic 
treatment (Kramer & Gordon, 1971; Lambden, Pickett, & Clarke, 2006; Matsumoto & 
Manire, 1970), amino acid limitation (Coles, Reynolds, Harper, Devitt, & Pearce, 
1993), growth within monocytes (L. Koehler et al., 1997), co-infection with certain 
viruses such as Herpes Simplex Virus (Vanover et al., 2008) and porcine epidemic 
diarrhea virus (Borel et al., 2010), culture with exogenous adenosine (Pettengill, 
Lam, & Ojcius, 2009), glucose deficiency (Harper, Pogson, M. L. Jones, & Pearce, 
2000; Iliffe-Lee & G McClarty, 2000), and iron-deprivation (J E Raulston, 1997).  The 
molecular mechanisms that contribute to the onset of the persistent phenotype are 
still unclear.  
 
It is thought that recurrent infection plays a role in the development of serious 
sequelae of C. trachomatis infection (Grayston, 2000; Grayston, S. P. Wang, Yeh, & C. 
C. Kuo, 1985; Hillis, Owens, Marchbanksa, Amsterdamd, & Mac Kenzie, 1997; Rihl, 
Köhler, Klos, & Zeidler, 2006) and confusingly, the same term, persistence, has been 
used to describe this in vivo chronic infection (Wyrick, 2010).   Early clinical reports 
indicated that seemingly spontaneous re-infection could occur in patients that had 
been culture-negative for weeks (W L Beatty, Morrison, & Byrne, 1994; R. J. Hogan, 
Mathews, Mukhopadhyay, Summersgill, & Timms, 2004).  Although in vivo 
persistence refers to chronic infection and not necessarily the presence of aberrant 
chlamydial phenotype, mounting evidence supports that the phenotypic 
characteristics of in vitro persistence do play a role in chronic infection, at least in 
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part.    For instance, chlamydial DNA and RNA were detected from culture-negative 
patients (Holland et al., 1992).  Moreover, aberrant RB morphology has been 
observed in animal models and human patients (Bragina, Gomberg, & Dmitriev, 
2001; Patton et al., 1994; Pospischil, Borel, Chowdhury, & Guscetti, 2009; Skowasch 
et al., 2003).  The in vitro models that have been shown to elicit a persistent 
chlamydial response could all be encountered in vivo.  Considering the link between 
chronic infection and disease sequelae (Grayston, 2000; Grayston, S. P. Wang, Yeh, & 
C. C. Kuo, 1985; Hillis, Owens, Marchbanksa, Amsterdamd, & Mac Kenzie, 1997; Rihl, 
Köhler, Klos, & Zeidler, 2006), clearly research into the in vitro phenotype is 
warranted. 
 
1.8 The transcriptional response to persistent growth conditions 
 
A number of studies have examined the transcriptional response of Chlamydia 
during induction of persistence by various means (Belland, Nelson, et al., 2003; Dill, 
Dessus-Babus, & J E Raulston, 2009; Goellner et al., 2006; Klos, Thalmann, J. Peters, 
Gerard, & Hudson, 2009; Maurer, Mehlitz, Mollenkopf, & Meyer, 2007; Nicholson, 
Olinger, Chong, Schoolnik, & R S Stephens, 2003; Ouellette et al., 2006; P Timms et 
al., 2009).  One consistent observation is the down-regulation of late-stage gene 
products (Belland, Nelson, et al., 2003; Maurer, Mehlitz, Mollenkopf, & Meyer, 2007; 
Nicholson, Olinger, Chong, Schoolnik, & R S Stephens, 2003).  In particular, the 
expression of omcB, (which codes for a cysteine rich outer-membrane protein), has 
been correlated to the RB to EB re-differentiation.  Whether this protein plays a 
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mechanistic role in the maintenance of the aberrant phenotype is unclear, however 
its transcriptional repression during late stages of infection has been observed in 
response to several models of persistence (Belland, Nelson, et al., 2003; Iliffe-Lee & 
McClarty, 2000; Ouellette et al., 2006; P Timms et al., 2009).  Similarly, the 
expression of euo has been linked to the persistent phenotype under multiple 
models of persistence (Belland, Nelson, et al., 2003; Ouellette et al., 2006; P Timms 
et al., 2009).  Because the euo gene codes for a DNA-binding protein thought to 
repress the transcription of late-stage genes (L. Zhang, Douglas, & Thomas P. Hatch, 
1998), its transcriptional elevation during the late stages of persistent infection was 
suggested as a candidate mechanism for the phenotypic conversion observed under 
persistence (Belland, Nelson, et al., 2003).   
 
Despite the presence of general persistence indicating genes such as euo and omcB, 
persistent phenotypes are not all the same.  Several direct comparison studies have 
suggested that the different stimuli of in vitro persistence elicit distinct stimulons 
that are tailored toward the particular stresses placed upon the chlamydiae 
(Goellner et al., 2006; A Klos, J Thalmann, J Peters, Gerard, & Hudson, 2009; P Timms 
et al., 2009).   Specific examples of some differentially expressed transcripts and 
products can be found in Table 1.1.  For example, the transcription profiles of ahpC 
and tyrP1 in C. pneumoniae depend on the persistence-mediating factor (Timms et 
al., 2009).  Under IFN-γ treatment, the transcription of a gene encoding a 
transporter of aromatic amino acids (tyrP1) was increased; under iron-limitation, its 
expression was unchanged from untreated.  In contrast, the transcription of a gene 
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whose function is predicted to function in oxidative stress response (ahpC) was 
elevated under iron-restriction, but not IFN-γ treatment.  This result illustrates the 
facultative ability of Chlamydia under different stress conditions. 
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Table 1.1- Differential expression in Chlamydiacea upon DFO-based treatment 
aDifferential expression that was different than observed upon IFN-γ treatment is shown in boldface 
 
 
 
Citation Organism Protein/Transcript Elevated Repressed Unchanged 
 
Timms et al. 
(2009) 
 
C.pneum. 
(A-03) 
 
qPCR of transcript; 
Iron-restriction, IFN-γ 
 
clpP1 
htrA 
euo 
birA 
ahpC 
clpB 
gspD 
 
 
lcrH1 
hctB 
omcB 
 
tyrP1 
(elevated in 
IFN-γ) 
Klos et al. 
(2009) 
C.pneum. 
(CWL-029) 
 
qPCR of transcript; 
Iron-restriction, IFN-γ 
rpsD groEL-2 
ftsW 
rpoD 
rpoN 
groEL-1 
groEL-3 
 
Dill et al. 
(2009) 
C.trachomatis  
Ser E (UW-
5CX) 
2D differential SDS-PAGE, 
qPCR of transcript 
(designates regulated at 
both protein and transcript 
level) 
(AhpC) 
(CADD) 
(Ct538) 
(DevB) 
(FabF) 
Def 
RopA 
RpoA 
NusA 
NusG 
 
 omcB 
euo 
ompA 
Mauer et al. 
(2007) 
C.pneum.  
(CWL-029) 
 
Microarray analysis of 
transcript level (verified by 
RT-qPCR) 
ahpC  
(gyrB2) 
(secA1) 
(htrA) 
 
(rpsD) 
(lcrH1) 
(hctA) 
(hctB) 
(omcB) 
 
tyrP1 
Goellner et al. 
(2007) 
C. psittaci  
(DC15) 
qPCR of transcript;  
Iron-restriction, IFN-γ, 
Penicillin 
incA 
euo 
omcB 
omcA 
hctA 
ftsW 
rpsD 
rpoN 
 
Cadd 
Mukhopadhyay 
et al. (2006) 
C.pneum.  
(A-03) 
2D differential SDS-PAGE 
Iron-restriction, IFN-γ 
BirA 
OmpA 
AhpC 
 
TrxA 
TrxB 
OmcB 
Wehrl et al.  
(2004) 
  
C.pneum.  
(CWL-029) 
2D differential SDS-PAGE BioA ParB 
TrxA 
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1.9 The importance of iron 
 
Iron is an essential nutrient for nearly all organisms, as it is utilized as an electron 
intermediate, cofactor, or prosthetic group in a number of conserved biochemical 
cellular processes.  Its biological importance is attributed to its role as a transition 
metal, possessing the ability to accept and donate single electrons as it alternates 
between the ferric (Fe3+) and ferrous (Fe2+) oxidative states.  One ubiquitous 
example of the importance of iron in biological systems is its use in the electron 
transport chain.  The stepwise harvest of energy created through the sequential 
oxidation and reduction of the iron molecules incorporated within the different 
cytochrome molecules is used to generate a proton gradient that is necessary for 
efficient ATP generation.  The ability to undergo these one-electron redox reactions 
makes iron almost irreplaceable in biological systems.   
 
However, under aerobic conditions the predominant species of iron is the Fe3+ state, 
which is not readily soluble under normal pH in aqueous solution (S. C. Andrews, 
Robinson, & Rodríguez-Quiñones, 2003).  Therefore, it is not surprising that both 
prokaryotes and eukaryotes have evolved complex mechanisms for the efficient 
acquisition of iron.  Moreover, the restriction of available iron is one of the first 
innate immune responses of vertebrates, such that pathogenic microorganisms 
must outcompete the hosts in which they reside for the vital biometal (Skaar, 2010).   
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1.10 Iron traffic in humans 
 
In order to understand how C. trachomatis competes with its host for this vital 
micronutrient, it is important to first understand how the host itself acquires iron.  
In humans and all other mammals, ferric iron, obtained through diet, must be 
reduced before transport across the intestinal epithelium.  This process is 
dependent on a cytochrome b-like ferrireductase (Dcytb) for the reduction to the 
ferrous state (McKie et al., 2001), and on Divalent Metal Transporter-1 (DMT-1) for 
transport of the divalent cation into the cytoplasm of the epithelial cell (Fleming et 
al., 1998; Fleming et al., 1997).  DMT-1 was shown to transport several different 
divalent cations, including Mn2+ and Zn2+, in a proton-coupled symport mechanism 
(H. Gunshin et al., 1997).   Export across the basolateral membrane of the intestinal 
epithelium is accomplished via ferroportin-1 (Donovan et al., 2000).  Two 
ferroxidases, ceruloplasmin and hephaestin, are responsible for the re-oxidation of 
ferrous iron to the ferric form (Hellman & Gitlin, 2002; Osaki, Johnson, & Frieden, 
1966; Vulpe et al., 1999).  This re-oxidation is important for binding by the serum 
carrier protein, transferrin (Tf).  Tf is a high affinity Fe3+ binding protein, with an 
association constant of approximately 1036 for the trivalent metal at a near neutral 
pH (Ratledge & Dover, 2000).  Between 20-25% of serum transferrin is saturated 
with iron at any given time, which drives a near immediate sequestration of ferric 
iron in plasma (Crichton & Ward, 1998; Ratledge & Dover, 2000).  Conformational 
changes occur upon the diferric saturation of transferrin, which, at neutral pH, 
allows the specific recognition of the diferric-holotransferrin (dfTf) over apo-
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transferrin at the cell surface by transferrin receptors (TfR) (Y. Cheng, Zak, Aisen, S. 
C. Harrison, & Walz, 2004).    Once bound, these dfTf-TfR complexes localize to 
clathrin-coated pits and are endocytosed (Harding, Heuser, & Stahl, 1983).  In the 
early endosome, proton pumps cause the decrease of vesicular pH, destabilizing the 
iron-transferrin complex.  While the apo-transferrin-TfR complex is not stable at a 
neutral pH, at an acidic pH, this complex remains in tact and is recycled back to the 
plasma membrane, where the return to neutral pH causes the dissociation of the 
apo-Tf, starting the cycle anew (A Dautry-Varsat, Ciechanover, & Lodish, 1983).  The 
ferric iron released in the early endosome must be reduced before its transport into 
the cytosol by DMT-1 (Fleming et al., 1998).  This reduction is accomplished by 
another membrane bound ferrireductase, STEAP3 (Ohgami et al., 2005). 
 
Once in the cytosol, iron is either immediately incorporated into iron utilizing 
proteins (termed the labile iron pool) or stored by the ferritin complex.  Ferritin 
storage complexes exist as multimers, which are composed of two subunits, 
designated the heavy (H) and light (L) chains.  These subunits surround an iron core 
that may contain up to 4500 iron atoms (P. M. Harrison & Arosio, 1996; Hentze, 
Muckenthaler, & N. C. Andrews, 2004).  The H-subunit possesses ferroxidase activity 
and can convert the Fe2+ molecules into the Fe3+ form (Lawson et al., 1989).  Little is 
known about how iron is released from ferritin complexes, although it is readily 
assumed that complex degradation functions in this process (Hentze, Muckenthaler, 
& N. C. Andrews, 2004).   A diagram of cellular iron-acquisition via the 
transferrinsystem is shown in Figure 1.2. 
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Figure 1.3- The eukaryotic transferrin system for ferric iron-acquisition.  The majority of iron 
brought into a mammalian cell originates from the transferrin / transferrin receptor system.  In this 
system, the iron-binding protein transferrin is secreted into the extracellular environment, where it 
is binds two molecules of ferric iron.  Once in the (diferric) holo-enzyme form, the compound is 
recognized by transferrin receptors, which are expressed at the surface of the plasma membrane.  
Diferric-transferrin-transferrin receptor complexes are endocytosed in a clathrin-pit dependent 
manner.  Upon decrease of pH within the endosome, the diferric iron is no longer stably bound by 
transferrin and the molecules are released into the lumen of the endosome.  The apo-transferrin-
transferrin receptor complex is recycled to the plasma membrane.  Ferric iron must be reduced in the 
endosome by STEAP3, which allows its transport into the cytosol via DMT1.  Ferrous iron entering 
the cytoplasm is incorporated into the labile iron pool (loosely bound iron incorporated as co-factors, 
etc), or is stored within the ferritin complexes (Pantopoulos, 2004). 
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1.11 Iron acquisition in pathogenic organisms 
 
Early estimates indicated that most microorganisms require a concentration of iron 
ranging from 4x10-7 to 4x10-6 M (E D Weinberg, 1974; 1978).   However, the 
concentration of available iron within the human body ranges from 10-19 to 10-18 M. 
(S. C. Andrews, Robinson, & Rodríguez-Quiñones, 2003). Considering this 
tremendous discrepancy between what is available and what is required, it is clear 
that all pathogenic microorganisms must outcompete the hosts in which they reside 
for this important biometal (Skaar, 2010).  The lone exception is Borrelia 
burgdorferi, which has evolutionarily eliminated its need for iron (Posey & 
Gherardini, 2000).   Besides Borrelia, other bacteria have evolved a diverse array of 
mechanisms to accomplish this feat that will be discussed in the following sections.  
  
1.11.1 Siderophores 
 
Siderophores are secreted, iron binding molecules, with tremendous affinity for 
ferric iron.  Greater than 500 different siderophores have been identified (Ratledge 
& Dover, 2000), which is a testament to the evolutionary selection of those bacteria 
that are efficient in the acquisition of iron.  The association constant for 
siderophores to ferric iron can exceed 1050 M, allowing the molecule to remove iron 
from loaded holotransferrin (Ratledge & Dover, 2000).  Some of the genera with 
characterized siderophore iron transport systems include Yersinia, Pseudomonas, 
Burkholderia, E. coli, Salmonella, Klebsiella, Shigella, Vibrio, and Mycobacteria 
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(Ratledge & Dover, 2000).  Receptors that recognize the holosiderophore molecule 
function to immobilize the iron-laden molecules to the outer membrane, and in a 
TonB dependent manner, translocate the metal-chelate into the periplasm.   
 
One of the best-characterized siderophore import systems is FhuA in E. coli.  FhuA 
was originally named TonA, and was identified (along with TonB) as being 
necessary for sensitivity to the T1 bacteriophage in E. coli (Ton = T one phage 
susceptibility).  Later, it was determined to be a receptor for the ferrichrome 
hydroxamate (Hantke & Braun, 1975) and renamed FhuA, for its role in ferric 
hydroxamate uptake (Braun, 2009).    The crystal structure of FhuA revealed that 
the C-terminus of the protein forms a β-barrel membrane pore of the outer 
membrane, while the N-terminus forms a structure that fills the pore from the 
periplasmic side.  Interestingly, the B-sheets that form the barrel are linked 
extracellularly through extended loop structures.  The authors proposed a 
mechanism in which these loops bind and facilitate the deposition of the 
ferrichrome hydroxamate into the external pocket of the C-terminal Β-barrel 
channel, at which point activated TonB transverses the periplasm to bind FhuA, 
causing a conformational change which uncorks the channel and translocates the 
ferrisiderophore into the periplasm (A. D. Ferguson, 1998).   
 
Once in the periplasm, ferrichrome hydroxamate is transported to the cytosol via a 
conserved subclass of proteins, the ABC-type metal-chelate transport complexes.  
These complexes function to transport metal-chelates across the inner membrane, 
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using the hydrolysis of ATP to drive the process (ABC= ATP-binding-cassette).  In E. 
coli, the ABC transporter for ferrichrome hydroxamate has been aptly labeled 
FhuB/C/D, in which fhuD codes for a periplasmic solute binding protein, fhuC codes 
for an ATPase, and fhuB codes for the transmembrane channel protein.  Once in the 
cytosol, ferric reductases must convert the Fe3+ molecule bound by the siderophore 
to Fe2+, in order to remove the atom from the compound (Ratledge & Dover, 2000).   
 
One exquisite example of this process is the IrtAB system in M. smegmatis.  
Interestingly, the IrtAB complex maintains dual functions: 1) the transport of the 
ferri-siderophore across the inner-membrane, and 2) the recruitment of a 
ferrireductase, FAD, to a cytoplasmic binding domain within IrtA.  This recruitment 
allows the efficient reduction of the ferric molecule into the ferrous state, allowing 
its release from the siderophore, which is then recycled (Ryndak, S. Wang, I. Smith, 
& Rodriguez, 2010).     
 
1.11.2 Expression of receptors for host iron-proteins 
 
Alternatively, some pathogens express receptors that recognize host iron-carrying 
proteins, such as heme or transferrin/lactoferrin.  The best-characterized example 
of this strategy is employed by the Neisseriaceae in which transferrin binding 
proteins, TbpAB, functions to recognize and immobilize host holo-Tf at the 
outermembrane, at which point TbpA, an OM porin of similar function to FhuA, 
transports the iron from the transferrin molecule into the periplasm (Pintor, Gómez, 
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Ferrón, Ferreirós, & Criado, 1998) in a TonB-dependent process (Ratledge & Dover, 
2000).  Ferric iron reaching the periplasm is transported into the cytosol via the Fbp 
transport system, which is a member of the ABC transporter system superfamily for 
metal ions (Adhikari et al., 1996). 
 
1.11.3 ABC metal transporters 
 
The ABC-type metal transport systems were first discovered in Gram-negative 
bacteria.  These systems are composed of multiple proteins, including periplasmic 
solute (metal) binding protein, at least one membrane spanning permease, and at 
least one ATP-binding cassette (ABC), which are usually transcribed together in a 
polycistronic operon (Claverys, 2001).  One well characterized ABC-type metal 
transport system is encoded by the troABCDR operon of Treponema pallidum.  In 
this system TroA is a Zn2+/Mn2+ binding protein, TroB is the system ATPase, TroC/D 
are membrane permeases, and TroR is a metal-dependent transcriptional regulator 
(Hazlett et al., 2003); TroR is discussed in more detail in section 1.13.2.   
 
The crystal structure of TroA revealed that upon binding of Zn2+ within the metal 
binding site, significant conformational changes were observed (Y.-H. Lee et al., 
2002).  The authors discussed a mechanism in the membrane permeases (TroCD) 
could distinguish between the apo- and Zn-TroA; subsequent binding could then 
lead to additional conformational shifts that resulted in the release the zinc, 
allowing its ATP-driven transport across the membrane (Y.-H. Lee et al., 2002).  
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Other systems, such as the SitABCD of Salmonella and the YfeABCD of Yersinia pestis 
have been shown to transport molecular iron (Bearden, Staggs, & Perry, 1998; D. 
Zhou, Hardt, & Galán, 1999). 
 
Of note, although both siderophore and host iron-molecule adsorption are TonB 
dependent, that does not mean that metal transport is TonB dependent.  Studies 
have shown that molecules of approximately less than 600 daltons are permeable to 
the outermembrane of gram-negative bacteria (Nakae & Nikaido, 1975; Nikaido & 
Vaara, 1985).  Thus, transition metals and other ions should be permeable to the 
outermembrane.  In pathogenic situations, the limiting factor for iron acquisition is 
the rate of diffusion in the host, as iron is extremely rare.  However, if a pathogenic 
microbe maintained a TonB-independent mechanism for concentrating metal ions 
within its periplasm, iron-uptake via ABC-metal transporters, like the Tro or Yfe 
systems, could function to import iron.  Thus, iron-acquisition would not be TonB 
dependent in such a scenario.  This distinction is important, as no Ton-B homologue 
has been identified in C. trachomatis, to date.       
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1.12 Dangers of excess iron 
 
The redox capability that is essential for carrying out certain biochemical reactions 
in the cell can also be an unwanted aspect of elemental iron, as free ferrous iron 
molecules can catalyze the formation of toxic hydroxyl free-radicals.  In this process, 
the Haber-Weiss reaction (equation 1), which is thermodynamically unfavourable in 
biological systems, is catalyzed by Fenton chemistry (equation 2) for the efficient 
generation of hydroxyl free radicals in a biological system (equation 3) (Kehrer, 
2000).    
 
Free radicals can damage DNA (Mellofilho & Meneghini, 1984), protein (Dean, Fu, 
Stocker, & Davies, 1997), and lipids (Kehrer, 2000) of the cell, making it imperative 
that organisms control iron homeostasis.  Both prokaryotes and eukaryotes have 
evolved complex transcriptional and post-transcriptional regulation systems for the 
tight control of the acquisition and storage of this vital, but potentially dangerous, 
biometal.   
 
(1) O2 −+H2O2 → O2+OH−+OH  
 
(2) Fe3++O2 − → Fe2++O2 
 
(3) Fe2++H2O2 → Fe3++OH−+OH  
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1.13 Eukaryotic iron-dependent regulation 
 
Eukaryotes have evolved an exquisite post-transcriptional mechanism to regulate 
iron-homeostasis, which is illustrated in Figure 1.4.  In this process, two related 
proteins, termed iron responsive proteins (IRPs), become activated upon iron-
limiting conditions and are able to recognize and bind certain mRNA molecules 
containing specific secondary structures within their untranslated regions; these 
structures are aptly named, iron responsive elements (IREs).  If the IRE is present 
within the 5’ untranslated region (UTR) of the transcript, IRP binding blocks the 
pre-initiation complex of the ribosome, decreasing the translation of the mRNA.  In 
contrast, if the IRE is present within the 3’ UTR of the transcript, IRP binding 
prevents degradation from RNases.  The multiple locales of these IREs allow the cell 
to both repress and induce certain transcripts under iron-starvation.  For example, 
the mRNA transcript of ferritin heavy chain contains a single IRE within the 5’ UTR, 
while the mRNA transcript of transferrin receptor contains multiple IREs in the 3’ 
UTR.  Under conditions of low iron, active IRPs would bind the 5’ IRE of ferritin 
heavy chain mRNA and block translation, while at the same time bind and stabilize 
the mRNA transcript of transferrin receptor (Pantopoulos, 2004).   
 
The IRE-binding capability of IRP1/2 is activated in the absence of iron.  
Interestingly, IRP-1 is a bifunctional protein, becoming an active aconitase in the 
presence of iron, in contrast to its role as an mRNA stability regulator in the apo-
form (Haile et al., 1992).  IRP-2 is similar to IRP-1, except that it contains an extra 
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cysteine rich domain.  This domain may bind iron under metal-replete conditions, 
which in turn causes the oxidation of certain cysteine residues.  This oxidation 
actually allows the recognition of the protein by an ubiquitin-ligase, which targets 
the protein for proteosomal degradation (Narahari, Ma, M. Wang, & Walden, 2000).  
 
 
 
Figure 1.4- A schematic diagram of the eukaryotic IRP/IRE system for regulation of mRNA 
stability.  Under iron-replete conditions, IRPs bind iron and become inactivated for DNA binding.   
Under low-iron availability, IRP binds to 5’ IREs (top) or 3’ IREs (bottom) within the untranslated 
regions of mRNA molecules.  If bound at the 5’ UTR, IRPs prevent Ribosome (purple) initiation of 
translation; in contrast, if bound at the 3’ UTR, IRPs prevent RNase  (grey) degradation.  Thus, 
transcripts with 5’ IREs, such as of ferritin-H and -L chains are not accessible to ribosomes.  The loss 
of ribosome translation results in a net loss of mRNA stability, when compared to the polyribosylated 
mRNA that occurs under iron-replete conditions.  Transcripts containing 3’ IREs, such as of 
transferrin or dmt1, are protected from RNases upon IRP binding.  This protection does not occur in 
iron-replete conditions and the net result is a loss of mRNA stability.   
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1.14 Prokaryotic iron-dependent repressors 
 
In prokaryotes, iron homeostasis is usually regulated by one of two major families of 
iron-dependent transcriptional regulators: the Ferric uptake regulator (Fur) family 
or the Diphtheria toxin regulator (DtxR) family (Hantke, 2001; Ratledge & Dover, 
2000).  Members of both families are DNA binding proteins that are instrumental in 
the transcriptional regulation of genes coding for proteins involved in the 
acquisition and storage of iron.   
 
1.14.1 The Ferric uptake regulator superfamily 
 
The Fur superfamily of transcriptional regulators is represented in a variety of 
Gram-negative genera, including Escherichia, Salmonella, Yersinia, Vibrio, and 
Pseudomonas, and even some Gram-positive genera, including Bacillus and 
Staphylococcus (Hantke, 2001; Ratledge & Dover, 2000).  Fur was initially 
discovered via the isolation of a Salmonella mutant that constitutively expressed 
iron uptake and transport systems (Ernst, Bennett, & Rothfield, 1978).  A similar 
mutant was identified in E. coli (Hantke, 1982).  The gene responsible for the 
mutation was sequenced, resulting in the identification of a 17 kDa protein that was 
responsible for the repression of iron-uptake systems under iron-replete conditions 
(Schäffer, Hantke, & Braun, 1985).  Biochemical analysis revealed that in the 
presence of ferrous iron, manganese, or cobalt, the Fur protein inhibited the 
expression of a lacZ reporter gene under the control of the operating sequence from 
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a siderophore synthesis operon (Bagg & Neilands, 1987).  DNase footprint analysis 
of three E. coli iron-dependent gene promoter sequences (fhuA, fepA, and fucA) 
revealed that Fur recognized and bound a consensus 19-bp sequence when Fe2+, 
Mn2+, Cu2+, Co2+, Cd2+ and Zn2+ were included in the protection assay.  This sequence 
was defined as 5’-  GATAATGATAATCATTATC  -3’ (de Lorenzo, Wee, Herrero, & 
Neilands, 1987), and was later termed the Fur Box.  This sequence is relatively 
conserved, although minor variations have been reported in some organisms such 
as B. subtilis and Y. pestis.  FurBS recognized an inverted motif in a 7-1-7 orientation: 
5’- TGAtAATnATTaTCA -3’ (Baichoo, T. Wang, Ye, & Helmann, 2002).  Alternatively 
FurYP recognized the sequence 5’- AATGATAATnAATGATAAT -3’ (Gao et al., 2008).   
Thus the canonical Fur box has undergone several revisions, with the current 
accepted model that is based on the 7-1-7 inverted repeat described in B. subtilis 
(Baichoo, T. Wang, Ye, & Helmann, 2002).  In this model, the 19 bp sequence that 
was initially protected in the seminal DNase footprinting assay, originates from the 
binding of two dimers of Fur that occupied opposite sides of a DNA molecule 
containing two overlapping 7-1-7 inverted repeat sequences (Baichoo, T. Wang, Ye, 
& Helmann, 2002; J.-W. Lee & Helmann, 2007).   
 
The first Fur protein crystallized was a homologue from P. aeruginosa.  A winged 
helix DNA binding domain was observed in the N-terminus of the protein, while the 
dimerization and regulatory domains were found in the C-terminus.  The authors 
found that each monomer of Fur contained two metal binding sites.  Site 1 was 
designated the Fe2+ binding domain, while site 2 was deemed a structural Zn2+ 
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binding domain (Pohl et al., 2003).    Later, the crystal structure of FurEC provided 
actual evidence that metal binding in this regulatory domain caused the 
reorganization of helical domains in the N-terminus, presumably to allow DNA 
binding (Pecqueur et al., 2006).   
 
It is important to note that the Fur superfamily encompasses many related 
transcriptional regulators that influence the uptake and storage of several different 
metals, including zinc, manganese, and nickel.  Moreover, other homologues that 
sense and elicit regulons based on peroxide and heme levels have also been 
identified (J.-W. Lee & Helmann, 2007).  Thus specific biochemical analysis of 
activating metals must accompany every new genomic annotation for any validity of 
a metal dependent transcriptional regulator. 
 
1.14.2 Diphtheria toxin repressor superfamily 
 
The expression of the toxin produced by Corynebacterium diphtheria was reported 
to be elevated upon growth in low iron environments (Pappenheimer, 1977).  Initial 
analysis of the toxin promoter region suggested that it might be recognized and 
repressed by Fur (Tai & Holmes, 1988), however it was eventually revealed that a 
novel protein, named Diphtheria toxin repressor (DtxR), was responsible for the 
iron-dependent regulation of the toxin (Fourel, Phalipon, & Kaczorek, 1989).  
Homologues of DtxR have now been identified in a variety of bacteria, usually of 
high GC content, although this is not always the case (Hantke, 2001). Besides 
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Corynebacterium, DtxR homologues have also been identified in E. coli, S. 
typhimurium, Streptomyces, Mycobacteria (IdeR), Bacillus subtilis (MntR), 
Streptococcus (ScaR), Treponema pallidum (TroR).  In B. subtilis and T. pallidum, 
DtxR homologues regulate manganese homeostasis, instead of iron.   
 
Like Fur, metal binding within the dimerization domain of DtxR caused 
conformational changes that allow DNA binding (J. A. D'Aquino, Lattimer, 
Denninger, K. E. D'Aquino, & Ringe, 2007).  DtxR protected a 30 bp region that 
partially overlapped the promoter region of the C. diphtheria tox gene.  Similar to the 
Fur Box, the protected region contains dyad symmetry.  However, Fur does not 
recognize the tox operator sequence, nor does DtxR recognize the Fur Box (Schmitt, 
Twiddy, & Holmes, 1992).  A consensus binding sequence for DtxRCD was identified 
as 5’ TWAGGTWAGSCTWACCTWA 3’ using a selective enrichment approach.  This is 
a 9 bp palindrome, which is separated by a single guanosine or cytosine base (Tao & 
J. R. Murphy, 1994).  This sequence differed from the protected DNA sequence of 
TroR, which was 5’  TACTTTGATGCATCAAAATTCA  3’, which is only 44% similar to 
the DtxRCD consensus sequence (Posey, Hardham, Norris, & Gherardini, 1999).  As a 
side note, DtxR and some its homologues contain an extra SH3-like domain at the C-
terminus; the function of this domain is not yet known (X. Qiu, Pohl, Holmes, & Hol, 
1996). 
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1.15 Iron is an essential nutrient for Chlamydia 
 
To date, Borrelia burgdorferi is the only organisms without an absolute need for 
iron.  In this organism iron within the essential conserved enzymes and compounds, 
such as ribonucleotide reductase and cytochrome molecules, iron has been replaced 
by alternative, less efficient transition metals (Posey & Gherardini, 2000).    This 
evolutionary trade between optimal enzyme function and independence from the 
rare biometal has occurred only once in nature, to date.   In contrast, Chlamydiacea 
clearly require iron as an essential nutrient.  Chlamydial ribonucleotide reductase, 
which is required by all organisms for the generation of nucleotides utilizes a 
unique manganese (IV) / iron (III) metal core to generate an enzymatic free-radical 
that drives substrate reduction (Jiang et al., 2007).  Moreover, Raulston et al. (1997) 
demonstrated that C. trachomatis entered the persistent growth state in response to 
long-term treatment with the iron-chelator, deferoxamine mesylate (DFO) and 
cycloheximide (Raulston, 1997).  Later, Al-Younes et al. (2001) showed that this 
induction of persistence was not specific to C. trachomatis, and that by using the 
same treatment protocol, C. pneumoniae was also susceptible to iron-limitation (Al-
Younes, Rudel, Brinkmann, Szczepek, & Meyer, 2001).  Together, these publications 
concluded that when exposed to iron-limiting conditions, the Chlamydiae elicited a 
persistent response, which was characterized by a loss of infectious progeny, and 
formation of aberrant RB morphology.  
 
 
 55 
1.16 Insights into Chlamydia iron biology from its genome annotation 
 
Despite the initial observations that iron was an essential nutrient for Chlamydia, 
how these intracellular pathogens acquired iron from inside a parasitiphorous 
vacuole remained a mystery.  C. trachomatis does not possess any homologues for 
known siderophore biosynthesis pathways or receptors for host iron-proteins, such 
as transferrin or hemoglobin; this is not surprising considering the intracellular 
niche of the bacteria.  Moreover, genes encoding a homologue of TonB have not been 
identified (Stephens et al., 1998).  Because TonB is essential for the transport of 
ferrisiderophores across the outer membrane, its absence in Chlamydia suggests 
that an alternative mechanism for acquisition has evolved.     
 
1.16.1 Putative chlamydial ABC-metal transporters 
 
C. trachomatis does possess a number of ABC- transport systems, of which two have 
been annotated as potential metal transport systems, named Ytg and Yeb systems 
for their closest known homologues at the time (Stephens et al., 1998).  Both of the 
homologous systems (in B. subtilis and E. coli, respectively) have been renamed 
since the chlamydial annotation, based on the metal substrate specificities, which 
have now been determined.  Ytg was renamed the Mnt system in B. subtilis, based on 
its function in Mn2+ transport (Gat et al., 2005; Que & Helmann, 2000).  The Yeb 
system in E. coli was renamed the Znu system, based on its function in Zn2+ 
transport (Patzer & Hantke, 1998).  Yet, because the metal-substrates of these 
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putative transport complexes have not been empirically determined in Chlamydia, 
their names have remained Ytg and Yeb.  
 
The Ytg system in C. trachomatis was predicted to encode a periplasmic metal 
binding protein (YtgA), an ATPase (YtgB), and two membrane-spanning domains 
(YtgC/D) (Stephens et al., 1998).  While it was named based on homology to the 
(later named) Mnt system in B. subtilis, it also closely resembles the well-
characterized Tro operon from T. pallidum.  Both the Mnt and Tro systems have 
been shown to transport Mn2+, although the Tro system may also be able to 
transport Zn2+ (Gat et al., 2005; Hazlett et al., 2003; Que & Helmann, 2000).  
Interestingly, YtgA was shown to be antigenic in human and non-human primates 
(Bannantine & Rockey, 1999; Raulston et al., 2007).  However, none of this 
information linked Ytg to iron-transport until the observation that YtgA expression 
was elevated at the protein level under long-term treatment with DFO and 
cycloheximide (Dill, Dessus-Babus, & Raulston, 2009; Raulston et al., 2007).  This 
result implied that there may have been an iron-dependent regulatory mechanism 
for its expression, although when the regulation was analyzed at the transcript level, 
it was not observed to be differentially expressed (Dill, Dessus-Babus, & Raulston, 
2009).  More recently, a biochemical analysis revealed that YtgA preferentially 
bound radioactive Fe3+ over Mn2+ or Zn2+, in vitro (J. D. Miller, Sal, Schell, 
Whittimore, & Raulston, 2009).   Whether or not Mn2+ or Zn2+ could be bound, even 
at low affinity, was not tested.  Therefore, while YtgA was shown to be iron-
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responsive at the protein level, and had exhibited a competitive preference for Fe3+, 
its role in iron transport had not been shown empirically.   
 
The second predicted ABC-metal transport system was given the name, YebLMI, 
based on homology to an operon in E. coli (Stephens et al., 1998) that was later 
renamed Znu.  The Znu system transports zinc into the bacteria, and is under the 
regulatory control of the Zur protein (Patzer & Hantke, 2000), which is a Zn-
dependent transcriptional repressor belonging to the Fur superfamily.  There is no 
current evidence to suggest that Yeb system functions in iron-transport.  However, 
as many of these transport systems support the traffic of multiple metal ions, the 
possibility should not be excluded. 
 
1.16.2 Putative metal-dependent transcriptional regulators in C. trachomatis 
 
Therefore, while it is clear that Chlamydiae require iron, the mechanism of its 
acquisition or the presence of metal-dependent transcriptional regulation remains 
unknown.  After the original annotation of the genome, it appeared that no Fur 
homologue was present in C. trachomatis.  However, a Fur homologue was 
eventually identified via structural homology and antigenic cross-reaction with 
antisera, raised against FurEC protein (Wyllie & Raulston, 2001).  The gene product, 
termed divalent cation repressor A (DcrA) was able to functionally complement an 
E. coli Fur mutant in the repression of an engineered lacZ reporter gene under 
control of the fhuA promoter, which is iron responsive (de Lorenzo, Wee, Herrero, & 
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Neilands, 1987).  The authors also showed that purified DcrA formed a stable 
homodimer that was apparently able to resist sodium dodecyl sulfate (SDS) 
treatment.  In vitro, DcrA was able to shift the migration of a probed oligonucleotide 
containing a Fur box in the presence of Mn2+ and Zn2+, but not Cu2+ or Ca2+.  Oddly, 
the addition of iron to the purified DcrA caused precipitation of the protein and was 
not able to be examined in the same manner (Wyllie & Raulston, 2001); therefore, 
whether DcrA activity is regulated by iron remains unknown.  A later study from the 
same group identified a handful of potential binding sites within the chlamydial 
genome using a heterologous Fur titration assay, in which genomic chlamydial 
sequences were tested for their ability to titrate FurEC away from the repression of a 
fhuF::lacZ fusion gene (fhuF is repressed by Fur under iron-replete conditions).  This 
approach led to the identification of 25 chlamydial ORFs with upstream intergenic 
regions that titrated FurEC repression away from the reporter gene.  While using 
FurEC to identify C. trachomatis DcrA binding sites is not ideal approach, the authors 
did at least verify that two of the target binding sequences were actually bound by 
DcrA, in vitro.  These two ORFs were mreB and glgP, which code for a shape-
determining protein and a glycan phosphorylase, respectively (Rau, Wyllie, 
Whittimore, & Raulston, 2005).  Whether these genes are differentially expressed 
under iron-limiting conditions has not been tested. 
 
As mentioned previously, C. trachomatis encodes a putative metal transport system 
that is homologous to the Tro system in T. pallidum.  The Tro system encodes its 
own DtxR-like transcriptional regulator at the end of the operon, TroR.  
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Interestingly, in Chlamydia, the DtxR/TroR homologue is not found at the end of the 
operon, but rather as a C-terminal fusion with the 3rd component of the operon, 
ytgC.  Because YtgC is predicted to be membrane bound, it was unclear if the TroR 
homologue (henceforth referred to as C-YtgC) was able to function in the same 
capacity as other members of the DtxR family of metal-dependent transcriptional 
regulators.  If C-YtgC did function as a DNA binding protein in Chlamydia, an in vivo 
cleavage or processing event would have to occur to liberate the C-terminal peptide 
away from the membrane portion of the protein and enact transcriptional 
modulation.   
 
1.17 Iron-restriction as an alternative approach for the identification of iron-
responsive regulation in Chlamydiae 
 
The bioinformatical approach in the identification of putative iron-transport and 
regulatory systems relies on homology to other systems in other bacteria.  Because 
the Chlamydiacea are so far removed evolutionarily from other bacteria, this 
approach is limited.  For instance, the sequence coding for a Fur-like transcriptional 
regulator was not originally annotated in the genome (Stephens et al., 1998), and 
was only found through a data mining project in which the researchers identified 
five putative homologues through predicted secondary structure, cloned and 
expressed those five homologues, and tested them empirically for Fur-
complementation (Wyllie & Raulston, 2001).  An alternative approach that relies 
less on bioinformatics and species homology, would be to artificially starve 
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Chlamydiae for iron, using synthetic iron-chelating agents, with the rationale being 
that genes responsive under iron-starvation conditions could have evolved such 
regulatory mechanisms due to an involvement in the maintenance of iron 
homeostasis.  This has been the more common approach for the study of chlamydial 
iron biology and will be discussed in the next sections. 
 
1.17.1 Iron-restriction studies of C. trachomatis 
 
In the first examination of attempted iron-restriction of C. trachomatis, Raulston 
(1997) used a cocktail of Deferoxamine mesylate (DFO), a high affinity ferric iron-
chelating agent, and cycloheximide, a host protein synthesis inhibitor, to elicit a 
persistence-like response from the bacteria (Raulston, 1997).  Instead of measuring 
infectious titers of Chlamydia, the percentage of particles that were infectious was 
reported.  Through extrapolation, recoverable IFU was estimated to be 40% of the 
untreated output (listed in Table 1.2); in other words, 40% of chlamydiae, upon this 
treatment, were not modulated into the persistent phenotype and, instead, 
displayed normal behavior and completed the developmental cycle in 24 hours.  
This slight inhibitory effect was reversible upon the replacement of iron-restrictive 
medium with complete medium containing holo-transferrin.  Thus, it was concluded 
that iron-restriction mediated the persistent phenotype.  Additional electron 
microscopy observations revealed that most inclusions contained an increased 
number of RBs compared to untreated samples, suggesting a lack of re-
differentiation into the infectious EB form.  Lastly, differential 2D SDS-PAGE of the 
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EBs purified from treated and untreated infected cell cultures identified 19 proteins 
that were elevated upon treatment.  One protein was identified antigenically as 
Hsp60 (Raulston, 1997).  Later, this protein was shown to be the isoform, cHsp60-2 
(LaRue, Dill, Giles, Whittimore, & Raulston, 2007), which codes a protein involved in 
the refolding of denatured proteins under heat shock.   
 
The obvious caveat to this study was the addition of cycloheximide to the iron-
restriction protocol.  Presumably, the addition of cycloheximide prevented IRP 
mediated elevation of iron acquisition proteins, such as transferrin receptor, in the 
host cell in response to restricted iron-availability.  However, it has been well 
established that Chlamydia alter the host protein synthesis and trafficking patterns 
to obtain nutrients (Carabeo, Mead, & T Hackstadt, 2003; Cocchiaro, Kumar, Fischer, 
Ted Hackstadt, & Valdivia, 2008; T Hackstadt, M A Scidmore, & Rockey, 1995; K A 
Rzomp, Scholtes, Briggs, Whittaker, & M A Scidmore, 2003; Wolf & T Hackstadt, 
2001).  Due to the additional non-iron related effects of cycloheximide treatment on 
the host, it was difficult to attribute the abnormal chlamydial growth that was 
observed solely to iron-starvation.  Obviously, such a treatment is not ideal, and it 
must be inferred that the addition of cycloheximide to DFO treatment was essential 
for the observation of persistent phenotype.  
 
Later, Al Younes et al. (2001) examined both C. trachomatis L2 and C. pneumoniae 
for response to DFO treatment (Al-Younes, Rudel, Brinkmann, Szczepek, & Meyer, 
2001).  In this study, cell cultures were pre-treated with DFO for 15 hours before 
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chlamydial invasion, and then treated throughout the course of infection.  Using this 
model, both C. trachomatis and C. pneumoniae were inhibited in the output of 
recoverable inclusion forming units (IFU).  However, C. pneumoniae was 
tremendously more sensitive to DFO treatment than C. trachomatis (Al-Younes, 
Rudel, Brinkmann, Szczepek, & Meyer, 2001).  Presumably, this difference lies in the 
relative slow-growing and fastidious nature of C. pneumoniae compared to C. 
trachomatis.  The exclusion of cycloheximide treatment in this study allowed for a 
more confident conclusion that iron removal by DFO was responsible for the 
abnormal growth of Chlamydia.  
 
The only other publication regarding the iron-starvation of C. trachomatis, was 
published in 2007, in which Dill et al. reported a differential 2D proteomic study of 
C. trachomatis RBs (Dill, Dessus-Babus, & Raulston, 2009), using the DFO 
pretreatment model developed by Al-Younes (Al-Younes, Rudel, Brinkmann, 
Szczepek, & Meyer, 2001).  This approach led to the definitive identification by mass 
spectrometry of 10 differentially expressed proteins.  Despite the authors’ 
speculation, none seem to have an obvious link to iron biology, except for maybe 
AhpC, which codes for an alkyl hydroperoxide reductase that, in other bacteria, 
functions to combat peroxide free-radical generation.  In many bacteria, the 
oxidative and iron responses are linked, as excess iron can generate free radicals.  
However, in this case, the decrease in iron had caused the elevation of a protein that 
putatively combats free-radical damage, which is counter-intuitive.  Nevertheless, 
the observation of AhpC elevation has been verified at the transcript level in C. 
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pneumoniae under conditions of iron-restriction (Timms et al., 2009).  Dill et al. 
revealed that five of the ten identified iron-responsive proteins were also 
transiently elevated at the transcriptional level, ahpC, devB, fabF, ct538, and cadd.  
However, in each case, the maximum differential expression was ~2-fold or less.  
Importantly, the persistence indicating genes, euo and omcB, were not modulated 
under their iron-starvation protocol, suggesting that C. trachomatis had not entered 
the persistent state, or that a significant portion of the treated population remained 
in an active, acute developmental cycle that may have masked differential 
expression of these genes.    
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1.17.2 Iron restriction studies in C. pneumoniae 
 
In contrast to iron-restriction of C. trachomatis, the iron-restriction of C. pneumoniae 
has been better studied.  A few of these studies have tested multiple models of 
chlamydial persistence for differential responses at the protein (Mukhopadhyay et 
al., 2006; Wehrl, Meyer, Jungblut, Muller, & Szczepek, 2004) and transcript level 
(Klos, Thalmann, J. Peters, Gerard, & Hudson, 2009; Timms et al., 2009).  In each of 
these studies, the authors have concluded that there are distinct regulons based on 
the mediating model of persistence, and that the persistent phenotype is not a 
general response.  One microarray analysis of iron-restricted C. pneumoniae has 
been performed (Maurer, Mehlitz, Mollenkopf, & Meyer, 2007)  in which the authors 
claimed that there was a mid and late-cycle gene transcript arrest upon iron-
restriction.  Whether or not the results of this study can be extrapolated to C. 
trachomatis is unclear.  Al-Younes et al. (2001) showed that C. pneumoniae is much 
more susceptible to DFO treatment than C. trachomatis (Al-Younes, Rudel, 
Brinkmann, Szczepek, & Meyer, 2001); this is presumably due to its notoriously 
fastidious nature of growth.  Moreover, while the genomes of C. pneumoniae and C.  
trachomatis are relatively similar, it is unclear to what extent regulatory 
mechanisms would be conserved.  For instance the transcriptional activator, ChxR, 
was identified in C. trachomatis (Koo, Walthers, Hefty, Kenney, & Stephens, 2006), 
yet no paralogue has been identified in C. pneumoniae to date. 
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Clearly, distinct differences are observed between the two species, including 
tryptophan synthesis, growth rate, host tropism, optimal temperature, genome 
content and (apparently) sensitivity to DFO treatment.  For these reasons, it is 
difficult to extrapolate information about C. trachomatis iron-response based on C. 
pneumoniae data.  Based on the paucity of data regarding C. trachomatis response to 
iron-limitation versus C. pneumoniae, we hypothesized that perhaps the DFO model 
for iron-restriction of C. trachomatis was not sufficient.  The rationale for this 
hypothesis will be discussed in the following sections. 
 
1.18 The Current Model for Iron-limitation Induced Persistence in Chlamydia 
 
The ability to starve an intracellular pathogen for iron is not trivial.  The in vitro 
growth of immortalized epithelial cell lines, such as HeLa or HEp2 that are 
commonly used as hosts for Chlamydia in vitro, require the growth factors usually 
supplied by bovine serum.  However, a major component of serum is transferrin, 
both holo- and apo-forms.  Therefore, in order to grow infected cell cultures in iron-
free optimal medium, one would need to fractionate the serum to remove traces of 
iron.  This process is tedious and sub-optimal.  The next option is to sequester the 
iron from culture using high affinity iron-chelators.  This has been the primary 
strategy used to remove iron from growing cultures, both eukaryotic and 
prokaryotic.  However, the simple addition of iron-chelating agents may not affect 
the intracellular pathogen.  The intracellular niche is one that is usually buffered 
from extracellular changes.  In other words, in order to starve Chlamydia for iron, 
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one must starve the host cell first.  There has been a variety of iron-chelation 
protocols used in the attempt to starve Chlamydia for iron, a summary of which is 
provided in Table 1.2.   
 
DFO has been the only iron chelator characterized against species of Chlamydiae.  
However, of the several ‘iron-restriction’ protocols used, nearly all have utilized 
auxiliary steps to achieve a more robust iron-starvation phenotype, including 
combination with cycloheximide (Al-Younes, Rudel, Brinkmann, Szczepek, & Meyer, 
2001; Dill, Dessus-Babus, & Raulston, 2009; Dill & Raulston, 2007; Raulston, 1997), 
pre-treatment of the host cell for 15-24 hours prior to infection (Al-Younes, Rudel, 
Brinkmann, Szczepek, & Meyer, 2001; Dill, Dessus-Babus, & Raulston, 2009; 
Mukhopadhyay et al., 2006; Timms et al., 2009), the use of cytotoxic concentrations 
(i.e. greater than 100 µM (Al-Younes, Rudel, Brinkmann, Szczepek, & Meyer, 2001)) 
for short time periods (LaRue, Dill, Giles, Whittimore, & Raulston, 2007; J. D. Miller, 
Sal, Schell, Whittimore, & Raulston, 2009; Rau, Wyllie, Whittimore, & Raulston, 
2005), and the daily replacement of DFO-supplemented media (J. Peters et al., 
2005). 
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Table 1.2- Iron-restriction models of Chlamydiacea 
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The lack of a straightforward protocol has lead to numerous caveats in data 
interpretation.  For instance, it is well known that Chlamydiae modulate host cell 
expression in order to gain access to necessary lipids (R A Carabeo, Mead, & T 
Hackstadt, 2003; T Hackstadt, Rockey, Heinzen, & M A Scidmore, 1996; M A 
Scidmore, Rockey, E R Fischer, et al., 1996), and general inhibition of protein 
synthesis, through the use of cycloheximide, is an unnecessary complication when 
considering analysis of the chlamydial transcriptional response to supposed iron-
restriction because of its potential effects on other host cell processes required by 
Chlamydia.   
 
In line with this rationale, an article was published in 2007 describing a failed 
attempt to inhibit Chlamydia by allowing them to infect a stably transfected cell line 
that over-expressed ferroportin, an efflux membrane iron transporter (Dill & 
Raulston, 2007); the cell line simply couldn’t export enough free iron into the 
extracellular environment to reduce chlamydial viability and block development.   It 
was clear from this report that the system was not sufficiently robust (Dill & 
Raulston, 2007), and highlighted the need for a new iron-restriction model for C. 
trachomatis infection.   
 
There are several reasons why DFO may not be an optimal iron-limitation model for 
C. trachomatis.  The first is that DFO is a hydrophilic compound that is unable to 
effectively cross the lipid bilayer (Cable & Lloyd, 1999; Glickstein, El, Shvartsman, & 
Cabantchik, 2005; Lloyd, Cable, & Rice-Evans, 1991; Persson, Z. Yu, Tirosh, Eaton, & 
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Brunk, 2003).  DFO is a high affinity ligand of ferric iron (Fe3+), with an association 
constant of 1030.  However, the association constant for ferrous binding is much 
lower, approximately 107 (Martell & R. M. Smith, 1977).  Even if DFO was slowly 
permeable to the host cell lipid bilayer, as has been suggested (Al-Younes, Rudel, 
Brinkmann, Szczepek, & Meyer, 2001; Cabantchik, Moody, Haupt, & Gordeuk, 1999), 
the predominant form of cytosolic iron (i.e. the labile iron pool) is ferrous.  Thus in 
the context of iron-deprivation of an intracellular pathogen, DFO can only prevent 
ferric iron uptake, through sequestration in the extracellular media.  Whether the 
chlamydial iron source is ferric or ferrous (or both) has not been determined.  
Therefore, the use of a ferric-specific membrane impermeable compound may have 
not been the most effective method for chlamydial iron-deprivation.   
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1.19 Specific Aims  
 
The overall goal of this project was the elucidation of molecular mechanisms of iron-
dependent transcriptional regulation in C. trachomatis, with the hope that the 
insight gained may lead to the mechanism for which C. trachomatis acquires iron 
within the host cell.  Below are the aims defined at the onset of the project.  At 
certain points, an alternate strategy was employed than listed here; these decisions 
are discussed where appropriate throughout the text. 
 
Aim I- To characterize the transcriptional response of C. trachomatis to growth 
under iron-limiting conditions 
 Sub-aim 1.1- to evaluate the effects of several iron chelating agents on 
growth and development of C. trachomatis in comparison to the published 
results regarding DFO, in order to elucidate a robust, efficient iron restriction 
model 
 Sub-aim 1.2- to analyze the transcription of C. trachomatis grown under iron-
limiting conditions via RT-qPCR of select transcripts AND the use of a novel 
microarray  
 Sub-aim 1.3- to identify the common cis-acting factors, if any, of verified iron-
responsive transcripts in C. trachomatis using a bioinformatical approach 
 
Aim II- To determine the role of the putative iron-dependent transcriptional 
regulators, DcrA and C-YtgC, on C. trachomatis transcription 
 71 
 Sub-aim 2.1- to clone, express, and purify recombinant DcrA and C-YtgC 
 Sub-aim 2.2- to determine the expected, theoretical consensus binding 
sequence of both proteins using a systematic evolution of ligands by 
exponential enrichment (SELEX) process 
 Sub-aim 2.3- to identify the putative DNA regulatory binding sites within the 
chlamydial genome and verify protein to DNA interaction in vitro 
 Sub-aim 2.4- to compare the expression of identified transcripts in vivo under 
iron-limiting and iron-replete conditions 
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Chapter 2- Methods 
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2.1 Bacterial Strains 
 
Chlamydia trachomatis UW-3/CX (serovar D) was originally obtained from Dr. Ted 
Hacksadt (Rocky Mountain Laboratory, NIAID), and was chosen as a model 
organism for the genitropic C. trachomatis serovars.  Past reports indicated minimal 
differences in development rates between C. trachomatis Serovar D, Serovar L2 and 
Serovar E (Miyairi, Mahdi, Scot P Ouellette, R J Belland, & Gerald I Byrne, 2006).  
Aliquots were stored at -80 C in Sucrose Phosphate Glucose (SPG) buffer, and were 
propagated as described (H D Caldwell, Kromhout, & Schachter, 1981).  Salmonella 
typhimurium SL1344 pipB2 pPipB2-2HA was a gift from Dr. Leigh Knodler (Rocky 
Mountain Laboratory, NIAID) (Leigh A Knodler et al., 2003).  Chemically competent 
Escherichia coli strains Top10 and BL21* were purchased from Invitrogen.   
 
2.2 Cell Culture and Infection 
 
HEp2 were chosen as an appropriate epithelial host cell line for intracellular 
bacterial infections, as it had been used routinely for study of intracellular 
Chlamydiae (S P Ouellette & Carabeo, 2010; S P Ouellette et al., 2006).  Original 
stocks were obtained from ATCC.  HEp2 cells were propagated in Iscove’s Modified 
Dulbecco’s Medium (IMDM), supplemented with 10% FBS, 20 mM L-glutamine 
(Gibco), and 10 µg/ml Gentamicin (Gibco), and grown at 37˚C, 5% CO2. HEp2 cells 
were subcultured routinely by removing media, washing with PBS, and adding 2-3 
ml 0.25% Trypsin-EDTA until cells detached, adding fresh media, and diluting 1:10 
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to 1:3 in a new flask.  HEp2 cells were used for experiments only between the 4th 
and 25th passage. 
 
2.2.1 C. trachomatis infection 
 
HEp2 cells were plated at density of 80-95% confluency the day prior to infection in 
a 6-well plate.  For infection, media was decanted before the monolayer was washed 
twice with PBS, and then incubated with 1 ml of 45 µg/ml DEAE-Dextran in HBSS at 
37˚C for 10-20 minutes.  Solution was decanted prior to the monolayer being 
washed with PBS, and then inoculated with cold HBSS containing C. trachomatis 
(serovar D).  Plates were spun in a Beckman table-top centrifuge at 1500 rpm for 12 
minutes at 4˚C, then incubated at 37˚C for 20-30 minutes, allowing infectious 
particles to invade.  Inoculum was aspirated and monolayers washed twice with PBS 
prior to addition of pre-warmed media ± experimental supplements.  The 
multiplicity of infection was approximately 0.5 infection forming unit per plated cell.     
 
2.2.1.1 Iron-restriction models 
 
Deferoxamine mesylate (Sigma, CAS: 138-14-7) was diluted to a stock concentration of 
50 mM in ddH2O, filter sterilized and stored at 4 ˚C for no more than two months.  
Salicylaldehyde isonicontinoyl hydrazone (SIH) was a gift from Dr. Prem Ponka 
(McGuill University, Montreal, Quebec Canada) and was stored in a stock solution of 
100 mM in DMSO at -20˚ C.  2,2’-Bipyridyl (Sigma, CAS: 366-18-7) was diluted in 
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ethanol to a stock concentration of 100 mM, aliquoted and stored at -80˚C.  Iron-
chelating agents were diluted into the pre-warmed intended for infected cell culture 
approximately 5-10 minutes before its use.  Concentrations are indicated for each 
experiment.   
 
2.2.1.2 Metal-titration experiments 
 
FeCl3 (Sigma; CAS: 7705-08-0), FeSO4 (Sigma; CAS:7782-63-0 , GaNO3 (Sigma; CAS: 
69365-72-6) were dissolved in water immediately prior to supplementation in media ± 
iron-chelating agents.  Supplemented media was incubated for 20 minutes prior to use in 
culture.   
 
2.2.2 Salmonella typhimurium infection 
 
Luria-Bertani (LB) broth cultures of S. typhumurium SL1344 pipB2 pPipB2-2HA 
containing 30 µg/ml chloramphenicol were incubated overnight at 37 C, 200 rpm.  
0.3 ml of overnight culture was sub-cultured into 10 ml antibiotic free LB broth and 
incubated at 37 C, 200 rpm until an OD600=0.75 (approximately 4 hours).  1 ml of 
sub-culture was transferred into a 1.5 ml eppendorf tube and centrifuged at 8000 
rpm for 5 minutes.  Supernatant was aspirated and replaced with 1 ml of HBSS.  
Media was decanted from HEp2 monolayers before they washed with PBS twice.  30 
µl of Salmonella solution were added directly to each monolayer, before incubation 
at 37˚C for 10 minutes.  Inoculum was then washed away with PBS three times 
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before the addition of IMDM containing 50 µg/ml Gentamicin was added for 1 hour 
to eliminate extracellular bacteria.  Infected monolayers were washed with PBS one 
time before addition of cIMDM containing 10 µg/ml gentamicin ± iron-chelating 
agents. 
 
2.3 Immunofluorescent analysis (IFA) of intracellular Chlamydia trachomatis 
 
Samples grown on square glass coverslips in wells of a 6-well tissue culture plate 
were fixed and permeabilized with approximately 1 ml of methanol, rocking at room 
temperature for 6 minutes.  After washing with PBS, samples were stained with 1 ml 
of convalescent human sera (1:750 in PBS) and then 1 ml of Alexa-594 conjugated 
goat anti human antibody (1:1000 in PBS).   Coverslips were washed with water 
before mounted on glass slides with MOWIOL solution.  Images were captured using 
the Leica SP2 Upright confocal microscope (CF1).   
 
2.4 Recoverable IFU 
 
Infected monolayers were washed before the addition of 1 ml SPG buffer.  Samples 
were then dislodged using a sterile cell scraper and entire 1 ml solution was 
transferred to a 1.5 ml eppendorf tube containing 3 sterile glass beads.  Tubes were 
vortexed for 45 seconds before storage at -80 C.  
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For quantification, fresh monolayers of HEp2 cells were plated to confluency in 
wells of a 24-well plate.  Samples were serially diluted and appropriate dilutions 
were used to infect monolayers (250 µl), in triplicate.  After 1 day of incubation, 
infected monolayers were fixed, permeabilized, and immunofluorescently stained as 
described in section 2.3.  Mature inclusions were counted in five fields of each well 
using an Axiovert-100 inverted fluorescent microscope (Zeiss, Germany).  Infectious 
titer was calculated based on the number of inclusion forming units (IFU) per ml of 
inoculum added.   
 
2.5 Cytotoxicity Assay 
 
HEp2 cells were plated to 80% confluency and cultured in complete IMDM ± SIH 
(100 µM), DFO (50 µM), or DFO (50 µM) + CH (0.5 µg/ml).  After 24 hours of 
treatment, monolayers were disrupted into solution.  Cells were stained with 
Trypan Blue and the numbers of live and dead (blue) cells were counted on a 
hemocytometer.   
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2.6 Type Three Secretion Assay in Salmonella typhimurium 
 
S. typhimurium SL1344 pipB2 pPipB2-2HA was used to infect HEp2 cells as 
described in section 2.2.2.  At 10 hpi, monolayers were fixed with 4% 
paraformaldehyde, rocking at 4˚C O/N.  Fixed samples were permeabilized with 500 
µl of 0.1% Triton-X 100 in PBS, rocking for 6 minutes.  Localization of the tagged 
effector, PipB2-2HA, was determined by immunostain with mouse anti-HA epitope 
antibody (1:1000 in PBS), and then with Alexa-594 conjugated goat anti-mouse 
antibody (1:1000 in PBS).  Images were captured using the Zeiss Imager M1 
fluorescence microscope with Zeiss AxioVision software. 
 
2.7 Nucleic Acid Extraction and preparation 
 
2.7.1 Total genomic DNA extraction from Chlamydia-infected HEp2 cells 
 
Samples were dislodged from the well-bottom using 0.5 ml of 0.25% Trypsin-EDTA 
for 5 minutes.  After quenching trypsin with 0.5 ml of cIMDM, suspension was 
transferred to a 1.5 ml eppendorf and centrifuged for 8 minutes at 8000 rpm at 
room temperature.  Supernatant was aspirated and replaced with 200 µl of PBS.  
Samples were stored at -80˚C.   
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Genomic DNA isolation was performed using the DNeasy Blood and Tissue Kit 
(QIAGEN) using instructions of the manufacturer.  Samples were eluted in a volume 
of 100 µl TE buffer.   
 
2.7.2 RNA extraction 
 
Samples were washed with PBS, before addition of 1 ml Trizol Reagent (Invitrogen), 
and incubated at room temperature for 2-3 minutes.  Solution was pipetted up and 
down several times using P1000 until no longer viscous.  Extraction was then 
transferred to a 1.5 ml eppendorf tube, and allowed to incubate for another 5 
minutes.  Each extraction received 0.2 ml chloroform and was shaken vigorously for 
15 seconds.  After two minutes, samples were centrifuged at 16000 rpm at 4˚C.  450 
µl of the aqueous (top, clear) layer was carefully removed from each extraction, and 
transferred into an eppendorf containing 500 µl isopropanol.  Samples were stored 
at -80˚C for less than 2 weeks.   
 
2.7.3 DNase treatment of RNA samples 
 
DNA-contaminated RNA samples from Trizol extractions were thawed on ice and 
then centrifuged at 16000 rpm for 15 minutes at 4˚C.  Isopropanol supernatant was 
removed carefully before 500 µl of ice-cold 80% EtOH was added to each pellet.  
Pellets were pulse vortexed before centrifugation at 16000 rpm for 10 minutes at 
4˚C.  80% EtOH was carefully aspirated.  Pellets were dried for 5 minutes at room 
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temperature.  RNA was resuspended in 20 µl of 10 mM Tris-HCl pH=7.5.  15 µl of the 
suspension was DNased using the TURBO DNase Kit (Applied Biosystems) according 
to the instructions of the manufacturer. 
 
2.7.4 cDNA synthesis from DNase-free RNA 
 
Concentrations of DNase-treated RNA were quantified using a ND-1000 nano-drop 
spectrophotometer (Labtech).  Superscript III cDNA synthesis kit (Invitrogen) was 
used to generate cDNA from 2 µg of this RNA, according to the protocol of the 
manufacturer.  cDNA samples were diluted to a final volume of 160 µl in Tris-HCl 
pH=7.5 and stored at -80˚C until RT-qPCR quantification. 
 
2.8 Real Time-qPCR 
 
2.8.1 Reaction set-up 
 
RT-qPCR was carried out in a 96 well optical plate using Applied Biosystems 7300 
Real time PCR System.  Primers were designed using Applied Biosystems Primer 
Express 3.0 Software and were tested for specific product generation prior to 
experimental use.  Primers are listed in Table 2.1 below.  Each sample was tested in 
triplicate using: 5 µl cDNA sample, 25 µl 2X SYBR Green master mix (Applied 
Biosystems), 0.45 pmol each primer (.09 µl volume), and 19.8 µl of RNase/DNase 
free water (Applied Biosystems).  No Reverse transcription (RT) and no template 
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controls were performed regularly.  A summary list of primers used for qPCR is 
given in Table 2.1 
 
Table 2.1 Primers used for qPCR in this study 
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2.8.2 RT-qPCR Normalization 
 
For relative quantification studies (eukaryotic only) target genes were compared to 
endogenous GAPDH controls using the Pfaffl (2Ct) method (Pfaffl, 2001). For 
absolute quantification studies, C. trachomatis genomic DNA purified from EBs was 
diluted serially and used as a standard curve for each run.  cDNA quantities were 
normalized by the corresponding C. trachomatis genome quantity obtained from 
parallel samples for each time-point.  Thus each transcript expression is 
represented as cDNA copies per copy of the C. trachomatis genome. 
 
2.9 DNA manipulation 
 
A summary of all plasmids created and primers used in this study is provided in 
Tables 2.2 and 2.3, respectively.  For all PCR reactions, forward and reverse 
primers were used in a final concentration of 50 µM.  Template ranged from 1-10 ng 
per reaction.  For PCR amplifications of DNA sequences intended for use in cloning, 
Pfx master mix (Invitrogen) was utilized.  For diagnostic PCR, Taq PCR mastermix 
(Invitrogen) was utilized.   
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2.9.1 Generation of pET151-FurEC, pET151-DcrA, and pET151-C-YtgC 
 
Full-length ORFs of DcrA (C. trachomatis) and Fur (E. coli K12) were amplified using 
primer pairs 1-2 and 3-4, respectively, in which an engineered “CACC” sequence was 
added the 5’ terminus.  The coding sequence corresponding to the TroR-like peptide 
within YtgC was amplified using primer pair 5-6, which introduced the “CACC” 
sequence and an artificial start codon at the 5’ terminus.  The primer sets did not 
amplify the stop codons from their respective templates.   
 
These PCR products were ligated into the pET151-D/TOPO vector (Invitrogen), 
which uses the homologous recombination of the CACC sequence to directionally 
insert the PCR product into the vector.  The resultant expression of these vectors 
yielded proteins that were N-terminally tagged with a 6x histidine epitope.   
 
2.9.2 Generation of fragments used in the dot blot assays 
 
PCR products were amplified using Taq mastermix (Invitrogen) as described in the 
following sub-sections.  DNA amplicons were purified using EtOH precipitation, in 
which entire PCR reactions were added to a solution containing 0.1X volumes of 
Sodium Acetate (pH=5.2; Applied Biosystems) and 3 volumes of 96% EtOH and 
stored at -20 ˚C overnight.  DNA was sedimented the next day via 25 minutes of 
centrifugation at 14000 rpm in a tabletop microcentrifuge.   Supernatant was 
aspirated and pellet washed with 70% EtOH, followed by another 15 minute 
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centrifugation step at 14000 rpm.  Supernatant was aspirated carefully and pellets 
were dried in a chemical hood.  Pellets were resuspended in 20-50 µl of nuclease 
free water.  
 
2.9.2.1 Fur Box and Random Oligonucleotide 
 
Single stranded oligonucleotides corresponding to sequences 7 and 8 were ordered 
from Invitrogen.  These sequences contained known forward and reverse flanking 
regions, of which primers were designed against 9 and 10, respectively.  Single 
stranded oligonucleotides 7 and 8 were used as template in a PCR reaction 
containing primer 10 and a 5’ biotinylated version of sequence 9 to amplify double 
stranded oligonucleotides that contained either a random sequence, or the 
canonical Fur Box sequence, flanked by known regions.   
 
2.9.2.2 Chlamydial intergenic region oligonucleotides 
 
The full-length IGRs upstream of ytgA and tyrP1 were amplified using primer sets 
11-12 and 16-17, of which 11 and 17 were conjugated to a biotin molecule at the 5’ 
terminus.  The ytgA Promoter oligonucleotide was amplified using primer set 12-15, 
of which primer 12 was biotinylated.  The ytgA 5’ UTR Long fragment was amplified 
with primer set 11-14, and the ytgA 5’ UTR Short fragment was amplified using 
primer set 11-13; in both cases primer 11 was biotinylated.   
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2.9.3 Generation of pCCT101 Reporter plasmid constructs 
 
2.9.3.1 Generation of pCCT100 
 
A nucleotide region of 2100 bp containing a tetracycline resistance cassette (TetR) 
and a p15A origin of replication sequence was amplified from pACYC184 using 
primer set 18-19, which incorporated a BglII and XhoI restriction endonuclease 
sites on the 5’ and 3’ flanks, respectively.  A nucleotide region of 4878 bp was 
amplified from the pBAD-TOPO/LacZ/V5-His control expression vector using 
primer set 20-21 which incorporated XhoI and BglII restriction endonuclease sites 
at the 5’ and 3’ flanks, respectively; this amplified sequence containing an araC gene, 
an arabinose inducible promoter (PBAD), a sequence coding for β-galactosidase 
tagged C-terminally with V5 and polyhistidine epitopes, and rrnB T1 and T2 
transcriptional termination sites.  The two PCR products were double digested with 
XhoI and BglII, prior to resolution on 0.7% TAE agarose gel, gel purification.  
Digested products were circularized using T4 ligase treatment overnight at 16˚C.  
Ligation reaction was used to directly transform chemically competent Top10 E. coli 
(Invitrogen), which were plated on LB agar plates containing 15 µg/ml tetracycline.  
Resultant colonies were verified for the presence of the full expression vector using 
diagnostic PCR, followed by sequencing verification (GATC; Germany).   
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2.9.3.2 Site-directed insertion of the KpnI restriction endonuclease site to 
pCCT100 
 
The DNA sequence in between the arabinose inducible promoter (PBAD) and the 
vector ribosome binding site (RBS) for expression of the LacZ-V5-pHis peptide was 
selected for site-directed mutagenesis.  pCCT100 was methylated, and used as 
template in an inverse PCR using the primer set 22-23, of which primer 23 
contained the mutagenesis nucleotides for the introduction of a KpnI restriction 
endonuclease site.  A fraction of the PCR reaction was resolved by agarose gel 
electrophoresis, verifying the presence of a product of approximately 7000 bp had 
been amplified.  The PCR product was used to transform Top 10 Chemically 
competent E. coli.  Resultant transformants were grown overnight in selective LB 
broth, and a plasmid preparation was performed using the QiaSpin MiniPrep Kit 
(QIAGEN).  KpnI restriction digestion of mini-preps was utilized for diagnosis of a 
successful site-directed mutagenesis.  Plasmids that were linearized by KpnI 
treatment (labelled pCCT101) were verified by sequencing. 
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2.9.3.3 Intergenic region insertions into pCCT101 
 
Primer sets 24-25, 25-26, 24-27, and 24-28 were used to amplify the ytgA IGR FL, 
Promoter, 5’ UTR Long, and 5’ UTR Short regions from C. trachomatis genomic DNA, 
and to incorporate flanking KpnI sites. Additionally, primer set 29-30 was used to 
amplify the tyrP1 IGR FL, in the same manner. Importantly, the native RBS from the 
IGR of ytgA and tyrP1 was excluded.  DNA molecules were gel extracted and 
digested with KpnI.  These sequences were mixed with KpnI-linearized pCCT101 
and ligated at 16˚C overnight with T4 ligase.  Ligation reactions were used to 
transform Top10 E. coli, and the resultant transformants were checked for the 
presence of inserts using diagnostic PCR with primers flanking the KpnI insertion 
site.  Insert directionality was determined through plasmid sequencing using the 
primers 31 and 32.  Except for the ytgA IGR FL reversed insert construct, all other 
inserts were oriented in the native 5’ to 3’ direction.   
 
2.9.4 Generation of pBAD-Flag-YtgC-V5-pHis (pBAD-FYH) 
 
Equal molar amounts of complimentary single stranded oligonucleotides 33 and 34 
were synthesized from Invitrogen, and annealed by incubation at 95 ˚C followed by 
the gradual decrease in temperature (0.5 ˚C decrease per minute) until the solution 
had reached 20 ˚C.  This double stranded DNA molecule was engineered to contain a 
5’ NcoI restriction site, and a 3’ KpnI restriction site that flanked the FLAG epitope 
(DYDDDK).   
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The full length YtgC ORF, excluding the stop codon, was amplified from C. 
trachomatis serovars D, which incorporated a KpnI site at the 5’ terminus of the 
molecule.  This PCR product, and the annealed double stranded leader sequence 
were digested with KpnI, purified (PCR purification kit; QIAGEN), and ligated 
together.  Ligation reaction was used as template for a PCR amplification using 
primer set 37-35, which corresponded to regions of the N-terminal flag sequence 
and the YtgC 3’ terminus, respectively.  This PCR product was gel extracted, and 
incubated with Taq supermix containing supplemented adenosine nucleotides in 
order to add 3’ adenosine extensions.  Extended PCR product was used in a TOPO-
TA ligation into the pBAD-V5-His vector, which was transformed into Top 10 E. coli.  
Sequence orientation was verified by sequencing (GATC; Germany).  To eliminate 
the expression of a short vector leading sequence, the plasmid was digested with 
NcoI, which cut immediately after the vector RBS and immediately before the start 
codon placed in the Flag-leader sequence.  Re-ligation of the vector allowed 
transformation of the final pBAD-FYH vector into Top10 E. coli.  Sequence of the 
vector was verified through sequencing (GATC; Germany).   
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Table 2.2- Plasmids generated in this study 
 
 
Table 2.3- Primers used for PCR amplification in this study 
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2.10 Dot-blot assay optimization  
 
2.10.1 Single membrane dot blot assay  
 
Whatman Optitron BA-5 83 0.2 µm nitrocellulose (NC; Millipore) membrane was cut 
into a rectangle of 13 x 4.5 cm.  NC membrane was soaked in 0.4 M KOH for 5 
minutes, before 3x 5 minute washes with ddH2O.  Membrane was equilibrated in 
wash buffer (20 mM Tris-HCl pH 8.0, 50 mM KCl, 5% glycerol, 0.5 mM DTT, 2 mM 
MgCl2) for at least 15 minutes at 4˚C.  Protein (pHis-FurEC) was diluted serially into 
water and added to a mixture of reaction buffer (wash buffer + 100 µM MnCl2) and 
allowed to equilibrate for 15 minutes at room temperature.  DNA oligonucleotides 
(as indicated in Figure 5.8) were added and samples were allowed to incubate for 
20-40 minutes at room temperature.  Filter paper was cut to the same size as the 
membrane, and soaked with cold wash buffer.  Membrane was placed on top of filter 
paper within the dot blot hybridization manifold (DHM-48; Fischer).  Wells were 
flushed with wash buffer 2x.  Samples were transferred to respective wells and 
vacuum filtered.  Wells receiving samples were washed 2x with wash buffer.  
Apparatus was disassembled, and the NC membrane was blocked in TBS + 0.1% 
Tween-20 containing 3% Bovine serum albumin (Sigma).  Blot was probed with 
HRP-conjugated streptavidin in the same blocking buffer at a dilution of 1:20000 for 
1-2 hours at room temperature.  Biotinylated DNA was detected using the 
Immobilon HRP-substrate chemiluminescent detection kit (Millipore), and images 
were captured using the FUJI-3000 LAS imager at -30˚C.   
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2.10.2 Double dot blot assay modifications 
 
For double dot blot procedure, a nylon membrane was equilibrated in wash buffer 
at 4˚C as described in the protocol above.  The nylon membrane was placed 
inbetween the filter paper and the NC membrane in the dot blot vacuum apparatus.  
Samples were filtered as described above.  After disassembly of the apparatus, the 
nylon membrane was placed in a Stratagene-3000 UV cross-linker and exposed to 
24000 kJ of UV energy.  Blot was then blocked in a solution of 6X SCC buffer (52.6 
g/L NaCl (Sigma), 26.5 g/L Sodium Citrate (Sigma), pH=7), 5X Denhardts reagent 
(0.2% polyvinylpyrrolidone, 0.2% BSA, 0.2% sucrose), 1% SDS, and 500 µg/ml 
sheared salmon sperm DNA.  Blot was probed in the same blocking solution 
containing 1:20000 dilution of HRP-conjugated streptavidin, and detected as 
described.   
 
2.10.3 Metal-specificity dot blots 
 
For metal-specificity dot blots, protein samples were either incubated with metal-
chelating agents as controls, or treated with Chelex-100 before addition to sample 
buffer in order to remove chelatable metal co-factors.  In these experiments the 
reaction buffer was composed of wash buffer supplemented with 100 µM ascorbic 
acid and the indicated amounts of MnCl2, FeSO4, or iron-chelating agents.  Metal 
solutions were dissolved immediately before use as supplements.   
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2.11 Western Blot Analysis 
 
Bacterial culture samples for western blot analysis were collected, and 0.01 OD 
units per µl were stored in 1X laemmli sample buffer (4% glycerol, 5% ß-
mercaptoethanol, 2% SDS, 0.06 M Tris pH 6.8, 0.2% bromophenol blue) at -20˚C.  
Samples were boiled for 5-10 minutes at 100˚C prior to resolution by Tris-Glycine-
SDS polyacrylamide gel electrophoresis (SDS-PAGE).  Polyacrylamide gels were then 
equilibrated in transfer buffer (25 mM Tris, 192 mM glycine, 20% MeOH, pH=8.3).  
Whatman 0.2 µm NC membrane was equilibrated in transfer buffer at 4˚C for at least 
15 minutes.  Proteins were transferred to NC membrane via the Trans-Blot SD Semi-
Dry Electrophoretic Transfer Cell (Bio-Rad) at 25 V for 30-45 minutes.  Transfer 
efficiency was verified by staining with ponceau solution (Invitrogen).  Membranes 
were washed of Ponceau with TBS + 0.1% Tween-20, and blocked in the same 
solution containing 3% BSA for 1 hour at room temperature.  After blocking, 
membranes were probed in solution containing primary antibody for 1-2 hours at 
room temperature or overnight at 4 ˚C.  When the primary antibody was not 
conjugated to horseradish peroxidase enzyme (HRP), a secondary antibody 
(conjugated to HRP) was applied at a dilution of 1:5000 in blocking buffer.  
Chemiluminescent detection was performed as described in section 2.10.1. 
 
When necessary, blots were stripped after the first antigenic detection, using a low 
pH buffer (200 mM glycine, 0.6 % SDS, pH=3- lowered with HCl) for 20 minutes at 
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room temperature.  The blot was then rinsed 3x with TBS + 0.1% Tween, incubated 
with the HRP substrate solution, and imaged to ensure stripping procedure was 
sufficient.  Substrate solution was washed away and the second antigen was 
detected as described above.   
 
2.12 Protein purification 
 
2.12.1 Expression and purification of FurEC-pHis and DcrA-pHis 
 
These purifications were carried out by Sophie Nicod, under my supervision, who 
was a visiting researcher to our laboratory group.  LB broth cultures inoculated with 
pET151 constructs for the recombinant expression of Fur and DcrA tagged pHis 
proteins were grown overnight, and sub-cultured the next day to an OD of 
approximately 0.05.  After OD600 had reached 0.5, cultures were induced by 
supplementation with Isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final 
concentration of 0.75 mM.  After 5 hours of incubation at 37 ˚C, 200 rpm, cultures 
were sedimented, and frozen at -80˚C for 1 hour.  Pellets were thawed on ice for 30 
minutes, prior to resuspension in 5 ml of lysis buffer (50 mM NaH2PO4, 300 mM 
NaCl, 10 mM imidazole, pH=8.0 with NaOH).  Lysozyme was supplemented to a final 
concentration of 0.1 mg/ml and suspensions were left for another 30 minutes on ice.  
Cells were lysed by sonication and the cell debris sedimented by centrifugation at 
160000 * g.   
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The soluble fraction was incubated in a capped 5 ml polypyrene column (QIAGEN) 
with 0.5 ml of Ni-NTA-sepharose bead slurry overnight at 4˚C, rotating.  The next 
day, columns were uncapped and flow-through was collected.  Columns were 
washed 3x with a wash buffer, which was similar to the lysis buffer except with a 
concentration of 20 mM imidazole to reduce non-specific binding to the column.  
Samples were collected from each wash.  Recombinant protein was eluted 4x 
through the addition of 0.5 ml of an elution buffer that contained 250 mM imidazole.  
Fractions were resolved by SDS-PAGE and stained with coomassie.  Fractions 
containing purified recombinant protein were pooled and concentrated in a 3000 
MWCO centrifugal filter.  Sample buffer was replaced with a Tris based buffer (50 
mM Tris HCl, 50 mM NaCl, 0.1 mM DTT, 5% glycerol, pH=7.0) that was more suitable 
for low temperature freezing.  Samples were aliquoted and flash-frozen at -80˚C.   
 
2.12.2 Purification of C-YtgC 
 
Because C-YtgC remained insoluble when bacterial lysates were fractionated, a 
separate approach than the one used for the purification of DcrA and Fur was 
necessary.  Protein expression was induced as described previously in a sub-culture 
of BL21* E. coli harboring the pET151-CYtgC vector in a 200 ml culture.  After 5 
hours of induction, the culture was sedimented and frozen at -80˚C overnight.  The 
next day, the pellet was thawed on ice, incubated in lysis buffer containing 
lysozyme.  The suspension was sonicated and then fractionated.  The soluble 
fraction was incubated with a base buffer (50 mM Tris HCl, 50 mM NaCl, 0.1 mM 
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DTT, 5% glycerol, pH=7.0) supplemented with 0.1 mM EDTA and 2% deoxycholate 
for 1 hour at 4˚C, rocking.  Suspension was then sedimented and the insoluble 
fraction was again incubated in the same buffer for another hour at 4˚C.  After this 
second detergent wash, suspension was sedimented.  The insoluble fraction from 
this step contained the inclusion bodies that housed the insoluble protein.  The 
inclusion body preparation was resuspended in the base buffer supplemented with 
0.25% sarkosyl (also known as sodium lauroyl sarcosinate; Sigma) and incubated at 
4˚C for 1 hour.  Fraction was sedimented again and the soluble fraction collected.  
The insoluble fraction from this step was washed again with the sarkosyl buffer, and 
after sedimentation, the two soluble fractions were pooled.  Pooled fractions were 
dialyzed in a 10000 MWCO dialysis cassette (Pierce) overnight into a buffer suitable 
for Ni-NTA column purification 
 
The next day, pHis-C-YtgC was purified using the Ni-NTA column purification 
system as described for DcrA and Fur.  Samples were concentrated into a Tris based 
buffer and flash frozen at -80 ˚C.  
 
 
 
 
 
 
 
 96 
2.12.3 Protein quantification 
 
Protein concentration of the flash frozen aliquots of transcriptional repressors was 
determined using the BCA Protein Assay Kit (Pierce) using the instructions of the 
manufacturer.  Sample dilution (1:50) was necessary for accurate protein 
concentration quantification.   
 
2.13 Miller Assay 
 
Miller assay for quantification of ß-galactosidase enzyme activity was performed as 
described (J. H. Miller, 1972; Sivaneson, Mikkelsen, Ventre, Bordi, & Filloux, 2010).  
Samples for assay were grown overnight from single colonies in selective LB, and 
sub-cultured the next day to an OD600 of 0.1.  Cultures were grown as indicated in 
the results section based on the experiment.  Generally, expression of the 
transcriptional repressor was induced for several hours prior to expression of the 
arabinose inducible promoter of the lacZ expression vectors that contained various 
intergenic region insertions.  Samples were collected and the expression of C-YtgC 
was checked via resolution by SDS-PAGE and coomassie stain (protein band at 
approximately 20 kDa).   
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2.14 Octet binding experiment 
 
Octet binding experiment was performed by Geeta Rao, in the laboratory of Dr. Scott 
Grieshaber (University of Florida, Gainesville, USA).  Disposable optical sensors 
coated with streptavidin were coated with the biotinylated ytgA IGR FL 
oligonucleotide.  Once saturated, tips were transferred to reaction buffer (20 mM 
Tris-HCl pH 8.0, 50 mM KCl, 5% glycerol, 0.5 mM DTT, 2 mM MgCl2, 200 µg/ml BSA) 
containing C-YtgC ± FeSO4, MnCl2, Bpdl (each at 100 µM), or just buffer.  Interference 
of absorbance at the sensor was read as nm of biolayer bound and plotted as a 
function of time.  Data was adjusted to the length of biolayer immediately prior to 
incubation in the protein solution.  Data plots were analyzed through non-linear 
regression as described in the text.   
 
2.15 Bioinformatics 
 
All figures involving the visualization, prediction, alignments of genetic elements or 
protein sequences were created in Geneious (Drummond et al., 2010).  Individual 
algorithms used as Plugins within the program were cited as used.  Parameters for 
alignments shown are indicated within the figure legends describing the alignment. 
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2.16 Statistics 
 
All statistical analyses, non-linear regression and graphs were generated using 
GraphPad Prism v5.0d.  Unless noted, all error bars within graphs represent one 
standard deviation from the mean (SD).  The difference between two means was 
typically determined using a two-tailed, unpaired t-test in conjuction with an F-test 
for the comparison of variance.  When the variance of two samples differed 
significantly (p<0.05 in F-test), then a Welsch’s correction was utilized within the 
unpaired t-test.  Constraints applied to non-linear saturation regression analysis are 
indicated in text.   
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Chapter 3- Characterization of an optimal iron-restriction 
model for growth of Chlamydia trachomatis 
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3.1 Introduction 
 
3.1.1 Rationale for the development of a more efficient iron-restriction model 
 
Deferoxamine mesylate (DFO) (Figure 3.1) binds ferric iron in a 1:1 molar ratio 
(Gaeta & Hider, 2005).  While these iron to DFO complexes are tremendously stable 
with an affinity constant (KA) of approximately 1030 (Martell & R. M. Smith, 1977), 
DFO is impermeable to biological membranes (Cable & Lloyd, 1999; Glickstein, El, 
Shvartsman, & Cabantchik, 2005; Lloyd, Cable, & Rice-Evans, 1991; Persson, Z. Yu, 
Tirosh, Eaton, & Brunk, 2003), and therefore, in the context of an in vitro Chlamydia 
infected-cell culture, DFO can only be utilized to sequester ferric iron within the 
extracellular media, or within endosomes as the compound is acquired via non-
specific pinocytosis (where it would inevitably be trafficked to the lysosome).  
Moreover, DFO can presumably only starve a cell culture after long-term treatment, 
as it is only able to prevent iron-acquisition, rather than remove iron stores within 
the cell.  Because the source of chlamydial iron is not yet known, it was unclear 
whether DFO was a suitable choice for the efficient iron-starvation of the 
intracellular pathogen.  Yet, at the onset of this study DFO has been the only iron-
chelating agent used in the attempt to starve Chlamydia for the biometal. 
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3.1.2 2,2’-Bipyridyl 
 
2,2’-Bipyridyl (Bpdl) is a membrane permeable iron-chelating agent (Figure 3.1).  
Its permeability and ability to bind both ferric and ferrous states of iron (Gaeta & 
Hider, 2005; R. M. Smith & Martell, 1975) provided the rationale to include the 
compound in this evaluation.  Past reports indicated that Bpdl-treatment inhibited 
replication of the Herpes simplex virus (Romeo, Christen, Niles, & Kosman, 2001), 
and has been utilized as an iron restriction agent in several prokaryotic models 
(Zaharik, Bruce A Vallance, Puente, Gros, & B Brett Finlay, 2002; D. Zhou et al., 
2006).   
 
3.1.3 Gallium 
 
Other microbial pathogens have been inhibited by treatment with gallium salts, 
including intracellular Mycobacteria, and Pseudomonas growing within a biofilm. 
(Kaneko, Thoendel, Olakanmi, Britigan, & Singh, 2007; Olakanmi, Britigan, & 
Schlesinger, 2000).  Gallium retains the same number of outer shell electrons as 
ferric iron, and is roughly the same size; therefore, it is incorporated into ferric 
binding proteins, including transferrin (Chikh, Ha-Duong, Miquel, & El Hage 
Chahine, 2007).  However, gallium is not stable at the 2+ oxidation state, and is 
unable to be reduced once inside the cell, thus acting as a non-functional 
competitive analogue of ferric iron for proteins involved in acquisition.  If C. 
trachomatis acquires ferric iron directly from the transferrin/transferrin receptor 
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pathway, then treatment with gallium may effectively block the source of chlamydial 
iron. 
 
 
 
 
 
 
Figure 3.1- Structures of iron-chelating agents analyzed in this chapter.  2,2’-Bipyridyl (Bpdl) is 
a membrane permeable chelating agent of both ferric and ferrous oxidation states of iron (R. M. 
Smith & Martell, 1975) 
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3.2 Results 
 
3.2.1 A previously used iron-restriction treatment is not sufficient for a 
uniform induction of persistence in Chlamydia trachomatis 
 
HEp2 cells were infected with C. trachomatis Serovar D at an MOI of approximately 
0.5, prior to incubation in normal media supplemented with various concentrations 
of DFO, ± CH (1 µg/ml).  For IFA, samples were incubated for 24 hours p.i. and then 
fixed and immunostained for analysis of inclusion development (Figure 3.2A).  The 
addition of CH to DFO treatment resulted in decreased inclusion size at each 
concentration of the iron-chelator tested, which clearly demonstrated the necessity 
of CH towards creating an observable phenotypic shift in C. trachomatis.  At 500 µM 
DFO ± CH, host cell toxicity was evident from spaces within the normally confluent 
monolayer.  Al-Younes et al. reported cytotoxicity at concentrations of DFO greater 
than 100 µM (Al-Younes, Rudel, Brinkmann, Szczepek, & Meyer, 2001).  At 100 µM 
DFO (without aid of CH), a heterogeneous population of chlamydial inclusions was 
observed; some appeared undeveloped, while others appeared no different in size 
from the untreated.   
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Figure 3.2- DFO treatment of C. trachomatis Serovar D within HEp2 cells mediates a 
heterogeneous population of chlamydiae in the absence of cycloheximide.  A dose-response 
analysis of C. trachomatis infected cells, treated with various concentrations of DFO (listed left of 
panel rows) ± 1 μg/ml cycloheximde (CH) was performed using IFA (A) and recoverable IFU (B) to 
ascertain chlamydial development and completion of the developmental cycle.  (A) Chlamydial 
inclusions were immunostained after 24 hours p.i. using convalescent human sera and a fluorescent 
secondary antibody.  Samples were visualized on an Olympus confocal microscope.  (B) Recoverable 
IFUs were quantified by disruption of the samples monolayers after 24 hours p.i., dilution, and 
reinfection onto fresh monolayers in triplicate.  Inclusions were counted the next day and infectious 
titer (IFU/ml) was calculated.  Graph represents the mean titer of one sample, replated in triplicate.  
Error bars represent SD.  Results representative of greater than 5 independent experiments. 
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The effects of these protocols were quantified using recoverable IFU as a measure of 
developmental cycle completion (Figure 3.2B).  The apparent inhibitory 
enhancement of CH addition to DFO treatment was verified by IFU.  For instance, at 
50 µM a 60% reduction of recoverable IFU from the untreated control occurred 
without CH supplementation (two-tailed unpaired t-test; p=0.0698), which was 
enhanced 65-fold upon its inclusion in the treatment protocol.  Moreover, the 
greatest inhibition observed with DFO without CH supplementation (at 100 and 500 
µM) could not surpass a 1-log reduction in output, suggesting that DFO was unable 
to affect the development of a significant proportion of chlamydiae.   
 
3.2.2 The effect of 2,2’-Bipyridyl on C. trachomatis development 
 
2,2’-Bipyridyl (Bpdl) is an intracellular iron-chelating agent (Breuer, Epsztejn, & 
Cabantchik, 1995; Konijn et al., 1999) that binds ferric and ferrous oxidation states 
of iron with similar affinity (R. M. Smith & Martell, 1975).  In a pilot experiment, 
Bpdl was utilized in a dose-response analysis of inclusion development (Figure 
3.3).  After 24 hours of infection/treatment, C. trachomatis infected cell cultures 
were fixed and stained using convalescent human sera and a fluorescent secondary 
antibody.  Images were analyzed via fluorescent microscopy, to ascertain the level of 
inhibition as indicated by general size of chlamydial inclusions.  Initial observations 
exhibited that there was no difference between the 50 µM Bpdl-treated sample and 
the 50 µM DFO-treated sample; both elicited a population of few undeveloped, 
among mostly normal sized, inclusions.  In stark contrast, the 100 µM concentration 
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of Bpdl elicited a uniform population of undeveloped chlamydial inclusions.  This 
effect seemed threshold dependent, rather than dose-dependent as 200 and 400 µM 
concentrations of Bpdl elicited similar uniform phenotypes.   
 107 
 
 
Figure 3.3- Bpdl retards development of C. trachomatis inclusions.  C. trachomatis was allowed 
to invaded HEp2 monolayers, after which cell cultures were cultured in complete IMDM, or complete 
IMDM containing DFO (50 μM) or various concentrations of Bpdl.  After 24 hours, samples were fixed 
and permeabilized before being immunostained with convalescent human sera and a fluorescent 
secondary antibody.  Images were captured using an Axio fluorescent microscope at 400X 
magnification.   
 
 108 
3.2.3 Bpdl is more potent than DFO and gallium in eliciting of an aberrant 
chlamydial phenotype. 
 
After the initial observation that Bpdl affected chlamydial development in the pilot 
experiment, a more in depth dose-response analysis of Bpdl, DFO, and gallium was 
then performed.  IFA was used to monitor inclusion development and individual 
bacterium morphology and recoverable IFU to quantify levels of inhibition.  Various 
concentrations of compounds were supplemented to the normal, iron-replete media 
that was used to culture HEp2 immediately post-chlamydial invasion.  The next sub-
sections describe the different analyses of these chlamydiae. 
 
3.2.3.1 Qualitative analysis of inclusion development 
 
A panel of confocal micrographs of the dose-response analysis of the various 
treatments was compiled (Figure 3.4).  Consistent with previous results, DFO failed 
to elicit a homogenous population of chlamydial inclusions at the 50 μM dose.  
However at 100 μM, most inclusions appeared undeveloped.  For Bpdl treated 
cultures, doses of 25 and 50 μM appeared to have no qualitative effect on the size of 
inclusions, compared to the untreated control.  However, at 100 μM, no mature 
inclusions were observed.  This result confirmed the observations of the pilot 
experiment, and suggested that inhibition from Bpdl treatment exhibited was 
threshold dependent, rather than dose-dependent like DFO.   
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In this experiment, no concentration of gallium seemed to elicit any appreciable 
decrease in the apparent size of inclusions throughout the infected culture, as the 
population of chlamydial inclusions in the 250 µM GaCl3 sample appeared no 
different than the untreated control.   
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Figure 3.4- Dose-response comparison of multiple iron-restriction models reveals Bpdl as a 
potent effector of a uniform phenotype of C. trachomatis.  C. trachomatis was allowed to invade 
HEp2 cell monolayers prior to culture with cIMDM or cIMDM supplemented with various 
concentrations of DFO, Bpdl, or gallium nitrate.  After 24 hours, samples were fixed, permeabilized 
and immunostained with convalescent human sera and a fluorescent secondary antibody.  Images 
were captured using a Leica SP2 upright confocal microscope.  Boxed inclusions are shown at higher 
magnification in Figure 3.6.   
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3.2.3.2 Quantification of recoverable infectious progeny 
 
The inhibitory effect of these treatments was quantified using the recoverable 
infectious progeny of a parallel set of treated samples.  After 24 hours of 
infection/treatment, sample monolayers were disrupted, diluted, and replated in 
triplicate to ascertain the number of inclusion forming units that existed after 
treatment.  In this experiment, infectious titres were expressed as a percentage of 
the untreated sample, which was 3.7x107 IFU/ml (Figure 3.5).   
 
DFO treatment (≤ 50 µM) resulted in a <1-log reduction in recoverable IFU when 
compared with the untreated control.  This was consistent with results published in 
Figure 3.2B.  In this particular experiment, DFO treatment (100 µM) caused a 
complete arrest of chlamydial development, as no recoverable IFUs were observed 
upon replating.  The highest dilution tested was 1:100, which made the limit of 
detection in this experiment approximately 0.0001 % of the untreated.  This result 
was not consistent with previous recoverable IFU output assays regarding 
treatment with DFO.    
 
Bpdl treatment elicited no inhibitory effect on C. trachomatis at the 25 and 50 μM 
doses (Figure 3.5), which was consistent with the IFA (Figure 3.4).  However, 
complete arrest was observed at the 100 and 250 μM concentrations, as no IFU 
were observed at a limit of detection approximately 0.0001% of the untreated.  The 
observation that the 50 μM dose had no effect while the 100 μM dose caused 
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complete arrest, suggested that inhibition may be dependent on a certain threshold 
concentration of Bpdl.  This is in contrast to DFO, in which a clear dose-dependent 
inhibition of IFU output was observed. 
 
Although gallium treatment elicited no apparent effects on inclusion development, 
IFU quantification revealed that an 80-90% reduction from the untreated control 
occurred upon each dose that was tested.  This inhibition seemed to be saturated, as 
no further decrease in IFU yield was observed in samples treated with increasing 
doses of gallium.  Thus, gallium failed to elicit an arrest of chlamydial development.   
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Figure 3.5- The effect of iron-restriction models on recoverable infectious progeny. C. 
trachomatis was allowed to invade HEp2 cell monolayers prior to culture with cIMDM or cIMDM 
supplemented with various concentrations of DFO, Bpdl, or gallium nitrate.  Recoverable IFU was 
quantified from parallel samples to those analyzed by IF.  Graph represents the recoverable IFU titer, 
which was assayed in triplicate, normalized by the mean IFU titer of the untreated sample.  Error 
bars represent the SD.  ND stands for none detected, i.e. no inclusions were observed upon replating 
at the lowest dilution of the sample suspension tested (1:10). 
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3.2.3.3 Analysis of chlamydial morphology 
 
The definition of the persistent phenotype dictates that chlamydiae undergo 
morphological shifts into large, aberrant RBs.  So while the qualitative analysis of 
inclusion size provides an efficient, first-glance look at the effect of a certain 
treatment on Chlamydia, it does not allow the differentiation between a delay in 
growth or whether the chlamydiae have entered the ‘persistent’ state.  To 
distinguish between these possibilities, morphological analysis must be completed 
on a scale where individual bacteria are visible.  Selected inclusions (outlined in 
Figure 3.4) that illustrated various degrees of aberrant morphology and inclusion 
composition in the different treatment protocols were chosen for further analysis 
(Figure 3.6). 
 
A typical mature chlamydial inclusion exhibits both RBs and EBs, with the RBs lining 
the periphery of the inclusion, whereas the EBs (which are not usually 
distinguishable individually by confocal microscopy) fill the centre of the inclusion.  
Such mature inclusions were observed upon culture with 25 µM doses of each of the 
three iron-restriction agents.  For DFO and Bpdl, increased concentrations yielded 
increased instances of aberrant inclusion composition and RB morphology.  For 
instance, at 50 µM DFO, both typical (Figure 3.6 top row, 2nd panel) and atypical (3rd 
panel) inclusions were observed.  Atypical chlamydial inclusions exhibit decreased 
diameter, and a preponderance of RBs over the EBs that normally fill the centre of 
the inclusion. At the highest dose of DFO tested (250 µM), RB morphology was 
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clearly aberrant, with some inclusions exhibiting just 3-4 enlarged RBs.  Because 
250 µM was reported as cytotoxic (Al-Younes, Rudel, Brinkmann, Szczepek, & 
Meyer, 2001), this induction of persistence cannot be solely attributed to iron-
restriction as poor host cell health may be involved.     
 
Most of the inclusions at the 50 μM concentration of Bpdl-treated cell cultures 
exhibited a preponderance for normal sized RBs, which was similar to the DFO 100 
µM sample.  At 100 μM Bpdl, tremendously enlarged RBs were observed, with some 
reaching almost 5 μm in diameter.  This divergence into the aberrant form is a clear 
sign of chlamydial persistence.  A similar phenotype was observed at 250 µM.  These 
characteristics were indications that Bpdl elicited a persistent chlamydial 
phenotype when included in the culture media at concentrations greater than or 
equal to 100 µM.    
 
Interestingly, culture with gallium chloride elicited a distinct phenotype from the 
DFO and Bpdl treated Chlamydia.  At first glance, inclusions did not appear to vary in 
the size even at the highest concentrations of gallium tested (Figure 3.4).  However, 
higher magnification images of these inclusions revealed that, while inclusion size 
seemed to be unchanged, the inclusion composition appeared to shift towards the 
RB state at the higher concentrations tested.  It appeared that gallium treated C. 
trachomatis failed to develop into typical mature inclusions.  Some RBs within these 
inclusions appeared slightly enlarged.  It was unclear whether this phenotype was a 
mere delay in growth or the induction of persistence. 
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The results of this dose-response analysis indicated that a single treatment with 
Bpdl at a concentration of 100 µM was able to elicit a uniform aberrant phenotype of 
C. trachomatis when added at the time of infection.  Nearly all of the observed 
chlamydiae upon this concentration of treatment resembled aberrant, persistent 
RBs by 24 hours.  The complete block of re-differentiation into the infectious EB 
state suggested a robust arrest of development, consistent with a uniform 
phenotype.  Provided the inhibition mediated by Bpdl was linked to iron-restriction, 
the uniform populations produced by treatment were sufficient for the study of 
iron-responsive transcription.  Gallium produced an interesting phenotype of 
seemingly developed inclusions that were full of normal or slightly aberrant RBs.  
This resulted in an 80-90% reduction in recoverable IFU output.  However, the 10% 
of normal Chlamydiae that remained disallowed the use of gallium as an efficient 
iron-restriction agent.  Whether gallium caused this moderate (but not complete) 
inhibition directly, or indirectly through the decrease in host cell iron acquisition is 
unknown.   
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Figure 3.6- Iron restriction models mediate aberrant chlamydiae morphology.  Selected 
inclusions (from the images shown in Figure 3.4) were examined at higher magnification and are 
organized by row for each treatment.  Concentrations of the specific compound are described in each 
panel image.  Size bar represents 10 μm in each image.  Leica SP2 confocal microscope captured 
images at 1000X and Adobe Illustrator was used to resize images in order to show the morphology of 
individual chlamydiae.  
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3.2.4 Treatment with 2,2’-Bipyridyl is not bactericidal 
 
A reactivation assay was performed in order to assess the viability of Chlamydiae 
after 18 or 24 hours of infection.  In this experiment, infected cell cultures were 
treated with 100 μM Bpdl from the time of infection for 24, 36, or 48 hours 
continuously.  Some samples were ‘reactivated’ by removing the supplemented 
media, washing briefly, and then culturing in normal, iron-replete media at 18 or 24 
hours p.i.  Infectious progeny from each sample was quantified after 24, 36, or 48 
hours p.i.  The infectious titres of each sample are shown in Figure 3.7A.  
Continuous Bpdl treatment caused a 3-5-log reduction in recoverable IFUs from the 
respective untreated controls at each time-point.  However, when supplemented 
media was replaced with iron-replete media at 18 or 24 hours p.i. and the cultures 
were incubated for another 18 or 24 hours (‘18+18’ and ‘24+24’, respectively), 
recoverable infectious progeny increased approximately 3-logs, compared to the 
continuously treated samples of the same durations.  Thus while Bpdl treatment 
caused a robust decrease in recoverable IFU, a significant portion of Chlamydiae 
remain viable for at least 24 hours, suggesting that Bpdl treatment was eliciting the 
chlamydial persistent response.  
 
However, the quantification of recoverable infectious progeny does not describe the 
total number of chlamydiae present within a sample, rather just the number of 
infectious EBs.  To determine whether Bpdl treatment affected the total number of 
chlamydiae, genomic DNA was extracted throughout a treated time-course 
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experiment, and analyzed via qPCR for quantification of Chlamydia specific DNA 
(Figure 3.7B).  This indicated that Bpdl-treatment caused a severe retardation in C. 
trachomatis genome replication.  However, importantly, the number of chlamydial 
genomes detected throughout the 30-hour time course did not decrease at any 
point.  This suggests that while infection EB re-differentiation was completely 
arrested at 24 hours, a significant number of RBs continued to replicate.   
 
Together, these experiments indicate that treatment with Bpdl does not result in the 
intracellular chlamydial death.  Rather, Chlamydiae seem to enter the persistent 
state of growth by continuing genomic replication without subsequent re-
differentiation into infectious particles.   
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Figure 3.7- Culture with Bpdl is not bactericidal.  C. trachomatis infected HEp2 cells were cultured 
with cIMDM ± 100 μM Bpdl for either 24, 36, or 48 hours.  For the 36 and 48 hour samples, the 
medium from a parallel set of infected monolayers was removed and replaced with unsupplemented 
cIMDM at 18 and 24 hours p.i., respectively.  Graph represents the infectious titer of samples, which 
was assayed in triplicate.  Patterned bars represent ‘reactivated’ samples (e.g. 18 hours of treatment 
followed by 18 hours of culture in normal media).  Error bars represent standard deviation. 
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3.2.5 Mechanism of inhibition by 2,2’-Bipyridyl treatment 
 
3.2.5.1 Treatment with 2,2’-Bipyridyl does not alter type three secretion in 
Salmonella 
 
T3S is important throughout the chlamydial developmental cycle, as the secretion of 
effector and INC proteins are instrumental in the modulation of host processes and 
vesicle traffic.  A class of T3S-inhibitors, termined INPs (for Innate Pharmaceuticals), 
inhibited development, but not invasion, of C. pneumoniae and C. trachomatis (Bailey 
et al., 2007; Muschiol et al., 2006).  Interestingly, inhibition was abrogated upon the 
addition of exogenous iron (Slepenkin et al., 2007).  Because the chemical structure 
of INPs resembled the structure of a well characterized cell-permeating iron-
chelating agent (Salicylaldehyde isonicotinoyl hydrazone; SIH), it was hypothesized 
that low intracellular iron availability could affect T3S in Chlamydia.  Therefore, a 
T3S assay was designed to test the ability of Bpdl to alter T3S.  In this assay, the 
secretion of a tagged SPI-2 effector of Salmonella (PipB2-2HA) was tracked after 10 
hours of treated infection.   For controls, intracellular Salmonella were treated with 
DFO (extracellular iron-chelator), SIH (characterized T3S inhibitor reversed by 
iron), or untreated.  The localization of PipB2-2HA was determined after 10 hours of 
infection/treatment by IFA (Figure 3.8).  Untreated and DFO treated intracellular 
Salmonella maintained the secretion of PipB2-2HA, as staining of the tag was 
observed throughout the cell in both samples.  SIH treatment prevented the 
secretion of the effector, as nearly all of the immunofluorescence against the tag 
 122 
resided within the Salmonella Containing Vacuoles (SCVs; arrows).  In contrast to 
SIH treatment, Bpdl treatment did not alter the secretion pattern of the effector, 
ruling out any probable effect of the compound, or low-iron availability on T3S in 
Chlamydia.   
 
 
Figure 3.8- Bpdl does not affect the secretion of a recombinant effector, PipB2-2HA, from S. 
typhimurium.  S. typhiumurium SL1344 ΔpipB2 harboring a plasmid to over express PipB2-2HA was 
allowed to invade HEp2 cells within a monolayer, before cIMDM (A) or cIMDM containing 100 μM 
concentrations of DFO (B), Bpdl (C), or SIH (D) was added.  After 10 hours, cultures were fixed, 
permeabilized and immunostained for the HA epitope and visualized with a fluorescent secondary 
antibody to ascertain the localization of the tagged effector.  Arrows indicate SCVs within the infected 
cells.  Images were captured on a Leica SP2 upright confocal microscope at 1000X.   
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3.2.5.2 Supplementation with exogenous iron abrogates chlamydial 
persistence mediated by 2,2’-Bipyridyl treatment 
 
In order to link the induction of persistence upon Bpdl treatment to the restriction 
of iron, an iron-titration experiment was performed in which various concentrations 
of ferric and ferrous oxidation states of iron were added to the Bpdl-supplemented 
media that was added immediately post chlamydial invasion.  Samples were 
cultured for 24 hours, prior to monolayer disruption, dilution, and replating on fresh 
monolayers in triplicate (Figure 3.9).  To illustrate the ability of Bpdl to bind both 
ferric and ferrous oxidation states, DFO treatment was included as a control, as it is 
only able to sequester the trivalent iron molecule.  In both the ferric and ferrous 
supplemented samples, the addition of iron did not alter the IFU output of the 
untreated samples, which is not surprising considering the regulation mechanisms 
employed by eukaryotes to prevent iron-overload and subsequent free-radical 
generation.  In the Bpdl and DFO treated samples, ferric iron (in the form of FeCl3) 
reversed the inhibition mediated by treatment in a dose dependent manner.  A near 
complete recovery of growth was observed at a 100 μM dose of iron for the Bpdl 
treatment.  While recovery of the DFO treated sample was observed, it was not 
complete; even at 500 μM ferric iron supplementation, rescue to untreated levels 
was not observed.     
 
As expected, the ferrous iron supplemented samples illustrated the differential 
binding capabilities of the two iron-chelating agents.  The effect of Bpdl treatment 
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was completely abrogated at the lowest concentration of iron added (20 μM).  DFO 
treated samples were not recovered by the addition of ferrous iron, as a 2-log 
discrepancy between untreated and DFO treated IFU output was observed at the 
highest concentration of metal supplementation tested (500 μM).  This was 
expected based on the reported specificity of DFO for the trivalent metal (Martell & 
R. M. Smith, 1977).   
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Figure 3.9- Two oxidation states of iron abrogate the effects of Bpdl on chlamydial 
development.  C. trachomatis HEp2 cells were cultured in cIMDM (black) or cIMDM supplemented 
with 100 μM doses of DFO (white) or Bpdl (grey), that contained various doses of two oxidation 
states of iron, FeCl3 (Fe3+) or FeSO4 (Fe2+).  After 24 hours, monolayers were disrupted, diluted, and 
replated onto fresh monolayers for quantification of inclusions the next day.  Graph represents the 
mean of one biological replicate assayed in triplicate.  Error bars represent SD.   
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3.2.5.3 The effect of 2,2’-Bipyridyl treatment on intracellular iron availability   
 
Others have monitored intracellular iron availability through the use of protein 
ferritin levels (Dill, Dessus-Babus, & Raulston, 2009), however the mechanism for 
ferritin complex degradation and its regulation is not fully understood.  Moreover, 
recent evidence has suggested Chlamydia may alter the function of the IRP/IRE 
regulatory system (Vardhan, Bhengraj, R. Jha, & Singh Mittal, 2009; Vardhan et al., 
2010), although these reports are still controversial.  Therefore, a more suitable way 
to measure intracellular iron availability was to monitor the expression of 
transcripts whose expression is influenced by the cytosolic iron pool, such as those 
from transferrin receptor and ferritin heavy/light chain genes.  Because the stability 
of these transcripts is influenced by the IRP/IRE system, ascertaining relative levels 
would allow an accurate description of the iron availability within the eukaryotic 
cytoplasm.  With this rationale, uninfected HEp2 cells were cultured with DFO or 
Bpdl, in comparison to an untreated control for 10 hours prior to RNA extraction 
and RT-qPCR analysis of iron-responsive transcripts. The relative expression levels 
of several iron-responsive transcripts upon treatment were transformed by natural 
log for graphical presentation (Figure 3.10).   
 
DFO treatment (100 μM) did not alter the expression of transferrin receptor, ferritin-
H, ferritin-L, or dmt1 transcripts, compared to the untreated control (one-tailed 
unpaired t-test; p=0.1966, p=0.1861, p=0.3204, p=0.1598, respectively).  In contrast, 
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Bpdl-treatment caused the robust elevation of transferrin receptor and dmt1, which 
are two genes coding for products involved in iron-acquisition (p=0.002, p=0.0065, 
respectively).  The transcripts of fer-H and fer-L were conversely repressed under 
low-iron availability via Bpdl treatment (p=0.0255, p=0.0186).  The results of these 
experiments indicated that Bpdl-treatment was able to effectively decrease the 
amount of available iron within the cytoplasm, as indicated by IRP mediated 
transcript stability, in just 10 hours of treatment.   
 
The differential modulation of these iron-responsive transcripts upon the different 
treatments clearly distinguishes Bpdl from DFO and validates the rationale for the 
use of a membrane permeable iron-chelator.  
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Figure 3.10- Bpdl elicits an iron-starved transcriptional response from uninfected HEp2 cells 
in 10 hours of treatment.  Uninfected HEp2 cells were cultured in cIMDM, or cIMDM containing 100 
μM of DFO or Bpdl for 10 hours.  Total RNA was extracted and converted to cDNA for the 
quantification of iron-responsive transcripts by RT-qPCR.  The ΔΔCt method was used for 
normalization with the mean GAPDH cycle threshold (Ct) serving as the endogenous control within 
each sample, and the mean untreated expression of each gene used as the calibrating factor.  
Expression levels are shown graphically as the natural log of the relative expression.  The values from 
each treatment are derived of two biological replicates assayed each in triplicate.  Error bars 
represent the SD.  Asterisks indicate level of statistical significant difference (unpaired, two-tailed t-
test; * p<0.05, ** p<0.01).   
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3.2.6 Transcript Expression validates the Bpdl model as an efficient mediator 
of chlamydial persistence and iron-starvation 
 
Culturing intracellular C. trachomatis in normal, iron-replete media, which was 
supplemented with 100 μM Bpdl, caused the induction of a uniform, persistent 
phenotype.  This phenotype was reactivateable, abrogated upon addition of 
exogenous iron, and no effect on T3S was observed.  Therefore the Bpdl model was 
deemed suitable for the analysis of iron-dependent transcriptional response of C. 
trachomatis.  Whereas previous results with DFO-based models showed marginal 
induction of differential gene expression, possibly due to the heterogeneity in the 
population of Chlamydia, with some exhibiting normal growth and others exhibiting 
the persistent phenotype, the Bpdl model consistently produced a uniform 
persistent phenotype, indicating that all chlamydiae present with in the sample 
were starved for iron.  This uniformity is essential for accurate identification of 
differentially regulated gene transcription.   
 
3.2.6.1 Analysis of persistence indicating genes 
 
Numerous reports have indicated that chlamydial persistent responses are distinct, 
and are tailored toward the particular persistence-mediating stress (Goellner et al., 
2006; A Klos, J Thalmann, J Peters, Gerard, & Hudson, 2009; P Timms et al., 2009).  
Despite these differences, some regulation patterns have been consistently 
observed among the different mediating models.  For the purposes of this report, 
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these genes will be referred to as ‘persistence-indicating’.  One of these genes is euo, 
which codes for a DNA-binding protein thought to repress the transcription of late-
stage genes (L. Zhang, Douglas, & T. P. Hatch, 1998).   The transcriptional elevation 
of this gene over the untreated control was observed upon both long-term DFO-
mediated iron restriction and IFN-γ mediated persistence in both C. psittaci and C. 
pneumoniae (Goellner et al., 2006; Timms et al., 2009).  Additionally, microarray 
analysis revealed that it was elevated upon IFN-γ treatment in C. trachomatis (R J 
Belland, D. E. Nelson, et al., 2003).  Because euo had been observed as 
transcriptionally elevated under multiple models of persistence, in multiple 
organisms, it was deemed as persistence indicating.  Another of these genes was 
deemed to be omcB.  OmcB is an outer membrane protein whose expression had 
been correlated to the re-differentiation of RB to infectious EB (R J Belland, G Zhong, 
et al., 2003).  Under IFN-γ treatment, its transcription was repressed during the late 
stages of infection in C. trachomatis (R J Belland, D. E. Nelson, et al., 2003) and C. 
psittaci.  Upon DFO-mediated iron-restriction, its transcription was also repressed 
in C. pneumoniae (Maurer, Mehlitz, Mollenkopf, & Meyer, 2007; Timms et al., 2009).  
Again, because the transcriptional expression of omcB had been observed as 
repressed under multiple models of persistence and in multiple organisms, it was 
deemed persistence indicating.   
 
Therefore, the expression of persistence indicating genes was monitored in C. 
trachomatis throughout the course of an untreated, DFO-treated, or Bpdl-treated 
infection. The levels of cDNA of the respective transcripts were normalized by the 
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number of chlamydial genomes present within parallel samples (Figure 3.11).  As 
predicted by previous expression studies (R J Belland, G Zhong, et al., 2003), euo 
exhibited expression consistent with the ‘early’ profile, with its expression 
increasing through the first 12 hours of infection before a peak and decline during 
the last 18 hours that were observed.  Not surprisingly based on previous results in 
this study, DFO (100 μM) did not alter this expression profile.  This profile was 
different upon Bpdl treatment, as an extended elevation of the euo transcript was 
observed throughout the late stages of infection; this elevation was present at every 
time-point tested.  The maximum differential expression was approximately ~6-fold 
at 24 hours p.i.  The extended elevation of the euo transcript clearly distinguished 
the Bpdl model for iron-restrictive growth from the DFO model in effective 
inhibition.   
 
The transcriptional profile of omcB in the untreated control exhibited the 
characteristics of a ‘late-gene’ as described by Belland et al. (2003).  The expression 
of the transcript was nearly undetectable at each time-point up to 18 hours of 
infection, at which point, its expression was ‘turned on.’  The expression profile 
omcB in the DFO-treated samples was similar to the untreated, with the only notable 
difference being the ~2-fold elevation over the untreated.  In contrast, Bpdl-treated 
samples exhibited a different profile to the untreated, i.e. the continued repression 
of omcB transcription.  This result suggested that Bpdl treatment elicited a complete 
block of development, which was consistent with past IFA and IFU results.     
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Together, the extended elevation of the early gene euo and the continued repression 
of omcB indicated that Bpdl-treated Chlamydia were phenotypically ‘persistent.’  
This is consistent with morphological analysis by IFA and quantitative analysis of 
recoverable IFU.  The observation that DFO treatment at the time of infection did 
not alter the expression of these persistence-indicating genes shows its lack of 
efficacy when utilized immediately post invasion.  The inability to alter such genes 
suggests that DFO used in this manner does not effectively starve Chlamydia for 
iron, which is in contrast to treatment with Bpdl. 
 
The expression profile of the 16S ribosomal RNA gene was monitored as a validation 
control for the chosen normalization technique (which was by genomic DNA content 
of parallel samples).  Ouellette et al. (2006) reported that 16S rRNA was not a 
suitable endogenous RT-qPCR normalization technique for the quantification of 
cDNA transcript levels under persistence mediating conditions (Ouellette et al., 
2006).  This finding was validated here by the observation of 16S rRNA elevated 
expression under Bpdl-mediated persistence during the late time-points of 
infection.  If 16S rRNA was suitable for normalization, the correlation between 
chlamydial genomic DNA to cDNA generated from total RNA would be linear, which 
it is clearly not based on the differential expression under Bpdl-mediated 
persistence. 
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Figure 3.11- Culture with Bpdl causes differential expression of persistence indicating genes 
in C. trachomatis.  C. trachomatis infected HEp2 cells were cultured in cIMDM ()or cIMDM 
containing 100 μM DFO () or Bpdl (----) for 6, 12, 18, 24, or 30 hours in quadruplicate.  At each 
time point, total RNA was extracted from two of four of each biological replicate.  Total genomic DNA 
was extracted from the remaining two biological replicates.  Duplicate RNA samples were pooled and 
converted to cDNA.  Levels of euo, omcB, and 16 rRNA cDNA were quantified by qPCR using a 
standard curve derived from genomic DNA extracted from EBs.  These values were normalized by the 
amount of Chlamydia specific genomic DNA detected in the parallel samples for each treatment time-
point.  Graphs represent the relative number of cDNA copies of each gene normalized by the number 
of C. trachomatis genome copies as a function of time.  Sample size: Euo N=5; OmcB N=4; 16S rRNA 
N=2, where N= the number of experiments, with each experiment consisting of two biological 
replicates pooled and assayed in triplicate.  Error bars represent standard error.  Asterisks indicate 
statistically significant differences from the untreated at the same time-point (unpaired, two-tailed t-
test; * p<0.05, ** p<0.01).   
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3.2.6.2 Analysis of C. trachomatis ‘iron-responsive’ genes 
 
To date, the only iron-responsive genes published have come from a report 
authored by Dill et al. (2009); they were ahpC, devB, fabF, ct538, and cadd.  However, 
in that study, euo and omcB were not differentially expressed (Dill, Dessus-Babus, & 
Raulston, 2009), indicating a lack of persistence presumably due to a lack of 
significant chlamydial iron-starvation.  The greatest difference in the level of 
transcription observed was approximately 2-fold, and no significant differential 
expression was observed for longer than one time-point (Dill, Dessus-Babus, & 
Raulston, 2009).  After validating Bpdl treatment as an efficient model for the 
uniform induction of persistence, the expression of some of these iron-responsive 
genes was examined.   
 
The number of cDNA amplicon copies of various C. trachomatis genes from samples 
that had been untreated, treated with DFO or treated with Bpdl were normalized by 
the number of C. trachomatis genome copies that were present in parallel samples 
(Figure 3.12).  The ahpC transcript exhibited the expression profile of a mid-stage 
gene with its expression peaking at 18 hours p.i.  DFO-treated C. trachomatis 
samples, did not display differential expression from the untreated control at any 
time-point.  Bpdl-treatment, in contrast, elicited the continued elevation of the 
transcript from 12-30 hours p.i., over the untreated and DFO-treated samples.  The 
maximum differential expression was observed at 24 hours p.i., and was 3-4-fold 
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over the untreated (two-tailed unpaired t-test; p=0.0008).  Clearly, ahpC transcript 
levels were elevated under Bpdl-treatment. 
 
The transcript of devB, which codes for a 6-phoslphogluconoolactonase that 
functions in the pentose phosphate shunt for NADPH (energy) production, was also 
continuously elevated upon Bpdl-treatment.  The maximum differential expression 
was observed at 24 hours p.i., and was approximately 4-5 fold over the untreated 
(p<0.0001).  DFO-treatment caused transcriptional elevation at 12, 24, and 30 hours 
p.i.; however this differential expression was variable from experiment to 
experiment, and did not exceed approximately 2-fold at any time point.   
 
The consistent and robust elevation of these transcripts, which were previously 
indicated as transiently up-regulated upon iron restriction via DFO-treatment, 
validated the Bpdl-model as a more efficient iron-restriction method for the growth 
of C. trachomatis and the analysis of iron-dependent transcriptional regulation.   
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Figure 3.12- Culture with Bpdl causes differential expression of known iron-responsive genes 
C. trachomatis.  C. trachomatis infected HEp2 cells were cultured in cIMDM ()or cIMDM containing 
100 μM DFO () or Bpdl (----) for 6, 12, 18, 24, or 30 hours in quadruplicate.  At each time point, 
total RNA was extracted from two of four of each biological replicate.  Total genomic DNA was 
extracted from the remaining two biological replicates.  Duplicate RNA samples were pooled and 
converted to cDNA.  Levels of ahpC and devB cDNA were quantified by qPCR using a standard curve 
derived from genomic DNA extracted from EBs.  These values were normalized by the amount of 
Chlamydia specific genomic DNA detected in the parallel samples for each treatment time-point.  
Graphs represent the relative number of cDNA copies of each gene normalized by the number of C. 
trachomatis genome copies as a function of time.  Sample size: ahpC N=5; devB N=3; where N= the 
number of experiments, with each experiment consisting of two biological replicates pooled and 
assayed in triplicate.  Error bars represent standard error.  Asterisks indicate statistically significant 
differences from the untreated at the same time-point (unpaired, two-tailed t-test; ** p<0.01, *** 
p<0.001, Bpdl vs. Untreated; ## p<0.01 DFO vs. Untreated).    
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3.2.7 The ytgA gene is transcriptionally regulated under conditions of iron-
restriction mediated by culture with Bpdl.   
 
Having validated the Bpdl-model as a robust and effective iron-restriction protocol, 
using previously reported iron-responsive genes, it was utilized to conclusively 
determine the regulation of specific genes that were hypothesized (but never 
explicitly shown) to be responsive at the transcriptional level to fluctuations in iron.  
One of these genes was ytgA, which codes for a periplasmic solute-binding protein of 
an ABC-metal transport system in C. trachomatis. Evidence that suggested ytgA was 
differentially transcribed due to fluctuations in iron originated from the observation 
that its expression at the protein level was weakly elevated upon short-term, high 
concentration DFO-treatment (J. D. Miller, Sal, Schell, Whittimore, & Raulston, 2009).  
It was also identified as iron-response at the protein level using a long term DFO 
treatment protocol in a 2D proteomic study.  However, when the same study 
examined ytgA expression using RT-qPCR, it apparently was not differentially 
expressed until after 36 hours p.i., when infection had become asynchronized (Dill, 
Dessus-Babus, & Raulston, 2009).  Working from the hypothesis that a gene coding 
for iron-acquisition protein should be regulated to maintain iron homeostasis, the 
transcripts expression was tested using the validated, more effective Bpdl model.   
 
As expected, ytgA transcript levels were elevated over the untreated during the 
middle to late stages of infection (Figure 3.13).  The greatest maximum differential 
expression was observed at 24 hours p.i. and reached about 2-fold.  Although not as 
 138 
robust as other iron responsive genes tested, such as ahpC, this elevation was 
reproducible and statistically significant over the last 18 hours of infection tested 
(unpaired two-tailed t-test; p=0.0099, p=0.0083, p=0.0433).  This was in contrast to 
DFO-treatment, which did not elicit any differential transcription of ytgA, even in 
another study that had employed pre-treatment (Dill, Dessus-Babus, & Raulston, 
2009), which illustrated the different efficiencies of the two protocols.   
 
Another gene that was hypothesized to be iron-responsive was dcrA.  As a 
homologue of Fur, DcrA was hypothesized to modulate the transcription upon 
fluctuations in intrachlamydial metal content (Rau, Wyllie, Whittimore, & Raulston, 
2005; Wyllie & Raulston, 2001).  In other organisms with Fur homologues, such as 
N. meningitidis and H. pylori, expression is auto-regulated, meaning that low 
concentrations of iron would prevent repression of its own transcription, resulting 
in a transcriptional elevation.  It was unknown whether dcrA was autoregulated.  
Upon Bpdl-treatment, a slight (1.3-fold) elevation was observed during the early 
stages of infection of this genes transcription.  This was below the threshold set in 
this study for ‘differential expression,’ as it is unclear what physiological role this 
observation could play.  Both the untreated and Bpdl-treated samples exhibited a 
decrease in the transcript levels of this gene during the late stages of infection.  
 
Timms et al. (2009) reported that, in C. pneumoniae, certain transcripts were 
differentially regulated based on the specific mediating factor of the persistent 
phenotype.  For instance, ahpC, which has consistently been reported as iron-
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responsive in Chlamydia was elevated upon long-term DFO treatment, but not 
persistence mediated by IFN-γ treatment.  On the other hand, tyrP1, which functions 
to acquire tryptophan (for which C. pneumoniae is an auxotroph), was elevated upon 
IFN-γ treatment, but not iron-restriction.  Because one of the mechanisms for 
inhibition by IFN-γ treatment is the depletion of available tryptophan pools, it was 
possible that C. pneumoniae could be capable of responding to specific nutrient 
stress, at least in regards to tryptophan starvation.  Transcription of tyrP1 had not 
been monitored upon iron-restriction in C. trachomatis to this point.  Although C. 
trachomatis is not auxotrophic for tryptophan (Fehlner-Gardiner et al., 2002), the 
regulation of tyrP1 was not hypothesized to fluctuate in response to iron-
availability.  In the untreated control, tyrP1 exhibited a transcriptional profile 
consistent with an early or middle stage gene.  As expected, Bpdl-treatment did not 
alter this profile, indicating that 1) tyrP1 is not iron-responsive in C. trachomatis, 
and 2) that the elevated expression of ahpC, devB, ytgA may be specific for low iron-
availability.   
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Figure 3.13- Transcription of ytgA is responsive to low-iron availability.  C. trachomatis infected 
HEp2 cells were cultured in cIMDM () or cIMDM containing 100 μM Bpdl (----) for 6, 12, 18, 24, 
or 30 hours in quadruplicate.  At each time point, total RNA was extracted from two of four of each 
biological replicates.  Total genomic DNA was extracted from the remaining two biological replicates.  
Duplicate RNA samples were pooled and converted to cDNA.  Levels of ytgA, dcrA, and tyrP1 cDNA 
were quantified by qPCR using a standard curve derived from genomic DNA extracted from EBs.  
These values were normalized by the amount of Chlamydia specific genomic DNA detected in the 
parallel samples for each treatment time-point.  Graphs represent the relative number of cDNA 
copies of each gene normalized by the number of C. trachomatis genome copies as a function of time.  
Sample size: ytgA N=2; dcrA N=2; tyrP1 N=2; where N= the number of experiments, with each 
experiment consisting of two biological replicates pooled and assayed in triplicate.  Error bars 
represent standard error.  Asterisks indicate statistically significant differences from the untreated at 
the same time-point (unpaired, two-tailed t-test; * p<0.05, ** p<0.01).    
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3.3 Chapter Discussion 
 
The development of C. trachomatis Serovar D within HEp2 cells was found to be 
insufficiently modulated upon treatment with non-cytotoxic concentrations of DFO, 
resulting in heterogenous populations that were not suitable for analysis of iron-
responsive transcription.  While other species of the Chlamydiacea are more 
fastidious than C. trachomatis (e.g. C. pneumoniae), and could probably be more 
easily starved for iron due to slow growth rates, the goal of the project was to gain 
insight into the iron-responsive transcriptional regulation of the genitropic 
chlamydial strains.  The rationale behind this decision was based on the fact that 
iron-levels within the female endometrium fluctuate greatly during menstration, 
causing others to hypothesize that the iron-responsive regulatory systems may be 
more important in the genital strains (Dill & Raulston, 2007).  Of the two most 
prevalent clinical genitropic serotypes (Serovar D and E), only the genome of 
serovar D had been sequenced and annotated (Stephens et al., 1998).  Therfore C. 
trachomatis Serovar D was selected as the most appropriate strain to represent the 
genitropic biovar.  As a host cell, HEp2 cells were selected as a robust epithelial cell 
line that has been routinely used as a host for intracellular chlamydial infections 
(Gerard, Whittum-Hudson, Schumacher, & Hudson, 2004; Gérard et al., 2002; Kokab, 
Jennings, Eley, Pacey, & Cross, 2010; Krausse-Opatz et al., 2009; Norkin, Wolfrom, & 
Stuart, 2001).    
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In the attempt to formulate a uniform population of iron-starved, persistent 
chlamydiae, two additional iron-chelators were identified for possible affects on C. 
trachomatis development.  The iron-chelator 2,2’-Bipyridyl (Bpdl), was originally 
identified because of its ability to permeate membranes.  While its association 
constant (KA) is just 1016 for ferric iron (compared to DFO which has a KA of 1030), it 
binds ferrous iron with a similar affinity (which DFO does not).  The ability to bind, 
sequester, and mobilize both ferric and ferrous forms of iron made it an attractive 
candidate.  Gallium was chosen because of its effects against intracellular 
Mycobacterium and Pseudomonas growing within a biofilm (Kaneko, Thoendel, 
Olakanmi, Britigan, & Singh, 2007; Olakanmi, Britigan, & Schlesinger, 2000).  
Gallium in these systems acts as a ferric iron analogue, being acquired by bacterial 
(or host) ferric iron binding proteins.  Many of the critical cellular functions of iron 
within enzymes require its ability to undergo one-electron redox reactions.  Gallium, 
in contrast to iron, does not readily under go these reactions, thus any iron-binding 
protein that acquires ferric iron is occupied by a non-functional metal atom.  For 
example, in the case of transferrin/transferrin receptor iron acquisition in 
eukaryotes, the uptake of gallium by transferrin and transferrin receptor is 
competitive for iron-uptake.  Gallium cannot be reduced within the endosome, and 
thus the transferrin/transferrin receptor ends up ‘spinning its wheels’ without 
functional iron import.   
 
It was hypothesized that if Chlamydia acquired ferric iron directly from the 
transferrin receptor system (without its reduction and transport to the cytosol), 
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then gallium would be a potent and efficient inhibitor of chlamydial growth.  
However, if Chlamydia acquires iron from the cytosol, then the use of gallium would 
be comparable to DFO treatment, in that both simply prevent iron from being 
acquired by the host cell, which would eventually deplete the cytoplasmic stores 
after long-term treatment.   
 
A dose-response analysis of these two iron-restriction protocols revealed that both 
modulated the course of C. trachomatis infection.  However, the phenotypes 
produced by the two agents were distinct.  Treatment with the gallium, which 
mimics ferric iron, produced seemingly mature inclusions.  Yet upon higher 
magnification IFA, those inclusions seemed to be entirely composed of RBs, instead 
of the typical RB and EB mix that is typically observed at the 24 hour p.i time point.   
The recoverable IFU quantification revealed that EBs were present within these 
populations however, which was suggestive of a significant portion of chlamydiae 
that were able to complete the developmental cycle.  It is unclear whether a longer 
time-course with the same treatment protocol would have yielded more recoverable 
IFU (i.e. gallium treatment simply caused a delay in development), or if longer 
treatments would have yielded similar levels of inhibition (i.e. culture with gallium 
causes a sudden onset of iron-starvation, at which point chlamydiae fail to continue 
acute development).  Regardless, it appeared that gallium had negative, albeit 
marginal influence on Chlamydia development. Therefore, its use for the analysis of 
iron-responsive transcription was deemed unsuitable. 
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In contrast, Bpdl elicited a seemingly ‘all or nothing’ inhibition of C. trachomatis 
development.  Both by IFA and recoverable IFU, concentrations of Bpdl of 25 or 50 
µM did not elicit any apparent inhibition of chlamydial development.  However, at 
concentrations of 100 µM or greater, the Bpdl produced uniform populations of 
persistent, iron-starved bacteria.  These effects are in contrast to culture with DFO, 
which typically inhibited C. trachomatis in a dose-dependent manner.  The higher 
degree of membrane permeability of Bpdl relative to DFO may explain its greater 
efficacy in inhibiting chlamydial growth. This greater membrane permeability would 
allow for the chelator to deplete intracellular and intrachlamydial iron pools that 
are inaccessible to chelators with limited membrane permeability, like DFO. 
Therefore it is likely that the compound must exist in stoichiometric excess of 
available iron in order to create an iron-starved state. 
 
Regardless of why Bpdl does not exhibit a dose-dependent effect in C. trachomatis, a 
100 μM dose was sufficient to induce a uniform, persistent phenotype at 24 hours 
p.i.  The effects of Bpdl were linked to iron-restriction, through the iron-titration 
assay, the inability of the compound to affect T3S in Salmonella, and through the 
monitoring of eukaryotic iron-dependent transcript stability.  Bpdl was able to 
create an iron-starved transcriptional state in the eukaryotic cell in a time-frame 
where DFO was not able.  This illustrated, yet again, the different efficacy in 
removing iron from the cell system.   
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Moreover, the Bpdl model was validated by demonstrating similar transcriptional 
profiles of a handful of genes reported to be either associated with persistence or 
iron starvation. Prior to this study, the only publication regarding iron-responsive 
transcription in C. trachomatis, reported that the genes euo and omcB did not follow 
a persistence-associated transcriptional profile, while ahpC and devB (which were 
hypothesized as iron-responsive) were only marginally elevated and not sustained 
throughout iron starvation, despite the 24-hour pretreatment with DFO prior to 
invasion and continuous presence of the chelator along with cycloheximide 
throughout the experiment. 
 
By contrast, using the Bpdl model, both euo and omcB were differentially expressed.  
The transcript levels of euo, remained elevated throughout the course of infection.  
Transcript levels of omcB were continually repressed through the entire infection.  
If, in fact, Euo is responsible for aspects of repressing late-stage gene transcription 
and OmcB is correlated to the re-differentiation of RB to EB, these results clearly 
illustrate that culture with Bpdl was causing a robust persistent phenotype, 
characterized by the arrest of acute development.   
 
Moreover, upon culture with Bpdl, the iron-responsive transcripts reported by Dill 
et al. (2009) were observed to be differentially expressed at multiple time points 
AND with greater magnitude of induction (2-fold).  For ahpC, the Bpdl model yielded 
a maximum differential expression of greater than 3-fold, whereas the DFO 
pretreatment model was less than 0.5 fold.  For devB, the Bpdl model yielded a 
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maximum differential expression of greater than 4-fold, compared to the 2-fold 
observed at one time-point using the DFO pretreatment model.  When considering 
that many microarray or SAGE studies set a cut-off criterion of 2-fold to classify 
transcripts as differentially expressed, genes whose transcripts were induced 
marginally in inefficient systems of iron starvation would be missed. The use of the 
Bpdl model over the DFO model (even with pretreatment) in a microarray or SAGE 
analysis would make a profound difference to the overall quality and accuracy in the 
identification of iron-responsive regulons in C. trachomatis.  The novel finding that 
the ytgA gene, which encodes for a periplasmic iron-binding protein was iron-
responsive at the transcriptional level underscores the greater efficacy of Bpdl.  The 
expression of YtgA had been observed as elevated under ‘iron-restriction’ at the 
protein level, although only marginally (J. D. Miller, Sal, Schell, Whittimore, & 
Raulston, 2009).  However its expression had never been published as iron-
responsive at the transcriptional level.  Employing the Bpdl model, ytgA was 
observed to be transcriptionally elevated during the mid and late stages of infection.  
This differential expression implicates that YtgA may have a role in the acquisition 
of iron, as others have hypothesized (J. D. Miller, Sal, Schell, Whittimore, & Raulston, 
2009).   
 
The transcript expression of another gene thought to code for a protein involved in 
iron homeostasis in Chlamydia is DcrA.  Although iron has not been shown 
experimentally to activate this DNA binding protein, its homology to the Fur family 
of transcriptional regulators indicated an involvement in iron-dependent 
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transcriptional regulation (Wyllie & Raulston, 2001).  Moreover, Fur is 
autoregulatory in some bacteria (Delany, Rappuoli, & Scarlato, 2004; Delany et al., 
2002).  Utilizing the Bpdl model, the transcriptional expression of dcrA was 
monitored.  In these experiments, dcrA exhibited an early or mid gene profile under 
normal conditions.  This was in contrast to the profile observed by Belland et al. 
(2003), in which expression was consistent throughout the developmental cycle (R J 
Belland, G Zhong, et al., 2003).  Transcript levels ChxR and TrpR, which are also 
transcriptional regulators, were also constant between 8 and 24 hours of infection 
(R J Belland, G Zhong, et al., 2003).  It seems counter-intuitive that transcriptional 
regulators (especially ones that are ligand dependent such as TrpR and DcrA) would 
prescribe to temporal regulation.  Perhaps a basal level of transcript expression 
would allow other forms of (self)-regulation to increase or decrease the transcript 
expression as needed.  The expression levels of dcrA had not been tested in response 
to iron-limitation in C. trachomatis to this point.  Upon application of the Bpdl model, 
the expression of dcrA appeared to be slightly elevated early during the course of 
infection.  However, during the later time-points observed, expression declined and 
was no different than the untreated control.  If an iron-dependent regulation 
mechanism for transcription of dcrA existed, then one would presume that as the 
Bpdl-treated chlamydiae became more and more iron starved as the infection 
progressed that the increased differential expression would be observed at the later 
time-points, which is contrary to what was observed.  As mentioned previously, 
DcrA, was never shown to be activated through the ligation of iron, as the addition 
of the biometal reportedly caused precipitation (Wyllie & Raulston, 2001).  
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Therefore it was unclear whether fluctuations in iron would have any bearing on the 
function of this protein.  Ultimately, the differential expression of the transcript 
remains inconclusive.  Slight increases (less than 2-fold) were observed during the 
early stages of infection, however transcription in the untreated control and Bpdl-
treated samples declined later in the infection, which is a period of time in which 
iron is presumably scarce.  The reproducibility of this expression profile in the 
experiments reported here may suggest some unintended difference between the 
culture protocols in this study and that of Belland and his colleagues (R J Belland, G 
Zhong, et al., 2003).   
 
One potential caveat to this chlamydial transcript expression data was that each of 
the genes shown to be elevated upon culture with Bpdl was a mid- or late-stage 
gene.  Thus it was possible that Bpdl treatment caused an unspecific upregulation of 
mid-gene and late-gene transcription.  Although the repressed transcription of omcB 
(a late gene) did not support this hypothesis, the expression of a mid-stage gene 
with no previous indication to be responsive to iron, tyrP1, was examined for 
differential expression upon Bpdl treatment to conclusively control for this 
potential caveat.  As stated earlier, Timms et al. (2009) reported that, in C. 
pneumoniae, tyrP1 transcription was elevated approximately 27-fold higher than 
untreated levels upon IFN-γ mediated persistent growth, but was not differentially 
expressed under long term DFO treatment.  Because tyrP1 codes for an aromatic 
amino acid transporter, its upregulation upon IFN-γ treatment (which depletes host 
tryptophan pools) suggested that C. pneumoniae possessed the ability to 
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facultatively respond to specific nutrient stresses.  C. trachomatis, unlike C. 
pneumoniae, is not auxotrophic for tryptophan.  Regardless, tyrP1 transcription 
should not have been regulated based on fluctuations in iron-availability.  Therefore 
its expression was monitored under Bpdl-treatment and normal growth conditions.  
As expected, no differential expression was observed.  This control allows the 
conclusion that Bpdl-treatment, i.e. iron-restricted growth, does not cause a non-
specific upregulation of mid-stage genes.  Thus it is possible that the  elevated 
expression of ahpC, devB, and ytgA may originate from individual or specific cis- or 
trans- regulatory mechanisms that have evolved in the maintenance of iron 
homeostasis.  The next chapter will provide evidence and discuss the implications 
for one of putative system.   
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3.4 Chapter Conclusions 
 Culture with Bpdl elicited a uniform persistent phenotype in C. trachomatis 
by 24 hours p.i. and was more potent than DFO when added at the time of 
infection 
 The effects of Bpdl appear to be attributable to the restriction of iron. 
o Bpdl did not alter T3S in Salmonella. 
o Exogenous iron reversed the Bpdl-mediated phenotype. 
o Bpdl elicited a strong iron-starvation transcript response in 
uninfected HEp2 cells, suggesting that LIP was depleted in less than 
10 hours. 
 Iron-restriction via Bpdl treatment caused differential transcription of both 
persistence and iron-responsive genes. 
 Transcript levels of ytgA (a putative iron-binding periplasmic protein) were 
elevated upon low-iron availability.   
 Transcript levels of dcrA (a chlamydial homologue of the Fur superfamily), 
did not appear to be robustly differentially expressed upon culture with Bpdl.   
 The iron-responsive elevation of ahpC, devB, and ytgA were not part of a 
general mid-stage gene elevation, as tyrP1, another mid-gene with no 
reported function in the maintenance of iron-homeostasis, was not 
differentially regulated at any time-point tested.   
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Chapter 4- The characterization of a novel DtxR-
homologue in Chlamydia trachomatis as an iron-
dependent DNA-binding protein 
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4.1 Chapter Introduction 
 
The characterization and validation of Bpdl treatment as an efficient mediator of C. 
trachomatis iron-restriction revealed that transcript levels of ytgA, a gene coding for 
an iron-binding periplasmic protein, were elevated under low-iron availability.  This 
elevation, combined with the predicted function of iron-acquisition of YtgA, led to 
the hypothesis that transcription of ytgA was under the control of an iron-
responsive transcriptional regulator, similar to the Fur recognition of the fhuA 
(which encodes iron import protein) promoter region in E. coli.  It was hypothesized 
that analogous cis- and trans- regulatory factors could be elucidated in C. 
trachomatis using the ytgA gene as a model system. 
 
To date, only one metal dependent transcriptional regulator in Chlamydia has been 
characterized, which was termed Divalent cation repressor A (DcrA).  DcrA was 
predicted to be a homologue of the Fur superfamily of metal-dependent 
transcriptional repressors.  In vitro DcrA bound the E. coli Fur-box in a Mn2+- and 
Zn2+- dependent manner, although strangely, ferrous iron was not able to be tested 
as it ‘precipitated’ the protein upon its addition (Wyllie & Raulston, 2001).  A later 
study attempted to identify sequences from C. trachomatis DNA that were 
recognized by FurEC in a heterologous E. coli Fur titration assay.  This method 
provided many chlamydial sequences that FurEC bound, however few were 
confirmed to be bound by DcrA in vitro (Rau, Wyllie, Whittimore, & Raulston, 2005).  
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Consequently, neither the effects of iron or the identification of a consensus binding 
sequence have been resolved, to date.  
 
Bioinformatic analyses presented here have suggested that another putative 
transcriptional regulator may exist in C. trachomatis within an operon (ytg) that 
possesses homology to the tro operon of T. pallidum.  The tro operon, which codes 
for an ABC-metal transport system of manganese, harbors its own transcriptional 
regulator (TroR) that belongs to the DtxR superfamily of metal-dependent 
transcriptional regulators.  Notably, in contrast to the Tro system, no homologue of 
TroR appeared to be present at the end of the ytg operon (Figure 4.1A).  However, 
gene sequence analysis provided by the STDGEN Database 
(http://stdgen.northwestern.edu) for C. trachomatis (derived originally from 
(Stephens et al., 1998)), indicated that ytgC was actually composed of sequences 
from two distinct genes: the N-terminus encoding a typical membrane bound 
channel protein of an ABC metal transport system, and the C-terminus encoding a 
sequence homologous to TroR and other DtxR-like transcriptional regulators 
(Figure 4.1B).  However, the predicted membrane association of the YtgC protein 
presented a conundrum as to how the C-terminal component could act as a DNA 
binding protein.  
 
The aim of research presented in this chapter was to characterize the putative trans-
acting regulatory protein responsible for the iron-dependent regulation of ytgA, via 
interaction with its upstream IGR, and the role of metals in its interaction with DNA. 
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The elucidation of such a trans-binding partner for the IGR upstream of the ytgA 
ORF would provide a molecular mechanism for the observed iron-dependent 
regulation of transcription, in a mechanism that may have broader implications 
throughout the chlamydial genome. 
 
 
 
 
 
 
 
Figure 4.1- C. trachomatis ytgC is genetic fusion coding for a protein with sequence homology to both 
TroC and TroR of T. pallidum.  (A) A schematic comparison of the tro (T. pallidum) and ytg (C. 
trachomatis) operons is depicted.  The tro operon encodes an ABC-metal transport system for manganese.   
The ytg operon does not encode a TroR-like ORF.  (B) Multiple sequence alignment of YtgC, TroC, and TroR 
amino acid sequences revealed that YtgC may encode two functionally distinct peptides that are similar to 
TroC and TroR (Geneious; Blosum 62 Cost Matrix with free end gaps), that have presumably undergone a 
genetic fusion.   
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4.2 Results 
 
4.2.1 Bioinformatic analysis of YtgC 
 
The STDGEN database (http://stdgen.northwestern.edu) annotation indicates that 
the protein encoded by the ytgC ORF could be divided into two distinct domains: an 
ABC metal-transport channelprotein at the the N-terminus and a TroR-related DNA 
binding protein at the C-terminus.  Two different transmembrane prediction 
algorithms (TMPred, (Arnold, L, Kopp, & Schwede, 2006); Hidden Markov Model 
Transmembrane prediction, (Drummond et al., 2010)) indicated the presence of 
seven potential transmembrane domains that oriented with the C-terminal tail 
being on the cytoplasmic side of the bacterial membrane (Hidden Markov Model 
shown in Figure 4.2A).  One implication of this orientation is that the TroR-like 
domain could be liberated if a processing or cleavage event occurred, in order to 
function as a DNA binding protein. 
 
The C-terminal domain of YtgC domain was aligned against TroR and DtxR to reveal 
an overall conservation of predicted secondary structure (Figure 4.2B).  Moreover, 
the metal binding sites identified from the crystal structure annotation of DtxRCD, 
were conserved in five of the 6 residues for both TroR and the C-terminus of YtgC, 
raising the possibility that, if functional, the C-terminal peptide could also be 
regulated through a metal co-factor. 
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The predicted cytoplasmic localization of the TroR-like domain of YtgC, combined 
with its homology and identity at several residues shown to be important for metal 
binding led to the hypothesis that this polypeptide could be a functional metal-
dependent transcriptional regulator in Chlamydia.  This putative polypeptide was 
termed C-YtgC, and was chosen for examination along with two characterized metal 
dependent transcriptional regulators, DcrA and FurEC.  
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Figure 4.2- The C-terminus of YtgC is predicted to be cytoplasmic and is homologous to the 
DtxR family of metal-dependent transcriptional regulators.  (A) Bioinformatic analysis of the 
YtgC amino acid sequence using the Hidden Markov Model Transmembrane prediction algorithm 
(Geneious) predicted that the C-terminal component of YtgC was most likely to localize to the 
cytoplasmic side of the bacterial membrane.  InterPro domain scan (Geneious) revealed the presence 
of two distinct motifs, a DNA binding Helix-turn-helix motif (red) and a metal binding regulatory and 
dimerization domain (pink).   (B) Multiple sequence alignment (Blosum 62 cost matrix with free end 
gaps) and predicted secondary structure (PSIPRED, SWISS-Model worksite) (Arnold, L, Kopp, & 
Schwede, 2006; D. T. Jones, 1999) revealed significant structural homology between the C-terminal 
component of YtgC (which we have termed, C-YtgC), DtxR, and TroR.  Secondary structures: -helices 
(Pink), ß-sheet (yellow), and conserved metal binding residues (blue) as determined from the DtxR 
crystal structure (Pohl, Holmes, & Hol, 1999). 
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4.2.2 The cloning, expression and purification of recombinant FurEC, DcrA, and 
C-YtgC 
 
In order to perform in vitro DNA binding assays, purified DcrA and C-YtgC were 
required.  The gene sequence corresponding to the entire ORF of dcrA, along with 
the region with predicted similarity to TroR from ytgC, were amplified by PCR from 
C. trachomatis serovar D genomic DNA.  For eventual use as a positive control, the 
fur ORF was also amplified from E. coli genomic DNA.  These sequences were ligated 
into the pET151-D/TOPO vector (Invitrogen), for the bacterial expression of N-
terminally fused pHis recombinant proteins.  Vectors were transformed into Top10 
E. coli and verified by sequencing, prior to plasmid transformation into BL21* E. coli 
for the expression of recombinant (pHis tagged) proteins.  Bacterial cultures were 
lysed and recombinant proteins were purified using the Ni-NTA nickel column 
purification system (QIAGEN).  Both DcrA (Figure 4.3A; 22 kDa band) and Fur 
(Figure 4.3B; 19 kDa band) were purified using a standard protocol and were 
detected as the major component in the elution fractions via coomassie stain of SDS-
PAGE resolved fractions.   
 
In contrast, C-YtgC was highly insoluble (Figure 4.3C; 20 kDa band).  To liberate C-
YtgC from the insoluble fraction, an inclusion body purification was performed, in 
which the insoluble fraction of a bacterial lysate was washed with a buffer 
containing the detergent, deoxycholate, in order to disrupt remaining bacterial 
membranes, and subsequently allowing purification of the bacterial inclusion 
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bodies, which contained the recombinant protein.  Subsequently, the protein was 
liberated from the inclusion body pellet, through treatment with a 0.25% sarkosyl 
solution.  This detergent treatment allowed the liberation of the protein into the 
soluble fraction.  Fractions from these steps were collected and resolved by SDS-
PAGE (Figure 4.3D).  Liberated soluble fractions were pooled and dialyzed to 
remove the detergent, and then the pHis-C-YtgC was purified using a standard 
protocol for the Ni-NTA nickel column purification system (QIAGEN; Figure 4.3E).   
 
The best purification obtained still contained two or more major protein bands.  
pHis-C-YtgC was predicted to resolve at around 20 kDa.  A protein-band 
corresponding to this molecular weight was eluted, plus another protein that 
resolved at approximately 45 kDa, which may or may not represent an unusually 
stable and SDS-resistant dimer of the recombinant protein.  This partially purified 
protein fraction was deemed adequate to be used in the subsequent DNA-binding 
assays with appropriate controls that considered the presence of the 45-kDa 
polypeptide. 
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Figure 4.3- Purifications of recombinant FurEC, DcrA, and C-YtgC.  Recombinant proteins were 
expressed and purified using the Ni-NTA purification system for polyhistidine tagged proteins 
(QIAGEN).  Samples were collected from the various steps of the procedure and resolved by SDS-
PAGE.  Gels were stained with coomassie blue, and destained for image acquisition.  (A) pHis-DcrA 
purification (22 kDa) (B) pHis-FurEC purification (17 kDa).  (C) In a pilot expression, sample 
resolution revealed that C-YtgC was retained to the insoluble fraction of the bacterial lysate.  (D) A 
bacterial culture expressing C-YtgC was fractionated and the insoluble fraction treated with a series 
of detergents to purify inclusion bodies from cell debris/membrane, prior to liberation of the protein 
from the inclusion bodies through gentle detergent treatment.  Liberated soluble fractions were 
pooled, dialyzed to remove the detergent and then applied to the Ni-NTA column for polyhistidine 
tagged protein purification (E). 
 161 
4.2.3 FurEC selectively retains a DNA-oligo containing a Fur Box sequence over 
random oligonucleotides in a dot blot assay   
 
To validate the use of a dot blot assay in characterizing protein-DNA interactions, 
recombinant Fur was incubated with biotin tagged DNA that was either random, or 
contained a classical Fur Box sequence.  Samples were filtered through a 
nitrocellulose (NC) membrane, to which only protein should bind.  Therefore, any 
biotinylated-DNA detected on the NC would be indicative of protein binding to the 
DNA molecule.  In this experiment, the reaction buffer contained MnCl2, which had 
been also shown to activate E. coli Fur binding activity, previously (Bagg & Neilands, 
1987).   
 
Visual analysis of the blot revealed that the FurEC bound and retained the Fur Box 
oligo, but not the random biotinylated DNA of the same size.  However, a significant 
amount of non-specific retention was observed in the absence of protein.  Therefore 
dot intensities were measured using ImageJ software to confirm results 
quantitatively.  Each dot intensity was adjusted according to the level of non-specific 
retention observed in the no-protein control corresponding to each oligonucleotide.  
Adjusted intensities were plotted as a function of protein amount (Figure 4.4B).  
Table 4.1 describes the lines of best fit applied to both oligonucleotides, using a 
saturation binding model (GraphPad Prism v5.0).   
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Figure 4.4- Recombinant, purified FurEC selectively retains a biotin-Fur Box DNA sequence 
over a Biotin-random sequence in a proof of principle dot blot experiment.  (A)  Various 
amounts of pHis-Fur were added to 25 fmol of Biotin-Fur Box or Biotin-Random sequence and 
filtered through a nitrocellulose membrane using a vacuum manifold dot blot apparatus.  DNA bound 
by the protein was retained by the nitrocellulose membrane (NC).  Tagged DNA was detected using a 
streptavidin-HRP probe followed by application of chemiluminescent substrate.  (B) Dot intensity 
was measured using ImageJ and relative values were normalized by the intensity of the no protein 
control of each lane.  Normalized dot intensity (INC-I0) was plotted as a function of the amount of 
pHis-Fur in each sample.  Lines of best fit were constructed following a saturation-binding model: y = 
(Bmax * x) / (Kd + x), where Bmax is the horizontal asymptote of specific intensity retention, and Kd is 
amount of protein required to obtain 50% of the Bmax. 
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Table 4.1- Line of best fit summary for plot for Fur dot blot retention assay 
 
 
Two data points from the Fur Box sample set were omitted because of a ‘blocking 
effect’ which is sometimes observed in high concentration protein samples.  This 
effect originates from the excess of protein compared to available binding sites on 
the NC blot.  This effect is described in greater detail in section 5.3.  After these 
omissions, the lines of best fit were only moderately robust (as indicated by the 
values of R2).  Within these lines of best fit, a Kd is calculated, which refers to the X-
value (protein amount, in this case) that results in half of the maximum detection 
being obtained.  When the two Kd values were compared for the different 
oligonucleotides, it was clear that the Fur Box was retained at greater efficiency 
than the random oligo (Kd = 2.007 and 504 fmol, respectively), despite non-specific 
retention.  Overall, this data suggests that the dot blot assay was a suitable method 
for determination of specific DNA binding activity.    
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4.2.4 The upstream intergenic region of ytgA is bound by C-YtgC.   
 
After confirming that the dot blot assay was a suitable method for the 
characterization of DNA binding by a purified protein, the assay was employed to 
test whether DcrA or C-YtgC could retain a DNA sequence corresponding to the 
upstream region of the ytgA ORF.  Various concentrations of protein were incubated 
with a biotinylated-ytgA IGR FL DNA fragment (20 fmol) in the same reaction buffer 
used to activate FurEC (shown if Figure 4.5).  This buffer was selected because the 
activating metal conditions for C-YtgC (if any) were not known, and the reaction 
buffer used for the Fur to Fur Box binding was a logical starting point.  This buffer 
contained 100 μM Mn2+, which had been shown to activate DcrA, previously (Wyllie 
& Raulston, 2001).  As an added control, samples were filtered through a double 
membrane of both NC and Nylon in a dot blot vacuum apparatus.  In this assay the 
NC blot (placed on top) should have retained all protein and any DNA bound by 
protein, whereas the nylon blot (placed underneath) should capture all of the 
unbound DNA that is not immobilized via protein binding.  This method allowed for 
the calculation of a percent of total retained at the NC, which would negate wells 
that have been slightly over- or under- loaded with DNA.   
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Figure 4.5- The upstream IGR of the ytgA ORF is retained by recombinant C-YtgC, and not 
recombinant DcrA.  (A) Various amounts of C-YtgC or DcrA were added to 20 fmol of the YtgA IGR, 
tagged with biotin.  Samples were filtered through a nitrocellulose and nylon double membrane.  
DNA bound by protein is retained on the top nitrocellulose membrane, while all unbound DNA is 
retained on the bottom nylon membrane.  Both blots were probed and detected for Biotinylated-DNA 
(YtgA IGR FL sequences).  (B) Dot intensities were measured with ImageJ, and the percent of 
intensity retained to the NC membrane was calculated, using the formula: proportion of Intensity on 
NC = [INC / (INC + INyl)] – I0, where I0 is the [INC / (INC + INyl)] of the no protein control.  Proportion of 
intensity retained was plotted as a function of protein concentration.  Line of best fit derived from a 
saturation binding model: y = (Bmax * x) / (Kd + x).   
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Both NC and nylon membranes were probed for biotinylated DNA corresponding to 
the ytgA IGR full length fragment (Figure 4.5A).  Qualitatively, DNA was apparently 
retained on the NC membrane at the lowest concentration of C-YtgC tested (125 
pM), whereas no significant amount of DNA was retained by DcrA at any 
concentration.  Dot intensities for both membranes were measured using ImageJ.  
The percent intensity retained by NC was normalized by the non-specific retention 
of the no-protein control, and plotted as a function of protein amount (Figure 4.5B).  
From these data sets, non-linear regression produced lines of best fit, using the 
saturated binding model (GraphPad Prism).  Because the same oligonucleotide was 
used in both binding experiments, a global Bmax was applied to both data sets such 
that comparisons of the Kd could be performed.  While this Kd in this scenario is not 
(and should not be used as) a measure of direct protein to DNA binding, it can be 
used to ascertain the relative level of discrepancy in a DNA retention assay.  In 
Table 4.2, a summary of the lines of best fit from Figure 4.5B is shown.   
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Table 4.2- Line of best fit summary for the percent retention of YtgA IGR Full Length DNA 
oligonucleotide by C-YtgC or DcrA 
 
 
Comparison of Kd values indicated that C-YtgC was more adept than DcrA in the 
retention of the oligonucleotide containing the ytgA IGR sequence.  The correlation 
coefficient for C-YtgC binding was just 0.743, which was probably due to the lack of 
baseline detection. It was expected that if a lower range of protein amounts had 
been utilized, a proper baseline for lack of retention would have created a robust 
non-linear regression line of best fit.   
 
4.2.5 C-YtgC DNA binding is iron-dependent  
 
 Preliminary evidence suggested that the IGR of ytgA was recognized by C-YtgC.  The 
reaction buffer utilized for this observation contained manganese.  This buffer was 
initially selected as a starting point due to its ability to activate FurEC.  Notably, many 
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metal-dependent transcriptional regulators, such as FurEC and DcrA possess metal-
binding regulatory sites that are promiscuous and allow a variety of divalent metals 
to enable DNA-binding function.  Therefore it was unclear whether C-YtgC was 
acting in the same manner.  It was hypothesized that iron would activate the DNA-
binding activity of C-YtgC, due to the differential transcription of ytgA under iron-
restricted conditions.  However, DNA-binding activity was clearly present in the 
absence of supplemented iron in the preliminary dot blot assay experiment.  
Whether C-YtgC metal binding was promiscuous, like FurEC or DcrA, or whether C-
YtgC was purified in a metal-bound state during its purification was unknown.   
 
4.2.5.1 Analysis of C-YtgC metal-specificity via dot blot assay 
 
To remove any chelatable iron that may have been co-purified with C-YtgC as a co-
factor, aliquots of C-YtgC were mixed with Chelex-100 resin, which sequesters 
divalent heavy metals (such as iron or manganese) effectively.  After treatment, the 
metal-free C-YtgC was incubated for 15 minutes with 125 μM concentrations of 
FeSO4 or MnCl2.  In this experiment, retention of the YtgA IGR FL DNA sequence was 
tested.  To control for any non-specific detection provided by any biotin in the 
protein sample itself, a no DNA control was also performed.   
 
Qualitatively, it appeared that only the iron-activated chelex-treated C-YtgC was 
able to retain the DNA on the NC membrane (Figure 4.6A).  The mock-activated and 
Mn-activated samples did not specifically retain the DNA to the NC blot.  The dot 
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intensities were measured with ImageJ software, and the percent intensity retained 
was calculated and adjusted by the mean intensity of the no protein control.  
Because the same DNA molecule was being observed in the different experimental 
groups, a global value for the maximum binding (Bmax) was used as a constraint for 
the construction of the lines of best fit (GraphPad Prism; summary shown in Table 
4.3). 
 
Because little retention was observed in the mock and Mn-treated samples, these 
sets of data did not conform effectively to non-linear regression (R2= 0.1023 and 
0.04477, respectively).  However, this approach led to a robust fit for the Fe-
activated sample (R2= 0.9879).  The Kd of the ferrous supplemented C-YtgC sample 
was 4.7±0.87 fmol.  From this experiment, it was clear that C-YtgC DNA-binding 
activity was positively regulated by iron, and that the activated C-YtgC bound the 
upstream IGR of its own operon.   
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Figure 4.6- Ferrous iron activates the DNA binding activity of C-YtgC for the IGR of ytgA.  (A) C-
YtgC was treated with Chelex-100 for 2 hours to remove all chelatable metals.  Various 
concentrations of metal-free C-YtgC were added to reaction buffer containing (125 µM) FeSO4, MnCl2, 
or water (mock-activated) and incubated for 10 minutes prior to the addition of Biotin-YtgA IGR FL 
(40 fmol).  After 20 minutes, samples were filtered in a double membrane dot blot.  DNA bound by 
protein was retained on the top nitrocellulose membrane, while unbound DNA was immobilized by 
the bottom nylon.  (B) Dot intensity was measured using ImageJ, and the percent detection retained 
by NC was calculated and plotted as a function of C-YtgC (fmol).  Curves of best fit were derived using 
a saturation binding model: y = Bmax * x / (Kd + x). 
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Table 4.3- Line of best fit summary for YtgA IGR FL retention after metal activation of C-YtgC 
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4.2.5.2 Analysis of C-YtgC metal specificity using the Octet optical biosensor 
 
To verify the metal specificity that had been observed utilizing the dot blot assay, an 
optical biosensor system was employed, through a collaboration with Dr. Scott 
Grieshaber (University of Florida, Gainesville).  This system, allows the detection of 
protein to DNA interaction through biolayer interferometry on disposable optical 
sensors.  In brief, biotinylated DNA corresponding to the ytgA IGR FL 
oligonucleotide was loaded onto a streptavidin-coated Octet biosensor.  Sensors 
were transferred to a solution containing C-YtgC that was unsupplemented, or had 
been supplemented with FeSO4 or MnCl2, for 30 minutes to allow association, 
followed by a 30 minute incubation in unsupplemented reaction buffer to measure 
dissociation.   The shift in wavelength ( in nm) which is a function of the thickness 
of the biomass present on the tip of the probe, was plotted as a function of time 
(Figure 4.7).  Data was adjusted to the length of the biolayer immediately prior to 
immersion in the protein containing solution (i.e. set to zero).   
 
Two non-linear regressions [ y = Bmax * x / (Kd + x) ] were performed on these data.  
The first (equation 1 in Table 4.4) did not constrain the Bmax for the data sets.  This 
analysis allowed the comparison of the maximum level of binding in each sample, 
and revealed that the FeSO4 supplemented sample exhibited the greatest binding 
capacity, which was nearly 2-fold greater than the 2nd closest binding sample 
(native).  Bpdl treatment of the protein did not appear to alter the binding profile of 
the native protein sample, presumably due to the low incubation time for the 
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protein with the chelator.  Supplementation with Mn2+ exhibited the lowest level of 
binding.  As expected, the no C-YtgC control exhibited zero binding during the assay.   
 
A second non-linear regression was applied to this set of data, in an attempt to 
determine the kinetics of binding.  This regression, summarized in equation 2 of 
Table 4.4, constrained the maximum binding to the highest observed in the assay, 
which was upon Fe2+.  This regression revealed a KA = 2.43 * 107 nM-1, which was 
>1-log stronger than each of the other samples.  The preliminary biochemical 
analysis confirmed that C-YtgC DNA binding was activated by iron, and less well by 
manganese in vitro.   
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Figure 4.7- Iron enhances C-YtgC binding of the IGR of ytgA.  Streptavidin conjugated assay tips 
were loaded with biotinylated- oligonucleotide that corresponded to the IGR of ytgA.  
Spectrophotometric absorbance at the end of the tip was measured and each tip was adjusted to 
zero.  Assay tips were transferred to a solution containing C-YtgC (native; black), C-YtgC plus 100 µM 
FeSO4 (blue), C-YtgC supplemented with 100 µM MnCl2 (orange), or reaction buffer (green; contained 
BSA) for 30 minutes (association phase), followed by transfer to unsupplemented reaction buffer 
(dissociation phase).  Binding is represented as nm of material bound to assay tips, which was 
measured spectrophotometrically.  Non-linear regression analysis was applied to each sample using 
a constrained Bmax for each sample (solid line).  Regression statistics are shown in Table 4.4. 
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Table 4.4- Non-linear regression comparison of octet binding 
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4.2.6 Identification of the C-YtgC binding region within the ytgA IGR 
 
Transcriptional repressors generally inhabit the same region as the promoter of the 
genes whose function they repress, such that RNA polymerase can not bind and 
initiate transcription (Pennella & Giedroc, 2005).  For DtxR-like homologues, this 
function is dependent on metal activation, thus under metal-replete conditions, the 
transcription of genes under the control of promoter regions with the cis-acting 
regulatory elements recognized by that protein are repressed.  In an attempt to 
narrow the region within the YtgA IGR that housed the cis-regulatory elements 
recognized by C-YtgC, the three biotinylated oligonucleotides (Figure 4.8) were 
added to C-YtgC that had been pre-incubated with iron, manganese, Bpdl, or EDTA 
and protein:DNA interaction was analyzed via the dot blot assay as previously 
described.  These sequences corresponded to the region overlapping the predicted 
transcriptional start site (“Promoter”), and two sequences of differing lengths that 
corresponded to the region of DNA that was transcribed but not translated (“5’ UTR 
Long / Short”).  It should be noted that henceforth Promoter, 5’ UTR Long and 5’ 
UTR Short, correspond to the sequences described in Figure 4.8. 
 
The chemiluminescent detection of the blots is shown in Figure 4.9.  Crease 
artificats in the nylon blots precluded the quantification of detection intensities.  
Qualitatively, it appeared the addition of Fe(II) caused the retention of the 5’ UTR 
Short and Long oligonucleotides to the NC blot.  None of the three DNA fragments 
were efficiently retained in the manganese, EDTA, or Bpdl supplemented samples, 
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which supported the notion that C-YtgC is activated by iron.  The Promoter 
oligonucleotide was not appreceably detected on either membrane in the Fe(II) 
supplemented sample.     
 
 
 
 
 
 
 
Figure 4.8- Schematic diagram of the biotinylated-DNA fragments used to narrow regions of 
cis-regulatory elements within the IGR upstream of ytgA.    The transcriptional start site for the 
ytgA gene in C. trachomatis L2 was published in a total RNAseq transcriptome study (Albrecht, C. M. 
Sharma, Reinhardt, Vogel, & Rudel, 2010).  The IGR upstream of ytgA in the L2 and D serovars is 98% 
identical.  Therefore it was predicted that the transcriptional start site for the gene in serovar D 
would be the same.   The region of the sequence that is transcribed, but not translated (UTR) is 
shown in light grey.  Using this information, several biotinylated DNA sequences were generated to 
correspond to the different regions of the ytgA IGR, including the Promoter (475 bp), the 5’ UTR Long 
(167) and the 5’ UTR Short (81 bp), and are indicated in dark grey. 
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Figure 4.9- C-YtgC is activated by iron and retains oligonucleotide sequences representing the 
the IGR of ytgA.  Various concentrations of C-YtgC were pre-incubated with 125 µM MnCl2 or FeSO4, 
or 100 µM EDTA or Bpdl for 15 minutes, prior to addition of various DNA fragments (described in 
Figure 4.8).  Samples were incubated for 30 minutes at RT and filtered through a double membrane 
dot blot.  Membranes were probed for biotinylated-DNA which was detected via application of a 
chemiluminscence HRP substrate.  Percent specific retention could not be calculated due to the 
artificts present in the nylon blots.   
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4.2.7 Verification of C-YtgC binding sites within the upstream IGR of YtgA. 
 
While the dot blot assay provided a semi-quantitative analysis of protein and DNA 
interaction, it was often variable, and depended greatly on the accuracy of the 
control samples.  Seemingly arbitrary retention in the no-protein control had a great 
influence the level of specific quantitative binding revealed by graphical analysis 
and non-linear regression.  Therefore, it was decided that the results obtained 
regarding in vitro binding were in need of verification through an independent 
method.  With this rationale, a reporter plasmid system was designed and 
engineered.  This engineered plasmid, pCCT101, allowed the insertion of various 
DNA sequences in between an arabinose inducible promoter (PBAD), and a full copy 
of the lacZ (ß-galactosidase) gene (of which a schematic diagram is shown in Figure 
4.10).  The hypothesis for this experiment was that if a sequence containing a C-
YtgC binding region was inserted into the KpnI restriction site within pCCT101, then 
upon the co-transformation of a plasmid expressing C-YtgC (pET151-CYtgC; shown 
in Figure 4.10B), expression of the lacZ reporter gene would be decreased.  Seven 
reporter plasmids with various inserts were engineered and are summarized in 
Table 4.5. 
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Figure 4.10- pCCT101 and pET151 vector backbones are compatible for co-transformation 
and contain different antibiotic resistance cassettes suitable for double selection of co-
transformants.    (A) pCCT101-EV was engineered from components of pACYC184 (NEB) and pBAD 
TOPO/V5/LacZ (Invitrogen) vectors.  A KpnI site was introduced using site-directed primer 
mutagenesis, and was utilized for the insertion of various DNA sequences into the region between 
the PBAD promoter and the RBS within the original vector.  (B)  The sequence corresponding to the 
TroR-like peptide encoded within YtgC was ligated into pET151-D/TOPO vector (Invitrogen) for 
polyhistidine tagged protein expression in E. coli. 
 
 
 
 
 
Table 4.5- Description of reporter plasmid IGR insertions used in this study 
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 E. coli were transformed with pET151-C-YtgC, pCCT101EV, or pCCT101YtgA IGR FL, or 
co-transformed with pET151-C-YtgC and either pCCT101EV or pCCT101YtgA IGR FL.  
The single transformation reactions were efficient, providing greater than 50 
colonies per 100 μl transformation reaction plated.  On the other hand, co-
transformants (selected through double anti-biotic treatment) were rare, resulting 
in just three clones for the pCCT101YtgA IGR FL with pET151-C-YtgC and zero clones for 
the pCCT101EV with pET151-C-YtgC.  To reduce the number of samples in this pilot 
assay, one pET151-C-YtgC transformant, two pCCT101EV transformants, three 
pCCT101YtgA IGR FL transformants, and three pCCT101YtgA IGR FL with pET151-C-YtgC 
co-transformants were selected for β-galactosidase enzyme activity.  Colonies were 
used to inoculate liquid cultures with appropriate antibiotics, that were sequentially 
induced with IPTG (for C-YtgC expression) and L-arabinose (lacZ expression).  
Samples were collected both for SDS-PAGE analysis of C-YtgC expression (Figure 
4.11A) and for measurement of enzymatic activity via the Miller Assay.  C-YtgC (19-
20 kDa) was clearly expressed in lanes 1 and 7-9, which corresponded to the 
pET151-C-YtgC single transformant, and three colonies harboring both the pET151-
C-YtgC and the pCCT101YtgA IGR FL constructs.  The presence of an intense protein 
band corresponding to 20 kDa was not apparent in samples without the pET151-C-
YtgC expression vector.   
 
The amount of ß-galactosidase enzyme activity was measured using the Miller 
Assay.  A low level of activity (<400 miller units) was measured from the strain 
harboring only the pET151-C-YtgC plasmid.  In contrast, the single transformants of 
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the pCCT101EV and pCCT101YtgA IGR FL constructs displayed mean enzymatic activity 
of 2431 and 1920 Miller units (M.U.), respectively.  The similarity in enzyme activity 
originating from the no-insert construct (pCCT101EV),  and the construct containing 
a 664 basepair insertion into the region between the promoter and vector ribosome 
binding site (pCCT101YtgA IGR FL) provided evidence that the insertion had no effect 
on enzyme output in the absence of C-YtgC.  By contrast, in the presence of a C-YtgC 
expression vector, the expression of β-galactosidase was severely repressed from 
the pCCT101YtgA IGR FL harboring strain.  This suggested that the presence of pET151-
C-YtgC caused the repression of the reporter gene, presumably through C-YtgC 
binding of the DNA sequence that had been inserted.  However, the control co-
transformation of the pCCT101EV and pET151-C-YtgC expression vector was not 
successful, and thus it remained unclear whether the addition of the transcriptional 
repressor would result in a similar decrease of the pCCT101EV control.  Thus, 
whether or not the decrease in expression from the pCCT101YtgA IGR FL was 
attributable to the presence of a binding site for C-YtgC or simply due to the added 
nutrient stress originating from the maintenance and expression of two vectors with 
in the bacteria was unknown. 
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Figure 4.11- The presence of C-YtgC causes repression of a reporter gene downstream of the 
YtgA IGR FL in E. coli.  Vectors were transformed individually into chemically competent BL21* E. 
coli and plated on selective LB-agar.  Alternatively co-transformation of the pET151-CYtgC and 
pCCT101- YtgA IGR FL were performed and plated on double selective LB agar.  Resultant colonies 
were used to inoculate LB broth cultures for overnight growth, followed by sub-culture the next 
morning, induction with IPTG (C-YtgC expression), and then induction with L-arabinose (ß-
galactosidase).  Samples were collected for verification of C-YtgC expression by SDS-PAGE (20 kDa) 
(A) or for measurement of ß-galactosidase enzymatic activity using the Miller assay (B).  Y-axis 
represents the mean M.U.  Error bars represent SD. 
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To ensure that all the necessary controls were in place in the next experiment, a 
sequential transformation protocol was utilized in which BL21* E. coli were initially 
transformed with pET151-C-YtgC and plated on selective LB agar.  A single 
transformant was used to inoculate an overnight LB culture, which was made 
electrocompetent through a series of wash steps.  The seven different reporter 
plasmids described earlier were electroporated into pET151-C-YtgC harboring 
bacteria, and plated on double selective media containing the colorimetric substrate 
X-gal, which is processed into a blue color upon ß-galactosidase activity.  The day 
after transformation, only colonies electroporated with pCCT101EV, pCCT101TyrP1 IGR 
FL, or pCCT1015’ UTR Short appeared blue, whereas colonies on all other plates appeared 
white, initially suggesting that only some transformation reactions possessed the 
reporter plasmid.  However, after an extra 12 hours of room temperature 
incubation, colonies of all the plates began to turn blue, indicating that ß-
galactosidase was, indeed, being expressed within all of the co-transformants.   
 
The Miller assay results of two independent experiments, in which three colonies of 
each co-transformant (i.e. 6 total biological replicates) were examined for ß-
galactosidase activity (Figure 4.12).  Co-transformants were grown in selective LB 
culture and induced for both C-YtgC and β-galactosidase expression.  The positive 
control, pCCT101EV did not appear to be inhibited by the expression of C-YtgC, as a 
mean of greater than 5000 Miller units (M.U.) was observed, which was comparable 
to expression from the pCCT101EV single transformant in a previous experiment.  By 
contrast, the expression from pCCT101YtgA IGR FL was repressed greater than 5-fold 
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(one-way ANOVA Tukey’s Multiple Comparisons Test, p<0.001) from the positive 
control.   
 
Although a previous experiment had shown no difference in expression between the 
pCCT101EV and pCCT101YtgA IGR FL single transformants, an added control was 
included in this experiment to exclude the effect of an extended artificial 5’ UTR on 
reporter gene expression.  The IGR of tyrP1 was chosen to test for this effect because 
the expression of the gene was not responsive to fluctuations in iron under Bpdl-
treatment, and no evidence suggested that it could be regulated through a metal-
dependent transcriptional regulator.  β-galactosidase expression from this control 
vector, pCCT101TyrP1 IGR FL was 3-fold higher than the YtgA IGR insert in the presence 
of C-YtgC (one-way ANOVA Tukey’s Multiple Comparisons Test, p<0.01), suggesting 
that a random insertion into the reporter plasmid was not the mechanism for 
decreased expression. 
 
It should be noted that the pCCT101YtgA IGR FL construct contains the putative 
chlamydial promoter, which could influence the expression of the reporter gene if 
efficiently recognized by the E. coli RNA polymerase.  Therefore, a reverse sequence 
control plasmid, pCCT101YtgA IGR FL (Rev), was made where the chlamydial promoter 
would direct transcription in the opposite direction, relative to the ß-galactosidase 
ORF, if the promoter element was recognized heterologously.   Indeed, expression 
from pCCT101YtgA IGR FL (Rev) was also repressed to near identical levels of its 
directional counterpart.  This suggested that C-YtgC binding does not need to be 
 187 
directional in order to inhibit RNA polymerase elongation, and that it was unlikely 
that any expression of the pCCT101YtgA IGR FL was attributable to recognition of the 
the chlamydial promoter element by E. coli RNA polymerase.    
 
The co-transformation assay also revealed that β-galactosidase gene expression 
from pCCT1015’UTR Long and pCCT101Promoter was significantly repressed from the 
pCCT101EV control (one-way ANOVA with Tukey’s multiple comparisons test, both 
p<0.001).  In contrast, the pCCT1015’UTR Short did not exhibit any repression of 
reporter gene expression, compared to pCCT101EV (one-way ANOVA with Tukey’s 
multiple comparisons test).  These results were somewhat inconsistent with the 
previous dot blot assay results indicating that C-YtgC binding sites were present 
within the YtgA IGR 5’ UTR Long and Short oligonucleotide sequences.  This assay 
indicated that no cis-regulatory element was located within the 5’ UTR Short 
fragment, and that, instead, a C-YtgC binding site was located within the Promoter 
oligonucleotide sequence.  However, both experiments indicated the presence of at 
least one C-YtgC binding site within the ytgA IGR. 
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Figure 4.12- Inserts corresponding to the YtgA IGR FL, YtgA Promoter, the YtgA 5’ UTR Long 
fragments allow repression C-YtgC repression.  Vectors were sequentially transformed into BL21* 
E. coli and resultant co-transformants were used to inoculate overnight LB broth cultures containing 
double selective antibiotics.  The next morning, samples were sub-cultured and grown to an OD>0.5, 
induced for C-YtgC expression for 4 hours, followed by 4 hours of ß-galactosidase induction.  Samples 
were collected at the end of the experiment for analysis of ß-galactosidase enzymatic activity using 
the Miller Assay.  The y-axis represents the mean miller units from 6 samples of each co-
transformation pair.  Error bars represent SD.  Statistical analysis (one-way ANOVA with Tukey’s 
multiple comparison test) is shown in Table 4.6. 
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Table 4.6- Statistical analysis of ß-galactosidase enzyme activity from Figure 4.12 
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 In summary, the co-expression of C-YtgC repressed the expression of a reporter 
gene downstream of the YtgA IGR FL, FL reversed, 5’ UTR Long and Promoter 
oligonucleotides.  This repression was not evident in the no-insert (EV) control, the 
non-specific insert (TyrP1 IGR FL) control, or the YtgA IGR 5’ UTR short fragment.  
This suggests that 1) C-YtgC binding is specific and the protein can distinguish 
between different DNA sequences, and 2) that it is likely that at least two 
independent cis-regulatory elements exist within the IGR upstream of the ytgA ORF. 
 
4.3 Chapter Discussion  
 
The aim of the research described in this chapter was to elucidate a molecular 
mechanism for the iron-dependent transcriptional regulation of ytgA that was 
observed when Chlamydia was subjected to iron starvation by treatment with the 
chelator, Bpdl.  C. trachomatis has been shown to express a protein homologous to 
the Fur family of transcriptional regulators, called DcrA , and was predicted to 
encode a polypeptide with similarity to the DtxR superfamily of transcriptional 
regulators, which was termed C-YtgC for this study.  Both of these transcriptional 
regulators were tested for binding of an oligonucleotide corresponding to the IGR 
upstream of ytgA, using a dot blot filtration assay that had been validated using 
FurEC as a positive control.  Recombinant C-YtgC, and not DcrA, was able to bind and 
retain the full length sequence of the ytgA IGR.  Binding was enhanced by 
supplementation with exogenous iron, and was reduced when the protein was 
treated with metal chelating agents.  Manganese did not activate DNA binding 
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activity.   Furthermore, dot blot evidence suggested that there may be at least two 
cis-regulatory elements within the IGR upstream of ytgA, as two DNA sequences 
corresponding to separate regions of the IGR were retained via C-YtgC binding.  This 
result was confirmed using a β-galactosidase reporter gene system, which, again, 
showed that C-YtgC was able to recognize two distinct DNA sequences that 
corresponded to non-overlapping regions of the IGR of ytgA.  Taken together, C-YtgC 
is a functional DNA binding protein capable of distinguishing different sequences of 
DNA, and whose activity is regulated via the presence or absence of iron.   
 
The major assumption for initiating the analysis of C-YtgC, is that it would be 
cleaved or processed away from its membrane-anchored N-terminal component at 
some point during infection.  Without knowing where such a cleavage point would 
occur, the first decision made in the in vitro characterization of the C-YtgC 
polypeptide occurred in the plan for cloning. Normally an entire bacterial ORF is 
amplified via PCR and ligated into an expression vector; this was the approach used 
for the cloning of DcrA and FurEC.  However, in this case of amplification from a fused 
gene, it was unclear where the TroR-like domain of YtgC actually began.  Therefore, 
a point in the gene that was midway between the last predicted transmembrane 
region, and the beginning of the predicted helix-turn-helix DNA binding motif was 
chosen as a starting point for amplification, which resulted in the amplification of 
the sequence corresponding to the last 138 amino acids of the YtgC protein.  The 
resulting recombinant protein (N-terminal polyhistidine and V5 tag) resulted in a 
protein of 178 amino acids that was, unfortunately, completely insoluble.   
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Whereas DcrA and FurEC were purified without any complication, the C-YtgC was 
nearly exclusively retained in the insoluble lysate fraction.  Perhaps the arbitrary 
selection of the start site for nucleotide amplification was suboptimal, resulting in 
the disruption of a normal secondary structure that would normally stabilize the N-
terminus of the protein.  Regardless, the insolubility of C-YtgC was remedied 
through the use of a new protocol, in which the inclusion bodies that contained the 
recombinant protein were isolated, and then treated with a gentle detergent to 
liberate the contents of these inclusion bodies into the soluble fraction.  This 
protocol yielded a sufficiently purified protein that was subsequently tested for in 
vitro DNA binding activity. 
 
In order to measure protein to DNA interaction, the dot blot assay was initially 
selected.  This method was chosen because the exact metal-activating conditions of 
C-YtgC (if any) were not known, and the dot blot method allowed the opportunity to 
screen many samples at the same time.  Electromobility shift assay was discussed, 
however this technique led to the identification of several false activating metals for 
Fur homologues, due to the inability of the researchers to clear the gel of 
contaminant metals prior to the retardation assay.  The dot blot provided a much 
more efficient way to screen many different metal binding conditions, along with 
various DNA sequences, as illustrated in Figure 4.8.  Moreover, the dot blot assay 
allowed the quantification of binding retention via the measurement of dot 
intensities, plotting those values against protein concentration, and performing non-
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linear regression on those plots.  It is important to note that this method does not 
measure binding affinity, per se, but rather the ability of a protein to retain DNA for 
detection.  Despite this limitation, conclusions regarding relative binding affinity 
could still be made.  Because this chemiluminescent detection probably does not 
observe a linear relationship with the amount of DNA present, any mention of a Kd 
for these dot blot assays should not be referred to as a binding constant.  Rather it 
simply refers to the amount of protein for which half of the maximum percent NC 
retention is observed.  However, Kd values can be used to compare the relative 
binding affinity of an oligonucleotide to different proteins, or one protein 
supplemented with different ‘activating’ ligands, as the detection becomes relative 
in this scenario.   
 
Another note about the dot blot assay is that commonly, the higher concentrations 
of protein added would result in lower amount of DNA detection on the NC blot 
compared to mid-range concentrations.  This phenomenon originates from a 
blocking effect, which was described previously (Czerwinski, Hovan, & Mascotti, 
2005), in which the amount of protein exceeds the binding capacity of the NC blot.  
In this scenario, protein that had bound the DNA, but could not be transferred to the 
NC blot due to binding constraints, would be washed away upon dot blot apparatus 
disassembly.  In situations where this effect was evident, for instance the 500-fmol 
sample of Fur retention of the Fur Box fragment (Figure 4.4A), specific samples 
were omitted from quantitative analysis.  This step was usually necessary for 
accurate line of best-fit derivations.   
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Regression was not always necessary to determine binding.  For instance, DcrA did 
not retain the tagged ytgA IGR FL sequence to the NC membrane.  Because the 
buffering conditions were identical to the conditions that allowed Fur to specifically 
bind the Fur Box sequence, and the initial characterization of DcrA reported that 
manganese was an activating metal ligand of the protein (Wyllie & Raulston, 2001), 
this result indicated that DcrA truly did not bind and retain the YtgA IGR sequence.  
However, to make this conclusion, a positive control would be necessary.  Perhaps 
generation of one of the sequences that was reportedly bound by FurEC in the Fur 
titration assay (Rau, Wyllie, Whittimore, & Raulston, 2005) would have sufficed.  
However, such experiments were beyond the scope of the goal, which was to 
determine the identiy of trans-regulating factors that could bind the IGR of ytgA.   
 
Considering the TroR transcriptional regulator from T. pallidum was shown to 
recognize the IGR of its own operon (Posey, Hardham, Norris, & Gherardini, 1999), 
C-YtgC was predicted to similarly bind to the IGR of ytgA.  What was perhaps 
surprising was that this specific buffering condition promoted DNA binding.  While 
the DtxR superfamily of transcriptional regulators are regulated by a variety of 
metals, C-YtgC was hypothesized to regulate in response to iron-deprivation, a la the 
elevated expression of ytgA under iron-restricted conditions.  However, the binding 
buffer used in this experiment was the same used in the Fur validation dot blot 
assay, and was chosen only as a logical starting point for analysis.  Whether binding 
was activated by the exogenous Mn2+, which was added to the reaction buffer, or 
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whether its native metal (e.g. iron) was ‘pulled-down’ during the protein 
purification from growth in a metal-replete culture was unknown.   
 
In order to test this, a resin (Chelex-100) was utilized to remove all chelatable 
divalent heavy metals from the protein stocks prior to metal resupplementation and 
dot blot assay.  This method led to the identification of Fe2+ as an essential co-factor 
for the DNA-binding activity of C-YtgC, whereas Mn2+ was not able to activate DNA-
binding over the mock-activated sample set.  This result provided a clear 
mechanism for the iron-dependent transcriptional regulation of ytgA that was 
observed upon Bpdl-mediated iron-depletion.  C-YtgC was only able bind a DNA 
sequence corresponding to the IGR of ytgA when iron was supplied as a co-factor.   
 
What are the implications that C-YtgC was activated by iron and not manganese?  
DtxRCD functions in the regulation of several functions, including both toxin 
production and iron-acquisition, and is regulated by several divalent metals (Tao & 
J. R. Murphy, 1994).  TroRTP, which autorepresses its own operon, which encodes a 
manganese uptake system (Hazlett et al., 2003), is regulated by manganese (Posey, 
Hardham, Norris, & Gherardini, 1999).  Recent evidence suggested that YtgA from C. 
trachomatis, selectively bound iron over manganese and zinc (J. D. Miller, Sal, Schell, 
Whittimore, & Raulston, 2009), which is consistent with the finding here, that C-
YtgC DNA binding activity was regulated only by iron in vitro.  This evidence 
supports the hypothesis that the Ytg ABC-metal transport system functions in vivo in 
the import of iron into the chlamydial cytoplasm.   
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The next step was to identify the cis-regulatory elements that were recognized by C-
YtgC.  Fortunately, the transcriptional start site of ytgA had been published in a 
RNAseq total transcriptome publication (Albrecht, C. M. Sharma, Reinhardt, Vogel, & 
Rudel, 2010) (shown in Figure 4.8).  This knowledge allowed the design of a range 
of oligonucleotides to test the binding capabilities of the different regions within the 
ytgA IGR.  One corresponded to the first 475 base-pairs of the IGR when read from 5’ 
to 3’, which encompassed the predicted promoter region and approximately 20 
base-pairs downstream of the transcriptional start site, and was termed the 
“Promoter” fragment.  The second was generated corresponding to the last 167 
base-pairs of the IGR (read from 5’ to 3’), and was termed the “5’ UTR” fragment.  
Because these fragments did not correspond to overlapping sequences, it was 
predicted that one would narrow the binding region, while the other would serve as 
a negative control sequence.   
 
In other examples of metal-dependent transcriptional repressors, these elements 
are normally found proximally the promoter region, where protein binding can 
interrupt the RNA polymerase initiation, thus inhibiting transcription.  Therefore it 
was predicted that the Promoter oligonucleotide would be bound by C-YtgC.  
However, initial in vitro Dot Blot results indicated that two oligonucleotides 
corresponding to the 5’ UTR of the ytgA transcript were bound by iron-activated C-
YtgC, whereas the Promoter oligonucleotide could not be detected on either 
membrane in this assay.  A somewhat different pattern of binding was observed by 
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the β-galactosidase reporter assay, which measured the ability of C-YtgC to bind and 
prevent transcription through a chosen sequence inserted between an artificially 
induced promoter, and the RBS binding site / lacZ ORF.  As the ytgA IGR FL, 
Promoter, 5’ UTR Long insertions allowed C-YtgC mediated repression of lacZ 
expression in this artificially induced system, it was clear that C-YtgC binding 
downstream of a promoter/transcriptional start site could prevent RNA polymerase 
elongation in vivo, albeit in a heterologous system to C. trachomatis.  On the other 
hand, it did not appear that E. coli RNA polymerase could recognize the C. 
trachomatis promoter elements that were inserted into the reporter plasmid.  
Therefore, it was not possible to test the ability of C-YtgC to prevent transcriptional 
initiation.  This caveat needs to be resolved.  The utilization of this system in an E. 
coli strain harboring genes for chlamydial sigma factors would allow the 
observation of the ‘native’ (i.e. not from the upstream arabinose inducible 
promoter) expression in the presence/absence of C-YtgC.  
 
The presence of two cis-regulatory elements within one IGR of a regulated transcript 
may indicate a DNA bending mechanism, analogous to the lac repressor in E. coli.  In 
this system, a series of operating sequences are recognized and bound by a homo-
dimer of the LacI repressor (Reznikoff, Winter, & Hurley, 1974).  At high enough 
concentration, two dimers can associate, creating a homo-tetramer of LacI, which is 
bound to two distinct operator sequences; this subsequently causes a topological 
bend in the DNA molecule.  This structure prevents the RNA polymerase initiation 
and represses the transcription of the lac operon at greater than 1300-fold from its 
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unbound state (Krämer et al., 1987).  If the C-YtgC and ytgA IGR FL presents an 
analogous system, perhaps the two binding regions observed in this study would 
allow the homo-tetramerization of C-YtgC and the subsequent topological bending 
of the ytgA promoter region in vivo.   
 
While interesting, the operating sequences recognized by C-YtgC had not been 
identified in full yet.  In an attempt to define the cis-regulatory elements responsible 
for C-YtgC binding, the fact that C-YtgC appeared to bind to two separate locations of 
the IGR upstream of ytgA was exploited.  The region of the 5’ UTR Long 
oligonucleotide that did not correspond to the 5’ UTR short oligonucleotide (which 
was not bound by C-YtgC) was aligned with the Promoter sequence (Figure 4.13).  
Interestingly, the predicted region of binding within 5’ UTR Long fragment aligned 
with the Promoter oligonucleotide in the general vicinity of the ytgA promoter 
operator sequences and the transcriptional start site.  Three consensus sequences 
were extrapolated from regions of homology that corresponded to 19-23 basepairs.  
However, individually, these consensus sequences were not homologous to each 
other and individually, these sequences (even allowing nucleotide mismatches) 
were not found anywhere else in the chlamydial genome.   
 
Normally, one would utilize DNase footprinting analysis to reveal the actual 
nucleotides that were protected via C-YtgC binding.  This approach was attempted 
in a pilot experiment using the biotin-tagged DNA molecules, however detection of 
the biotin DNA tag was not sensitive enough for this approach.  Normally this 
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technique is performed using radioactive end labeled oligonucleotides, and it was 
determined that this capability was essential for the successful application of the 
DNase footprint approach.  It is likely that collaboration with an expert in DNase 
footprint analysis would be the most efficient method for elucidation of such 
sequences.   
 
Alternatively, one could employ a selective enrichment approach, in order to define 
the optimal theoretical DNA binding sequence for the C-YtgC protein.  This 
technique, referred to as SELEX (systematic enrichment of ligands by exponential 
enrichment), utilizes continued rounds of binding reactions in which C-YtgC is 
activated and mixed with random oligonucleotides that contain known flanking 
regions.  After each round, oligonucleotides that were pulled down with the 
recombinant protein are amplified and used in another round of binding.  This 
process is continued until a predominant sequence is identified as the theoretical 
binding sequence for the protein.  This approach was attempted by a visiting 
scientist within our laboratory, Sophie Nicod.  However, due to technical issues, this 
approach was also unsuccessful.  
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Figure 4.13- Nucleotide alignment of regions shown to contain C-YtgC operating sequences.    
The regions of the analyzed oligonucleotides which had been observed as bound by C-YtgC were 
aligned using 65% similarity cost matrix (Geneious).  Highlighted nucleotides indicate identity.  The 
predicted promoter region for ytgA is highlighted by green.   
 
 201 
Thus unfortunately, the actual cis-regulatory elements for ytgA transcriptional 
modulation were not identified.  Regardless, a possible trans-acting factor for the 
modulation of ytgA had been identified and characterized as an iron-dependent DNA 
binding protein.  The identification of this polypeptide as a functional DNA binding 
protein was novel.  Although the attempt to define the operating sequences 
recognized by C-YtgC was unsuccessful, the regions containing such sequences were 
narrowed and a simple collaboration with an expert in DNase footprint analysis 
could easily determine such sequences. 
 
This entire chapter dealt with the in vitro characterization of C-YtgC.  However the 
major caveat to these reports is that the polypeptide is predicted to be a fused 
partner of a membrane bound channel protein.  Thus in order to validate these 
observations as relevant in vivo, YtgC needed to be examined for possible cleavage 
events that could liberate the C-terminal DNA binding polypeptide from the 
bacterial membrane.  Preliminary results for this characterization will be discussed 
in the next chapter. 
 
4.4 Chapter Conclusions 
 The polypeptide encoded at the C-terminus of YtgC (C-YtgC) maintains 
homology to the TroR metal-dependent transcriptional repressor of T. 
pallidum 
o The C-terminus of YtgC is predicted to reside in the bacterial 
cytoplasm 
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 C-YtgC binds the IGR upstream of its own operon in vitro  
o DNA binding activity is regulated by iron and not manganese 
 At least two cis-regulatory elements appear to be present within the IGR of 
ytgA 
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Chapter 5- Examination of a heterologous cleavage event 
of YtgC when recombinantly expressed in Escherichia coli 
 
 204 
5.1 Chapter Introduction 
 
The TroR-like peptide encoded within the C-terminus of YtgC (termed, C-YtgC) was 
proven to be a functional iron-dependent DNA binding protein.  It selectively 
recognized the IGR of its own operon, which indicated a possible mechanism for the 
differential expression of ytgA observed upon low-iron availability.  However, this 
DNA binding peptide could not function in vivo unless it was cleaved away from the 
membrane bound channel domain at the N-terminus of the protein.  Therefore, it 
was predicted that a cleavage event must occur such that the metal-dependent DNA 
binding polypeptide, could be liberated into the cytoplasm and exact transcriptional 
modulation.  Interestingly, a predicted zinc metalloprotease, YaeL (also known as 
RseP), exists downstream from the Ytg operon in both C. trachomatis and C. 
pneumoniae.   
 
In E. coli, YaeL cleaves the anti-sigma factor, RseA, away from its membrane-
embedded anchor peptide, to liberate the RseA-σE complex into the cytoplasm, 
where targeted proteolysis degrades the rest of the anti-sigma factor, allowing σE to 
enact transcriptional modulation (Alba & Gross, 2004).  Biochemical analysis of 
YaeL substrates revealed that helix-destabilizing residues were essential for the 
recognition and cleavage of transmembrane domains, which suggested that the zinc 
metalloprotease was able to recognize and cleave ‘loose’ transmembrane structures 
(Koide, Ito, & Akiyama, 2008).  It was hypothesized that a similar mechanism could 
be occurring in C. trachomatis, such that YaeL (or some other unknown integral 
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membrane protease) could be liberating C-YtgC from its membrane bound portion, 
perhaps in a metal-dependent manner.  Interestingly YaeL homologues from E. coli, 
V. cholera, and B. bronchiseptica were shown to be interchangeable in the 
complementation of a B. bronchiseptica ΔhurP (yaeL) mutant (King-Lyons, K. F. 
Smith, & Connell, 2007), suggesting that the different homologues were able to 
recognize and cleave the same substrates.  This presented a strong rationale to clone 
and express a double-tagged full length YtgC protein in E. coli, in order to detect any 
potential cleavage events that may occur heterologously.   
 
 
 
 
 
 
 
 
Figure 5.1- A gene coding for a membrane-bound zinc metalloprotease is proximal to the ytg 
operon.  The gene, yaeM, codes for a predicted metabolic enzyme in the non-mevalonate pathway for 
isoprenoid biosynthesis, and is directly downstream of the ytg operon.  The next gene downstream is 
yaeL, which codes for a predicted site 2 specific membrane bound protease that is zinc-dependent.   
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5.2 Results 
 
5.2.1 Recombinant C-YtgC is purified as a protein doublet 
 
During the purification of C-YtgC, described in chapter 5, the various fractions 
collected from the nickel resin column were resolved by SDS-PAGE and analyzed via 
coomassie blue protein staining.  In several attempts to purify the protein to a 
sufficient purity, a protein ‘doublet’ was eluted in the 19-20 kDa range.  A 
representative gel is shown in Figure 5.2.  This elution of a doublet was observed in 
six of eight attempts to purify C-YtgC to a single detectable protein.  It was 
hypothesized that the arbitrary selection for the C-YtgC starting point, had resulted 
in the cloning and expression of a protein with a hydrophobic or unstable N-
terminus, as indicated by its insolubility (Figure 4.2C).  The repeatable observation 
of a protein doublet corresponding to 19-20 kDa provided the hypothesis that 
perhaps some protease in E. coli could recognize and cleave this N-terminal 
hydrophobic domain (containing the polyhistidine tag) away from the rest of the 
TroR-like peptide, with subsequent protein dimerization resulting in the pull-down 
of the processed species with the unprocessed  pHis-C-YtgC.  To test this hypothesis, 
a full length YtgC ORF was ligated to a sequence coding for the FLAG epitope 
(DYDDDK) and cloned into a pBAD vector for the expression of a C-terminal V5 and 
pHis tag recombinant protein (vector map shown in Figure 5.3).  The resultant 
expression from the vector would yield the entire YtgC protein, tagged at the N-
terminus with the FLAG epitope and at the C-terminus with a V5 and pHis tags.   
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Figure 5.2- A protein doublet is eluted from a nickel column purification of polyhistidine 
tagged C-YtgC.  Liberated fractions from detergent treated inclusion body preparations were pooled, 
dialyzed and applied to a Ni-NTA (nickel) column (QIAGEN).  Fractions were collected at each step 
and resolved by SDS-PAGE, prior to visualization by coomassie staining.  FT- flow through; W- wash 
step (low imidazole), E- elution step (high imidazole).  C-YtgC was predicted to migrate at 20 kDa.  A 
magnification of the boxed portion of the gel is shown on the right, to illustrate the presence of two 
potential species of the C-YtgC protein.   
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Figure 5.3- A vector map of pBAD-FLAG-YtgC-pHis (pBAD-FYH).  Full length YtgC is tagged on the 
N-terminus with a FLAG epitope, and on the C-terminus with both V5 and pHis epitopes.  Tag epitope 
(purple), coding sequence (yellow), promoter (light green), promoter repressor and antibiotic 
resistance genes (green), origin of replication (light blue). 
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5.2.2 Recombinant YtgC is heterologously cleaved in E. coli 
 
The rationale for the design of the expression vector illustrated in Figure 5.3, was 
that if the full length YtgC was cleaved in E. coli, then the ability to visualize the 
migration pattern of both the resultant N-terminal and C-terminal peptides would 
identify the general region in which the protein was recognized and processed by a 
putative protease.  BL21* E. coli harboring this expression vector, pBAD-Flag-YtgC-
pHis (pBAD-FYH), were grown in LB broth that was unsupplemented (uninduced 
control), supplemented with D-glucose (expression repressed), or L-arabinose 
(expression induced).  Additionally, a pBADEV vector was utilized to determine 
antigen specificity.  Samples were collected at 2, 4, and 6 hours post induction and 
equal amounts of bacteria were resolved by SDS-PAGE.  A dilution/loading control 
was provided by staining a parallel gel with coomassie stain, and showed that all 
lanes were relatively evenly loaded.  Immunolabelling against the FLAG epitope 
revealed the presence of a 50 kDa protein that was specific to the uninduced and 
induced samples of the 2 and 4 hour time points.  This MW corresponded to the 
recombinant protein, which was predicted to have a MW of 55 kDa.  Interestingly, 
no detection of a protein band of this size was evident in either the uninduced or 
induced condition of the 6 hour sample.  This result suggested the degradation of 
the full-length protein, however, the FLAG antigen was not detected at a lower 
molecular weight, as was expected.     
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This blot was stripped and reprobed for the V5 epitope, which was tagged to the C-
terminus of YtgC in the expression vector.  This blot exhibited only one non-specific 
band that resolved at approximately 35 kDa, as evidenced from its detection in the 
EV control.  Similar to the FLAG detection, full length recombinant protein was 
detected at approximately 50 kDa in the uninduced and induced samples of each 
time-point, and was not observed in the repressed or EV control.  The protein was in 
the greatest quantity at 2 hours post induction in the induced sample.  The intensity 
of the band at this molecular weight decreased at 4 and 6 hours, which was 
consistent with the FLAG detection blot.  In the induced sample of each time-point 
an additional four or five products were observed at lower molecular weights.  The 
intensities of these lower molecular weight bands seemed to increase in an 
inversely proportional relationship to the full length (50 kDa) protein.  The 
molecular weight sizes of these bands ranged from approximately 26 to 32 kDa.   
 211 
 
Figure 5.4- Full length YtgC is heterologously cleaved in E. coli, resulting in the stable 
expression of multiple lower molecular weight forms of the C-terminal product.   Liquid 
cultures of bacteria harboring the pBAD empty vector or PBAD-FYH were grown in the presence of 
glucose (PBAD repression), arabinose (PBAD expression), or were not supplemented (uninduced 
control).  Samples were collected at 2, 4 or 6 hours after induction and equal OD amounts of the 
protein were resolved by SDS-PAGE.  Resolved samples were transferred to NC and immunoblotted 
for the presence of the FLAG-epitope (A).  After chemiluminescent detection, blot was stripped with 
a low pH buffer, and reblotted for detection of the V5-epitope (B).  The full length FLAG-YtgC-V5-
pHis protein was predicted to migrate around 50 kDa.  Bands specific to the uninduced and induced 
samples are indicated with arrows.   
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5.3 Chapter Discussion 
 
Preliminary results indicated that the full length YtgC protein was cleaved 
heterologously in E. coli, resulting in the decreased presence of the full-length 
protein and the increased presence of four-five low-molecular weight species of the 
YtgC C-terminus.  These fragments appeared as distinct protein bands, which 
indicated that specific sites were recognized and cleaved to form stable peptides.  
Whereas the decreased detection of full-length protein in the anti-V5 blot was 
correlated to an increase in the lower molecular weight fragment detection, this was 
not the case for the anti-FLAG blot.  The full-length recombinant protein appeared to 
decrease over time, yet no fragments of lower molecular weight were detected.   
 
One explanation could be that the membrane portion of YtgC is unstable on its own.  
In the Tro operon, TroC and TroD were predicted to form a complex in order to 
form a channel protein for the import of manganese (Hazlett et al., 2003).  It is 
predicted that the YtgC TroC-like domain and YtgD may form a similar interaction in 
vivo, thus stabilizing each other.  In order to test this, one could co-express YtgD (or 
even the entire operon) in order to determine if the presence of additional 
components of the transport complex would stabilize the N-terminal fragment of 
YtgC in this system. 
 
The presence of multiple C-terminal fragments (i.e. multiple versions of C-YtgC) was 
also unexpected.  The initial model proposed during the design and implementation 
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of this experiment was that there would be a protease recognition site that was 
proximal to the last transmembrane domain, and that such a cleavage would allow 
the predicted function of both protein components independent of one another.  
However, the presence of four to five detectable lower molecular weight bands of 
the C-terminal fragment that migrated at a range of approximately 26-32 kDa, 
suggested that many sites within the YtgC protein were recognized and cleaved by a 
putative protease.   
 
As mentioned previously, YaeL (RseP) was shown to recognize helix-destabilizing 
residues within transmembrane domains, such that it may cleave a protein 
substrate in a structure-dependent but sequence-independent manner (Koide, Ito, & 
Akiyama, 2008).  The transmembrane domains of YtgC were examined for residues 
of low-helical propensity (derived from (Pace & Scholtz, 1998)), and interestingly, at 
least one glycine residue (which was the second least helical amino acid) was 
present in 6 of 7 predicted transmembrane domains.  Putative cleavage sites were 
defined, and the molecular weight size of each of the resultant fragments was 
calculated in order to gauge where YtgC may have been cleaved (Figure 5.5).   
Taking into consideration that proteins do not always migrate at their exact 
molecular weight (i.e. the full-length Flag-YtgC-V5-pHis molecule was predicted at 
55.4 kDa but migrated at approximately 50 kDa), it appears that there may be 
multiple cleavage sites within the last three or four predicted transmembrane 
domains.  Cleavage events that had occurred in the first four transmembrane 
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domains were not apparent via the immunoblotting, as this would have resulted in 
the detection of the V5 epitope at molecular weights greater than 37 kDa.    
 
This non-specificity of cleavage sites was unexpected.  However, the cleavage of an 
N-terminal transmembrane domain does not preclude a subsequent cleavage of 
another domain downstream.  Therefore, the multiple fragments observed in this 
preliminary experiment does not alter the model that the TroR-like peptide at the C-
terminus of YtgC could, in fact, be liberated into the cytosol in order to enact its DNA 
binding function. One way to test this would include the fractionation of bacteria 
harboring the pBAD-FYH expression vector, in order to determine the solubility of 
the resultant fragments.  It is predicted that only the lowest molecular weight 
fragment would be present in the soluble fraction.  Another possibility is that the 
recombinant expression of YtgC without YtgD in E. coli yields an incorrectly folded 
protein.  Perhaps, through the stabilization of YtgD, the accessible transmembrane 
domains that were cleaved in heterologously would be inaccessible to proteolysis.   
 
Additional future directions include the expression of this construct in a yaeL E. 
coli could determine if the membrane protease was, in actuality, responsible for 
these heterologous cleavage events.  Of course, the major caveat to this experiment 
is that it is heterologous.  A concomitant experiment would be the generation of an 
antibody that recognizes the C-terminal portion of YtgC.  This way, the size of the 
full length YtgC protein could potentially be detected via western blot in the context 
of chlamydial infection in vivo.  Despite the preliminary nature of the data, it is 
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complelling enough to justify further and more detailed investigation of a 
potentially novel mechanism for the activity of iron-dependent repressors.  The 
generation of an antibody raised against the C-YtgC peptide is paramount to 
determining whether this regulated cleavage occurs during an infection. 
 
 
 
 
 
   
 
Figure 5.5- Schematic diagram of putative cleavage sites based on the presence of helix-
destabilizing residues within transmembrane domains of FLAG-YtgC-V5-pHis. Each 
transmembrane domain was analyzed for the presence of helix de-stabilizing residues, which could 
possibly be recognized by a YaeL protease.  Resultant C-terminal fragments from the hypothesized 
cleavage points are shown, along with their predicted molecular weight in kDa.  Yellow represents 
the YtgC coding sequence.  Red represents the predicted transmembrane domains (Hidden Markov 
Model TM prediction; Geneious).  Purple represents the recombinant tags.   
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 5.4 Chapter Conclusions 
 Full-length YtgC is cleaved when expressed recombinantly in E. coli 
 The N-terminal fragment produced by cleavage is unstable 
 Several C-terminal fragments of the cleavage event are stable 
o The molecular weight of these fragments correspond to cleavage 
events that would occur in the last three transmembrane domains 
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Chapter 7- General Discussion  
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Iron is an essential nutrient in nearly all organisms.  Its ability to undergo one-
electron redox reactions make it instrumental as an electron intermediate, co-factor, 
or prosthetic group.  All pathogenic bacteria must outcompete the hosts in which 
they reside for this micronutrient (Skaar, 2010).  This battle has been a clear 
selective force for the co-evolution of host and pathogen.  For instance, upon 
intracellular infection, the induction of IFN-γ causes the suppression of TfR 
expression and the induction of ferroportin for cytosolic iron export (Eugene D 
Weinberg, 2009), thus effectively reducing intracellular iron-concentration.  
Intracellular pathogens, such as Chlamydia trachomatis, must have some mechanism 
for overcoming this innate immunity of the host. 
 
In the context of intracellular iron traffic, where could Chlamydia access this vital 
micronutrient?  The predominant source of intracellular iron originates from the 
transferrin system.  Ehrlichia chaffeensis, a distant intracellular relative of C. 
trachomatis, recruits endocytic vesicles containing transferrin to fuse with its 
inclusion membrane, thus delivering iron directly to the bacteria (Barnewall, 
Rikihisa, & E. H. Lee, 1997).  However, chlamydial inclusions exhibit very few 
interactions with the endocytic pathway (Scidmore, Fischer, & Hackstadt, 2003).  In 
fact, the transferrin-laden (and presumably iron-laden) vesicles that enter the cell 
via the transferrin receptor mediated endocytosis do not fuse with the chlamydial 
inclusion, and instead accumulate around its periphery (van Ooij, Apodaca, & J. 
Engel, 1997; Ouellette & R A Carabeo, 2010; M A Scidmore, E R Fischer, & T 
Hackstadt, 1996).  If the recycling of the transferrin/transferrin receptor complex is 
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interrupted, chlamydial development is inhibited (Ouellette & R A Carabeo, 2010), 
which suggests an important role for vesicle recruitment to the periphery of the 
inclusion.   
 
If the recruitment of these vesicles is important for development, yet they do not 
fuse with the inclusion membrane, how does Chlamydia acquire iron?  To our mind, 
two possibilities exist.  The first is that the iron/transferrin-laden vesicles are able 
to briefly touch but do not completely fuse with the inclusion membrane, in a ‘touch 
and go’ mechanism, first postulated by Hatch & McClarity (G. M. Hatch & G McClarty, 
1998).  This would allow transient transfer of soluble endosomal cargo (including 
metal ions), while excluding the transfer of large glycoproteins or membrane 
components (Figure 6.1).  The second possibility is that ferric iron must be reduced 
and transported outside of the endocytic membrane prior to chlamydial acquisition 
(Figure 6.2); this scenario may or may not require a mechanism for iron transport 
across the inclusion membrane.  Heinzen et al. (1997) reported that the inclusion 
membrane was not permeable to markers of ≥520 daltons, although they were 
unable to test lower molecular weight tracers (Heinzen & T Hackstadt, 1997).  Thus 
the possibility exists that iron atoms that are exiting the recycling endosomes in the 
vicinity of the inclusion may diffuse into the inclusion lumen where they could be 
accessed via chlamydial import.  Alternatively, iron exiting the recycling endosomes 
into the space peripheral of the inclusion could be actively transported across the 
inclusion membrane via an Inc protein or another cation transporter.  In all cases,  
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the proximity of the recycling endosomes to the inclusion periphery could increase 
the propensity for cytosolic iron acquisition, instead of its typical incorporation into 
the ferritin-storage complex, which would make it inaccessible to Chlamydia. 
 
Once iron has traversed the inclusion membrane (either through transient 
endosome contact or through a cytosolic route) the Ytg ABC-transport system may 
be capable of importing iron into the bacterial cytoplasm in an ATP driven process.  
This is supported by the observation that YtgA localized to the chlamydial periplasm 
in vivo, and that it selectively bound iron in vitro (J. D. Miller, Sal, Schell, Whittimore, 
& Raulston, 2009). 
 
The observation of the relatively inefficient inhibition of chlamydial growth by the 
membrane-impermeable chelator DFO may offer a clue to the potential mechanism 
of intracellular iron-acquisition by Chlamydia.  Membrane-impermeability would 
restrict DFO to chelation of extracellular iron, and thus depleting the supply of iron 
that would normally be acquired via endocytic uptake.  The observed relative 
inefficiency in starving chlamydiae of iron by DFO indicates that there may be an 
alternative non-vesicular pool of iron that is utilized.  One possible source would be 
the cytosolic labile iron pool, i.e. the iron incorporated within lower affinity iron 
proteins, and independent of the ferritin storage complex.  Thus the increased 
potency of Bpdl treatment against chlamydial development could represent the  
depletion of this cytosolic pool of iron.  We also cannot discount the possibility that 
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the higher efficiency of growth inhibition by Bpdl was simply due to the ability of 
the chelator to access iron within the chlamydial organism.   
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Figure 6.1- Illustration of the ‘touch and go’ mechanism for direct acquisition of ferric iron by 
Chlamydia.  In this model, iron-laden vesicles, entering the host cell via the transferrin pathway, are 
trafficked to the periphery of the inclusion.  Iron is transferred into the inclusion through transient 
pores that form between the endocytic vesicles and the inclusion membrane.  Transient fusions 
would exclude the transferrin/transferrin receptor complex (which should be intact at the 
endosomal pH) from transferring into the inclusion membrane.   
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Figure 6.2- Illustration of a model for cytosolic iron-acquisition.  In this model, iron entering the 
cell via the transferrin system would be reduced by STEAP3 and exported into the cytosol via DMT1.  
The close proximity of these vesicles to the inclusion membrane would allow an increased propensity 
for iron to cross the inclusion membrane (if it is iron permeable), or for a putative chlamydial protein 
(such as a typical INC) expressed in the inclusion membrane to facilitate transport into the vacuole.       
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While suggestive, further research is necessary to make the conclusion that the 
chlamydial iron source originates from the cytosol, and is not acquired directly from 
the endosomes that surround the periphery of the inclusion.  One possible approach 
to tackle this issue is the depletion of the divalent metal transporter 1 (DMT1) 
protein, which is responsible for the transport of ferrous iron from the lumen of the 
endosome to the cytosol.  DMT1 should be dispensable for chlamydial growth if 
transient fusion is the principal mechanisms of transport of iron from the vesicle to 
the inclusion.  Alternatively, one could conduct an ultrastructural analysis of the 
recycling compartment/inclusion interface in an attempt to observe if any transient 
connections are formed via the ‘touch and go’ mechanism.   
 
Once iron has reached the lumen of the inclusion, the picture of chlamydial iron 
acquisition becomes clearer.  Previous reports have indicated that Ytg ABC 
transport system may import iron from the periplasm to the cytoplasm (J. D. Miller, 
Sal, Schell, Whittimore, & Raulston, 2009).  The observation that ytgA transcript 
levels were responsive to low-iron availability supports this hypothesis.  Moreover, 
we characterized a polypeptide encoded within the C-terminus of YtgC to be an iron-
dependent DNA binding protein, capable of recognizing the IGR of its own operon.  
Additionally, we observed that the full length YtgC protein was cleaved into several 
stable fragments heterologously in E. coli.   
 
In the context of chlamydial iron-homeostasis, we propose the possibility of a two 
level regulatory network, in which the cleavage of C-YtgC away from the chlamydial 
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membrane precedes the ability of the polypeptide to bind iron under iron-replete 
conditions.  Upon the formation of ferrous bound homodimers, C-YtgC would then 
be able to recognize the IGR of its own operon (i.e. upstream of the ytgA CDS).  Such 
binding would prevent RNA polymerase transcription, and subsequently shut down 
iron-acquisition for the bacterium.  This would represent a novel mechanism of 
regulating iron-dependent transcriptional repressors.  The conservation of the 
genetic configuration with the ytgC gene amongst all chlamydial species, as well as 
its organization relative to the yaeL gene implies an important biological function 
that was retained through evolution.  A schematic diagram of this proposed 
regulatory network can be observed in Figure 6.3. 
 
We propose YaeL as the candidate for the protease responsible for the liberation of 
C-YtgC from its membrane-anchored N-terminal domain.  Interestingly YaeL 
homologues are zinc metalloproteases.  Thus, the liberation of C-YtgC could 
potentially be regulated by the overall concentration of zinc within in the bacterial 
cytoplasm.  Because only two potential ABC-metal transport systems have been 
identified in C. trachomatis (Ytg and YebLMI), it is possible that one or both function 
in the import of multiple metals, or that they could be co-regulated.  If indeed true, 
the integration of iron and zinc homeostasis would be an attractive area of 
investigation. 
 
The cis-regulatory elements recognized by C-YtgC have still not been characterized.  
As stated previously, the elucidation of what sites are bound by the polypeptide 
 226 
probably requires the use of DNA footprint assay.  The sites recognized by DtxR are 
somewhat diverse in C. diphtheria (Yellaboina, S. Ranjan, Chakhaiyar, Hasnain, & A. 
Ranjan, 2004).  An alternative means for the determination of cis-regulatory 
elements of ytgA includes the use of ChIP-chip technology, in which C-YtgC could be 
immunoprecipitated while bound to genomic DNA.  Hybridization of the binding 
sequences against a microarray chip containing the entire genome of C. trachomatis 
(including IGRs) would allow the identification of its potential binding sites 
throughout the genome.  If no such chip was available, these DNA fragments could 
be sequenced using Next Generation Sequencing technology (ChIP-seq).  The 
compilation of binding sites could allow the generation of a single consensus 
sequences for C-YtgC, which could be identified throughout the chlamydial genome 
and compared to those of other DtxR family members.   
 
Regarding the DNA-binding ability of C-YtgC, we have readily assumed that these 
proteins function as dimers.  Yet, this has not been tested empirically.  The 
resolution of purified protein by native PAGE should confirm this assumption.  
Alternatively, one could use increasing concentrations of cross-linking reagent prior 
to resolution by SDS-PAGE to observe the prevalence of dimers, and even tetramers.  
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Figure 6.3- Model for C. trachomatis regulatory mechanism for iron homeostasis (right).  (A) 
Iron-starved state within Chlamydia.  The YtgABCD system functions to transport iron from the 
periplasm to the cytosol of the bacteria.  In this scenario, the C-YtgC polypeptide (orange) remains 
fused to the membrane channel complex of the N-terminus of YtgC (orange) and YtgD (green).  
Without liberation into the cytosol or iron-activation, the cis-regulatory elements within the IGR of 
ytgA remain unbound, allowing efficient RNA polymerase initiation and transcription of the operon.  
(B) Under iron-replete conditions, we envision that YaeL may become active through an unknown 
mechanism (such as zinc binding) which cleaves at a residue with low-helical propensity in the 
membrane bound portion of YtgC.  This cleavage liberates the C-YtgC polypeptide, which must bind 
iron and dimerize in order to activate DNA binding activity.  The presence of multiple cis-regulatory 
elements within the IGR of ytgA may indicate that a DNA bending mechanism is required for efficient 
repression.  In this scenario, two homo-dimers of C-YtgC would bind separate cis-regulatory 
elements, and then form a tetramer in their bound form, subsequently causing a topological shift in 
the DNA that prevents RNA polymerase initiation and transcription.  Thus, the expression of the Ytg 
metal-transport system would be repressed under iron-replete conditions.   
 228 
 229 
  
The results presented in this report regarding the cleavage of YtgC are preliminary.  
Several questions remain, including determination of the protease responsible for 
YtgC processing, identification of the residues responsible for substrate recognition, 
and whether the C-terminal fragments observed by western blot were functional 
DNA-binding proteins.  Most immediately, the procession of YtgC could be analyzed 
after fractionation of the bacteria, such that the soluble and insoluble fractions 
would be resolved separately.  We would expect that the N-terminal tag, full-length 
or otherwise, would be retained to the insoluble membranous fraction.  
Alternatively, detection of the C-terminal tag should vary between the full-length 
(anchored in the membrane) and processed (soluble) forms.  We observed 
instability in the N-terminal YtgC fragment, and predicted that, after C-YtgC was 
liberated, the N-terminal fragment was degraded in E. coli.  We hypothesize that the 
co-expression of YtgD, which is predicted to be the membrane-bound binding 
partner for the formation of a channel-protein in vivo, should stabilize the YtgC 
polypeptide, and reveal perhaps reveal the correct target cleavage site.  Finally, in 
order to determine the protease responsible for heterologous cleavage in E. coli, one 
could express our Flag-YtgC-V5-pHis construct in a conditional yaeL depletion E. coli 
strain (Alba, Leeds, Onufryk, Lu, & Gross, 2002).    In this strain, we would predict 
only the full-length recombinant YtgC would be detected.  
 
In summary, our research demonstrates that the intracellular iron-chelator, 2,2’-
Bipyridyl, is an optimal agent for the iron-restriction of C. trachomatis, and elicits a 
uniform population of persistent Chlamydiae in cell culture.  This uniform 
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population allowed the increased accuracy of mRNA transcript analysis, and an 
increased ability to determine trends in differential transcription.  Using this model, 
we elucidated that transcription of ytgA, which codes for a protein predicted to 
promote iron-acquisition, is iron-responsive.  A gene within the same operon, YtgC, 
encodes a predicted membrane channel forming peptide and a peptide with 
structural homology to the DtxR family of transcriptional regulators, which we have 
termed C-YtgC.  We verified experimentally that C-YtgC is a functional DNA-binding 
protein in vitro, and that its activity is enhanced in the presence of iron.  At least two 
distinct cis-regulatory elements for C-YtgC binding were detected in the IGR 
upstream of ytgA, although further experiments are required to determine the exact 
sequences that are recognized.  The full-length YtgC polypeptide is processed into 
multiple fragments in E. coli, of which the resultant C-terminal components appear 
to be stable.  These results indicate that C. trachomatis regulates DNA transcription 
based on levels of iron-availability, and that a two-step regulatory process may be 
responsible for this regulation.   
 
The role of iron-restriction mediated persistence in vivo is likely relevant to the 
sequelae of Chlamydia infection.  In this study, we have attempted to unlock 
molecular mechanisms of acquisition and maintenance of homeostasis for this vital 
metal in C. trachomatis. While the evidence presented in this report has not 
definitively shown the mechanisms by which C. trachomatis responds to fluctuations 
in iron, a great deal of insight has been gained that will hopefully be of benefit to the 
field.  To this end, the characterization of a new, more efficient model should be of 
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great benefit to the Chlamydia iron-biology field, as an efficient mechanism for iron-
starvation of the intracellular pathogen has seemed to preclude the identification of 
a global iron-responsive regulon.  Moreover, the identification of C-YtgC as a DNA 
binding protein is novel for the Chlamydia field, and joins a short, but growing, list of 
transcriptional modulators in C. trachomatis.  For a pathogen that had been 
considered limited in its facultative ability less than 10 years ago, the recent 
identification of new regulators, such as C-YtgC, continues to support the notion that 
the intracellular niche is not static and that the Chlamydiacea have evolved 
mechanisms to cope with the specific stresses of intracellular life.   The continued 
research into the facultative ability of Chlamydia will be vital to the battle against 
this medically and socially relevant human pathogen.   
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Iron is an essential cofactor in a number of critical biochemical reactions, and as such, its 
acquisition, storage, and metabolism is highly regulated in most organisms. The obligate 
intracellular bacterium, Chlamydia trachomatis experiences a developmental arrest when iron 
within the host is depleted. The nature of the iron starvation response in Chlamydia is relatively 
uncharacterized because of the likely inefficient method of iron depletion, which currently relies 
on the compound deferoxamine mesylate (DFO). Inefficient induction of the iron starvation 
response precludes the identification of iron-regulated genes. This report evaluated DFO with 
another iron chelator, 2,2a-bipyridyl (Bpdl) and presented a systematic comparison of the two 
across a range of criteria. We demonstrate that the membrane permeable Bpdl was superior to 
DFO in the inhibition of chlamydia development, the induction of aberrant morphology, and the 
induction of an iron starvation transcriptional response in both host and bacteria. Furthermore, 
iron starvation using Bpdl identified the periplasmic iron-binding protein-encoding ytgA gene 
as iron-responsive. Overall, the data present a compelling argument for the use of Bpdl, rather 
than DFO, in future iron starvation studies of chlamydia and other intracellular bacteria.
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existence of an iron-dependent gene expression – the best studied 
being dcrA, which encodes for a protein that has homology to the 
prototypical ferric uptake regulator (Fur) protein that regulate 
transcription of target genes. The exact function of this protein is 
not known, but it has been demonstrated by Wyllie and Raulston 
(2001) that it harbors a DNA-binding activity, and that it can bind 
the same palindromic sequence recognized by E. coli Fur. However, 
further attempts to identify the cis-acting sequence recognized by 
DcrA in Chlamydia was unsuccessful (Rau et al., 2005). Moreover, 
the lack of a genetically tractable system in Chlamydia has precluded 
the knock-out-mediated identification of the “DcrA-regulon.” This 
lack of further insight is not isolated to DcrA function in Chlamydia, 
but to the entire iron-dependent regulation of gene expression in 
general. We hypothesize that this paucity in our knowledge of this 
process could be attributed to a lack of an efficient iron starvation 
mechanism that overcomes the buffering ability of the cell in rela-
tion to the chlamydial organisms it harbors.
The only iron-chelating agent tested against members of the 
Chlamydiacea has been DFO, which binds Fe3 well, but Fe2 poorly 
(Martell and Smith, 1977). In addition, DFO is membrane imper-
meable, and thus its chelating ability is restricted to the extracel-
lular media, and perhaps the lumen of the endosomal vesicles 
(Lloyd et al., 1991; Cable and Lloyd, 1999; Persson et al., 2003; 
Glickstein et al., 2005). Of the published iron-restriction protocols 
for the Chlamydiacea, the overwhelming majority have utilized 
DFO with some  auxiliary mechanism for iron depletion, includ-
ing combination with cyclohexamide to block host up-regulation 
of the transferrin pathway (Raulston, 1997; Dill et al., 2009; Wehrl 
et al., 2004), or long-term pre-treatment of the host cells prior to 
infection (Al-Younes et al., 2001; Peters et al., 2005; Mukhopadhyay 
et al., 2006; Dill et al., 2009; Timms et al., 2009). Taken together, 
INTRODUCTION
As an obligate, intracellular pathogen, Chlamydia has an absolute 
requirement of the host for essential nutrients. The chlamydial 
requirement for the biometal, iron, has been well established 
(Raulston, 1997; Al-Younes et al., 2001). Iron is an essential nutrient 
for nearly all organisms, as it is utilized as an electron intermediate, 
cofactor, or prosthetic group in a number of conserved biochemical 
cellular processes. Its biological importance can be attributed to its 
role as a transition metal with the ability to accept and donate single 
electrons as it alternates between the ferric (Fe3) and ferrous (Fe2) 
oxidative states (Hentze et al., 2004). When deprived of iron via 
long-term treatment using the hydrophilic chelator, deferoxamine 
mesylate (DFO), Chlamydiae enter an alternative growth mode, 
termed persistence, which was defined as a “viable but non-culti-
vatable state” of growth (Beatty et al., 1994). Persistence induced 
by iron starvation is phenotypically similar to those induced by 
other well-characterized mediators, which include treatment of 
host cells with IFN-g (Beatty et al., 1993), amino acid limitation 
(Coles et al., 1993), and B-lactam antibiotic exposure (Matsumoto 
and Manire, 1970; Lambden et al., 2006), with all exhibiting the 
accumulation of aberrantly enlarged RBs within the inclusion and 
the loss of infectious progeny (Beatty et al., 1994; Hogan et al., 
2004; Mpiga and Ravaoarinoro, 2006; Wyrick, 2010). Noteworthy 
is the reversibility of this aberrant phenotype removal of the stress 
condition (Beatty et al., 1994).
Intracellular pathogens, like Chlamydia, are naturally buffered 
by the host cell from severe fluctuation of iron levels, given the 
ability of the host cell to maintain intracellular iron homeostasis. 
This raises the question of whether chlamydia requires, or even pos-
sesses iron-dependent regulatory mechanisms of gene expression. 
Analysis of the chlamydial genome reveals evidence to support the 
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permeabilized with MeOH and stained with convalescent human 
sera. Inclusions were visualized after secondary staining with Alexa-
594 conjugated mouse mAb anti-human IgG, and counted in five 
fields per well for the calculation of infectious titer.
IMMUNOFLUORESCENT ANALYSIS AND MICROSCOPY
Infected samples were fixed and permeabilized with MeOH, and 
immunolabeled with convalescent human sera. Alexa-594 conju-
gated mouse mAb anti-human IgG was used to visualize chlamydial 
morphology. Images were captured using Leica SP2 upright confo-
cal microscope. Bars represent 10 µm in each image.
NUCLEIC ACID PREPARATION
Infected monolayers were trypsinized, pelleted, and resuspended in 
200 µl PBS for genomic DNA extraction, using the DNeasy Blood 
and Tissue Kit (QIAGEN) following the instructions of the manu-
facturer. Samples were eluted in a volume of 100 µl TE buffer.
RNA was extracted using Trizol Reagent (Invitrogen) using the 
instructions of the manufacturer for cells grown in a monolayer. 
Extracted RNA was DNAsed using Turbo DNase Kit (Applied 
Biosystems), precipitated in 80% ethanol overnight, dried, and 
resuspended in 20 µl nuclease free water (Applied Biosystems). 
RNA concentrations were measured using Nanodrop ND-1000 
spectrophotometer. Equal amounts of total RNA (2 µg) were 
converted to cDNA using Superscript III reverse transcriptase kit 
(Invitrogen) according to the instructions of the manufacturer. 
Reverse transcription was primed using random nonamers (New 
England Biolabs). cDNA mixture was diluted 1:8 with 10 mM Tris 
(pH 7.5), for a final volume of 160 µl and stored at 80oC.
REAL TIME QUANTITATIVE PCR (RT-qPCR)
Applied Biosystems 7300 Real time PCR System was used to carry 
out quantification of cDNA or gDNA sequences. Primers were 
designed using the Applied Biosystems Primer Express 3.0 Software 
and are listed in Table 1. Primer sets were tested for amplification 
these published protocols imply that DFO, by itself, may be an 
unsuitable or inefficient method for the iron starvation of the intra-
cellular pathogen, Chlamydia trachomatis. Moreover, the need for 
additional manipulations raises caveats in data interpretations. 
Therefore, we sought to identify an alternative means of starving 
Chlamydia of iron with minimal manipulation of the experimental 
system. We discovered that a single treatment at 100 µM dose at the 
time of infection with the compound, 2,2a-bipyridyl (Bpdl), which 
was previously identified as a membrane permeable iron-chelating 
agent capable of depleting the cytosolic labile iron pool (Breuer 
et al., 1995; Romeo et al., 2001), proved effective in inducing an 
iron starvation response in both the host cell and chlamydia. We 
present evidence that the compound Bpdl is more potent than DFO 
in inducing an iron-starved, persistent phenotype in C. trachomatis. 
Direct comparison with DFO also revealed a more robust and con-
sistent induction of the transcription of previously reported iron-
responsive genes. As final evidence of the superiority of Bpdl over 
DFO, ytgA, which encodes for an iron-binding periplasmic protein 
was found to be induced in iron-limiting conditions. Thus, we 
present an iron starvation protocol that requires minimal manipu-
lation, and possesses a potential broader applicability to Chlamydia 
and other intracellular bacteria.
METHODS
CELL CULTURE AND CHLAMYDIAL INFECTIONS
Human endothelial HEp2 cells (CCL-23, ATCC) were grown 
at 37oC with 5% CO
2
 in Iscove’s Modified Dulbecco’s Medium 
(IMDM, Gibco) supplemented with 10% (v/v) fetal bovine serum 
(FBS), 20 mM l-glutamine (Gibco), and 10 µg/ml gentamicin. C. 
trachomatis UW-3/CX (serovar D) was originally obtained from Dr. 
Ted Hackstadt (Rocky Mountain Laboratory, NIAID), and propa-
gated as described (Caldwell et al., 1981).
For infections, HEp2 or HeLa cells were plated to 85–90% 
confluency in six-well tissue culture treated plates and incubated 
overnight. Next day, monolayers were treated with 45 µg/ml DEAE-
Dextran (Sigma) in HBSS for 10–15 min at 37oC prior to inocula-
tion with C. trachomatis. Plates were centrifuged at 1500 rpm at 4oC 
prior to a 30-min invasion step at 37oC. Inoculum was decanted, 
cells were washed with PBS, and cultured in complete IMDM (plus 
or minus iron-chelating agents).
IRON-CHELATING AGENTS
Deferoxamine mesylate (Sigma, CAS: 138-14-7) was diluted to a 
stock concentration of 50 mM in ddH
2
O, filter sterilized and stored 
at 4oC for no more than 2 months. Bpdl (Sigma, CAS: 366-18-7) was 
diluted in ethanol to a stock concentration of 100 mM, aliquoted, 
and stored at 80oC.
QUANTIFICATION OF RECOVERABLE INFECTIOUS PROGENY
HEp2 cells were infected and treated as described. At 24 h post-
infection (p.i.; unless noted), infected monolayers were washed 
prior to physical dislodgement into 1 ml SPG buffer. Suspension 
was transferred to sterile eppendorf tubes containing three glass 
beads (3 mm, VWR) and vortexed for 60 s. Samples were stored at 
80oC. For quantification, samples were diluted serially and appro-
priate doses were used to re-infect fresh, confluent monolayers 
of HEp2 cells in triplicate. The next day, samples were fixed and 
Table 1 | Primers used for quantitative PCR.
Gene Organism Fwd primer (5a–3a) Rev primer (5a–3a)
gapdh H. sapiens ctgctcctcctgttcgacagt accttccccatggtgtctga
tfr H. sapiens cattctttggacatgctcatctg tgatgaccgagatggtggaa
dmt1 H. sapiens ggagtactcttgttttagctttc ccagactgcaaatcggattca 
  gtaaa
fer-H H. sapiens tgaagctgcagaaccaacga cgctctcccagtcatcacagt
fer-L H. sapiens accgtttttgtggttagctcctt caggtcggtggaataattctga
euo Ctr serovar D gctgttcctgttacttcgcaaa aacatagatagcctgacgag 
   tcaca
omcB Ctr serovar D ccaaagcgaaagacaacacttct aaccggagcaacctctttacg
ahpC Ctr serovar D ccagttagctggacaaacca cgttccattgacgaggaat 
  ttccg tgcgt
devB Ctr serovar D acgaagatgtagaagctgg tgcggtatccatacgaaag 
  aagta atttg
ytgA Ctr serovar D ctcttgtgtttagcaggctgtttc tgcgattcatagacaagacat 
   agatg
tyrP-1 Ctr serovar D tcgcaggaacaaccattgg gtaacgtcgtaggcagga 
   atcc
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1986; Kato et al., 2007), resulting in the net increase in the levels of 
these transcripts. Conversely, ferritin heavy/light chain transcripts, 
which code for proteins that form a complex for the storage of 
excess iron, are normally degraded under the same low-iron condi-
tions (Kato et al., 2007). Based on previous reports of intracellular 
iron-chelation, we expected Bpdl to cause an iron-starved tran-
scriptional state of eukaryotic cells. Indeed, Bpdl treatment caused 
an elevated expression of tfr and dmt-1, which reached 5.2- and 3.5-
fold over the untreated sample, respectively (unpaired, one-tailed 
t-test, p = 0.0054 and 0.0065, respectively). Moreover, treatment 
with Bpdl elicited an approximate twofold reduction in ferritin 
heavy/light chain (fer-H/L) transcripts (p = 0.0255 and 0.0458, 
respectively). The ability for Bpdl to cause an “iron-starved” tran-
scriptional response from uninfected HEp2 cells, in a time frame 
where DFO could not, raised the possibility that Bpdl could induce 
a relatively robust iron starvation response and/or growth inhibi-
tion in C. trachomatis.
THE EFFECT OF BIPYRIDYL ON ACUTE C. TRACHOMATIS INFECTION
The observation that Bpdl was able to induce a greater iron star-
vation response from the host cell highly suggested that a similar 
response could be elicited from intracellular chlamydiae. Therefore 
we tested both Bpdl and DFO for effects on chlamydial develop-
ment and inclusion morphology, with an emphasis on the simplest 
possible iron starvation protocol, which involves a single treatment 
at the time of infection. In order to test the effect of Bpdl on C. 
trachomatis development, a dose-response analysis of recoverable 
inclusion forming units (IFU) was performed (Figure 3). HEp2 
cells were infected with C. trachomatis serovar D at an MOI of 
0.5 prior to culture in normal (iron-replete) medium containing 
various doses of DFO or Bpdl for 24 h. Infectious progeny were 
harvested and replated onto fresh monolayers for quantification. 
C. trachomatis growing in iron-replete medium consistently pro-
duced over 107 IFUs/ml. No significant inhibition of recoverable 
IFUs was observed upon addition of low doses (25 or 50 µM) 
of Bpdl to the culture medium. The same doses of DFO (25 
and 50 µM) each caused an approximate 70% decrease in IFU 
output that was significantly lower than the untreated control 
(unpaired, two-tailed t-test; p = 0.0046 and p = 0.0072, respec-
tively). However, at concentrations of 100 and 250 µM, Bpdl was 
more effective relative to the untreated sample. At 100 µM, Bpdl 
caused a 2.5-log reduction of recoverable IFUs from the untreated 
control (p = 0.0001). Moreover, inhibition of infectious progeny 
efficiency against gDNA extracted from purified EBs, and for the 
generation of specific products using 7300 system post-run Tm 
function. Samples were assayed in triplicate wells of a 96 well plate; 
each reaction contained 5 µl DNA (complimentary or genomic), 
25 µl 2X SYBR green master mix (Applied Biosystems), 0.45 pmol 
forward and reverse primers, and 19.8 µl RNase/DNase free water 
(Applied Biosystems). No RT and no template controls were per-
formed regularly.
Relative expression of eukaryotic iron-responsive transcripts 
was quantified using the Pfaffl method (2$$Ct method; Pfaffl, 2001). 
Target iron-responsive transcripts were normalized to gapdh 
transcript levels and calibrated to the untreated sample. Absolute 
expression of Chlamydia transcripts was quantified using seri-
ally diluted C. trachomatis genomic DNA, which was extracted 
from EBs, as a standard. Levels of mRNA were normalized to the 
number of Chlamydia-specific genomes, which were derived from 
parallel samples.
GRAPHS AND STATISTICAL ANALYSIS
Generation of all graphs and statistical tests were performed in 
GraphPad Prism v5.0 Software. Specific statistical tests are described 
in the Section “Results” and figure legends. Unless noted, graphs 
represent mean averages p SD.
RESULTS
EUKARYOTIC IRON-RESPONSIVE TRANSCRIPTION AFTER IRON-
CHELATOR TREATMENT
Intracellular chlamydia are naturally protected from severe fluc-
tuations of extracellular environmental conditions, and thus 
eliciting a response for the bacterium would first require that the 
host cell be affected. Two different iron chelators, DFO and Bpdl 
(shown in Figure 1) were evaluated for their ability to induce an 
iron response from the host cell, with the underlying assumption 
that iron starvation of the host would lead to iron starvation of 
intracellular chlamydiae. To assess the level of host iron starvation, 
we chose to examine the differential regulation of a handful of 
iron-related transcripts that are known to respond to changes in 
iron levels. We utilized the mRNA levels of specific iron-responsive 
transcripts from uninfected HEp2 cells that had been treated with 
DFO or Bpdl for 10 h (Figure 2). The mRNA of two genes cod-
ing for iron-acquisitional proteins, transferrin receptor (TfR) and 
divalent metal transport protein 1 (DMT1) are normally stabilized 
under conditions of low cytoplasmic iron availability (Rao et al., 
FIGURE 1 | Chemical structure of iron-chelating agents. Deferoxamine mesylate (DFO) is a hydrophilic compound with a high affinity for ferric iron (Martell and 
Smith, 1977). It binds ferric iron in a 1:1 (hexadentate) complex (Gaeta and Hider, 2005). 2,2a-bipyridyl (Bpdl) is a membrane permeable compound with similar 
moderate affinities for Fe2 and Fe3 (Smith and Martell, 1975), and binds both species of these molecules in a 3:1 molar ratio (bidentate; Gaeta and Hider, 2005).
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control (p = 0.0002). However, this result was highly variable with 
a percent recovery that ranged from 0 (complete arrest) to 12.5% 
of the untreated control. Compared directly, treatment with Bpdl 
was 26-fold more effective than DFO in limiting the development 
was highly  reproducible with the percent recovery ranging from 
just 0 to 0.33% of the untreated control over three independent 
experiments. At 100 µM concentration administered at the time 
of infection, DFO yielded a 95% reduction from the untreated 
FIGURE 2 | Bipyridyl treatment modulates eukaryotic iron-responsive 
transcription. Human epithelial HEp2 cells were incubated in complete medium 
containing 100 µM DFO or Bpdl for 10 h before select transcript levels were 
measured via RT-qPCR. Reported iron-responsive genes, transferrin receptor (TfR) 
and divalent metal transporter 1 (DMT1), and iron-repressed genes, ferritin heavy 
and light chain (Fer-H/L) were normalized to endogenous glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) mRNA levels and then calibrated to the 
untreated control ($$Ct method; Pfaffl, 2001). The y-axis presents the natural log of 
the target gene relative expression. Bars represent the natural log of mean relative 
expressions p SD in one representative experiment containing two biological 
replicates per treatment, each assayed in triplicate. Experiment was performed 
independently two times and obtained similar transcriptional profiles in each case 
(i.e., total of four biological replicates were observed). Statistical significance from 
the untreated was determined by unpaired, one-tailed t-test (*p  0.05, **p  0.01).
FIGURE 3 | Infectious progeny of C. trachomatis samples cultured with 
iron-chelating agents. Various concentrations of DFO (black bars) or Bpdl (white 
bars) were included in the culture medium added immediately post-chlamydial 
invasion. Infectious titers were quantified after 24 h of treatment and presented 
as inclusion forming units (IFU) per milliliter of inoculum (y-axis). Graph represents 
the mean p SD derived from at least two independent experiments, assayed in 
triplicate. Statistical significance determined with unpaired, two-tailed t-test in 
conjunction with F-test (*p  0.05, **p  0.01, ***p  0.001). Asterisks without 
brackets represent comparison to the untreated control; brackets indicate the 
comparison of DFO to Bpdl at the same concentration.
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of the experimental system. Under such conditions, Bpdl appeared 
to be more efficient in initiating and maintaining a developmental 
arrest in C. trachomatis.
CHLAMYDIAL VIABILITY UPON BIPYRIDYL TREATMENT
The term “persistence,” refers to the ability of non-cultivatable 
chlamydiae to re-enter the acute life-cycle and cause disease upon 
the removal of the condition of stress. We chose to examine the 
reversibility of the persistent phenotype of chlamydia exposed to 
Bpdl in two ways. First, persistent Chlamydiae often exhibit con-
tinued genomic replication, albeit at a reduced rate, despite a lack 
of re-differentiation into the infectious EB form (Belland et al., 
2003; Lambden et al., 2006). Therefore Chlamydia-specific genomic 
DNA (gDNA) was monitored longitudinally during iron-chelation 
treatment using real time qPCR. Incubation with DFO and Bpdl 
(100 µM) retarded chlamydial DNA replication, compared to the 
untreated control. However, consistent with the recoverable IFU 
and IFA data, Bpdl treatment caused an even greater growth defect 
than that of DFO-treatment (Figure 5A). During the exponen-
tial phase of growth (between 12 and 24 h post-infection), Bpdl-
treated C. trachomatis gDNA doubled once every ^ 5.5 h, compared 
to approximately each 2.5 and 3.3 h for untreated and DFO-treated 
cultures, respectively, over the same time period. Importantly, the 
number of genomes increased during each time period tested 
of infectious progeny (p = 0.0408). While both compounds caused 
similar reduction in recoverable IFU at 250 µM, some cells were 
lost indicating possible cytotoxicity (data not shown). Therefore, 
100 µM was deemed a suitable concentration for both iron-chelat-
ing agents for subsequent experiments.
As the loss of recoverable infectious progeny due to develop-
mental arrest is a hallmark of the chlamydial persistent phenotype 
(Beatty et al., 1994), we examined C. trachomatis samples cultured 
with Bpdl for another characteristic of persistence, the formation 
of aberrantly enlarged RBs. Infected cell cultures were treated 
for 24 or 48 h with 100 µM concentrations of Bpdl or DFO and 
visualized by immunofluorescent confocal microscopy (Figure 4). 
Compared to the untreated control, culture with both DFO and 
Bpdl (100 µM, administered at the time of infection) caused a 
qualitatively similar reduction in the size of chlamydial inclusions 
at 24 h p.i. (Figures 4A–C). Enlarged, aberrant RBs, character-
istic of the persistent phenotype, were only observed after 48 h 
of culture with Bpdl (Figure 4F). Interestingly, the same 48-h 
length of treatment with DFO (Figure 4E) yielded a population 
of chlamydial inclusions, the majority of which resembled that of 
the untreated, 24-h p.i. sample (Figure 4A), suggesting that DFO 
may not be suitable for time-points of this length. It should be noted 
that growth media was neither replaced nor additional chelators 
added, consistent with our intention of minimizing manipulation 
FIGURE 4 | Chlamydial morphology after long-term incubation with 
inhibitory doses of Deferoxamine or Bipyridyl. C. trachomatis-infected cell 
cultures were incubated with 100 µM DFO (B, E) or Bpdl (C,F) in conjunction 
with untreated controls (A,D). Images from the top panel row (A–C) were fixed 
after 24 h p.i. and images from the bottom panel row (D–F) were fixed after 48 h 
p.i. Samples were stained immunofluorescently using convalescent human 
sera. Aberrant RB morphology and a lack of EB particles within the inclusional 
lumen was only observed upon 48 h of Bpdl treatment (F). Samples treated 
with DFO for 48 h (E) exhibited similar characteristics of untreated 24 h growth 
(A). Images were captured using Leica Confocal microscope. Bars represent 
10 µM in each panel/inset. Images selected represent the overall trends 
observed in four independent experiments.
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EXOGENOUS IRON ABROGATES CHLAMYDIAL INHIBITION CAUSED BY 
BIPYRIDYL AND DEFEROXAMINE
To ensure that effects elicited by culture with Bpdl resulted from 
the restriction of iron, an iron-titration experiment was performed, 
in which increasing concentrations of Fe3 or Fe2 were added to an 
inhibitory dose (100 µM) of the two iron-chelating agents, prior to 
their incubation with infected cell cultures. To confirm the bind-
ing capabilities of Bpdl, we utilized species of both ferric (FeCl
3
) 
and ferrous (FeSO
4
) oxidative states of iron. Based on reported 
affinities (Smith and Martell, 1975; Martell and Smith, 1977), it was 
not surprising that both Bpdl and DFO-mediated inhibition was 
abrogated by the addition of exogenous ferric chloride (Figure 6A). 
In contrast, the addition of ferrous sulfate was not able to rescue 
DFO-mediated inhibition of recoverable IFU output (Figure 6B), 
which was expected, based on its reported specific affinity for fer-
ric iron (Martell and Smith, 1977). The lack of recovery exhibited 
by ferrous iron supplementation illustrated the inability of DFO 
to bind the divalent metal in the extracellular medium, coupled 
with the inability of the host cell to efficiently import the supple-
mented ferrous iron. The end result was the unaltered sequestra-
tion of ferric iron in the extracellular media, which, of course, is 
the main source of host cell iron acquisition. This result was not 
the case for Bpdl-mediated inhibition, as recoverable IFU output 
was completely reversed at 20 µM of FeSO4, which was the lowest 
dose tested, reflecting its ability to bind the divalent oxidation state 
for Bpdl-cultured samples, indicating active genomic replica-
tion, and thus viable organisms, despite the lack of infectious EB 
re-differentiation.
Reactivation of developmentally arrested chlamydiae upon 
removal of the chelator was monitored using recoverable IFUs 
as a measure of viability. Infected HEp2 cells were incubated with 
Bpdl for 18 or 24 h, and then “reactivated” by the replacement of 
Bpdl-supplemented media with normal (iron-replete) medium 
for another 18 to 24 h of incubation. The infectious titer of each 
sample was quantified and compared to samples incubated with 
Bpdl for the entire course of infection (Figure 5B). A near com-
plete arrest of infectious EB re-differentiation was observed at 
24, 36, and 48 h of continuous treatment with Bpdl, which was 
consistent with the aberrant morphology observed by immun-
ofluorescent analysis at 48 h p.i. (Figure 4F). In contrast, “reac-
tivated” samples exhibited an increase in recoverable infectious 
progeny of 2–3 logs over continuously treated samples. Although 
reactivated chlamydial samples were not completely rescued to 
the untreated output levels, a majority of chlamydiae were able 
to re-enter the acute life-cycle and re-differentiate into the infec-
tious EB form.
FIGURE 5 | Viability of C. trachomatis cultured with Bipyridyl. (A) 
Chlamydia-specific DNA was quantified via RT-qPCR from total genomic DNA 
extracted each 6 h. The numbers of chlamydial genomes (y-axis) were 
extrapolated from a standard curve of genomic DNA obtained from purified 
chlamydial EBs. Data points represent the mean p SD of two independent 
experiments, which were representative of greater than five independent 
time course experiments. (B) Bpdl-cultured C. trachomatis were reactivated 
by washing and incubation with normal, iron-replete medium (“18  18” and 
“24  24”) and compared to cultures treated with Bpdl throughout the entire 
experiment (“24,” “36,” “48”). C. trachomatis treated with Bpdl for 18 and 
24 h were still viable when cultured with normal media. Graph represents data 
combined from two independent experiments, each assayed in triplicate. Bars 
represent mean p SD.
FIGURE 6 | The effect of iron on iron-chelator mediated recoverable IFU 
inhibition. Increasing concentrations of ferric (A) or ferrous (B) iron were 
used to titrate out the inhibition of C. trachomatis infectious progeny caused 
by treatment with (100 µM) Bpdl or DFO. Exogenous iron was added to 
medium containing chelators immediately prior to its use in culture. Samples 
were harvested at 24 h p.i. for infectious titer quantification. Bars represent 
the mean p SD of one experiment representative of two independent trials in 
which similar trends were obtained.
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known to be induced under iron-limiting conditions. We moni-
tored the expression of known molecular markers of persistence 
– the continued expression of the early gene euo (Belland et al., 
2003; Ouellette et al., 2006; Timms et al., 2009) and the failure to 
induce transcription of the late gene omcB (Iliffe-Lee and McClarty, 
2000; Belland et al., 2003; Ouellette et al., 2006; Timms et al., 2009). 
Therefore the expression of persistence markers, euo and omcB, was 
measured longitudinally from DFO, Bpdl, and untreated cultures 
via RT-qPCR and normalized by the genome copy number derived 
of the metal. Taken together, the addition of exogenous ferric and 
ferrous iron abrogated the inhibitory effects of Bpdl, while only 
ferric iron restored IFU yield in DFO-treated samples.
THE EFFECT OF BIPYRIDYL TREATMENT ON CHLAMYDIAL 
TRANSCRIPTION
Having validated Bpdl treatment as an efficient mediator of the 
chlamydial persistent response, we decided to test its effects on 
chlamydial transcription of genes associated with persistence or 
FIGURE 7 | Time course analysis of selected transcript expression of C. 
trachomatis. Samples were cultured in normal iron-replete medium (--v--), or in 
conjunction with deferoxamine (----) or bipyridyl (--$--). Total RNA was extracted 
longitudinally and reverse transcribed to cDNA for quantification using specific 
primer sets (Table 1). cDNA levels were adjusted to reflect the number of 
chlamydial organisms by using the number of chlamydial genomes determined 
from parallel samples. (A) Transcripts whose expression were altered under 
multiple models of persistence (Iliffe-Lee and McClarty, 2000; Belland et al., 
2003; Ouellette et al., 2006; Timms et al., 2009). (B) Transcripts from C. 
trachomatis whose expression were altered under iron-restriction. (C) ytgA, a 
transcript whose expression was hypothesized to be responsive to fluctuations 
in iron availability, along with tyrP1 whose transcription was altered under IFN-g 
treatment, but not iron-restriction in C. pneumoniae (Timms et al., 2009). 
Statistical significance relative to the untreated control was determined using 
two-tailed t-test (Bpdl-treated samples: *p  0.05, **p  0.01, ***p  0.001; 
DFO-treated samples: ##p  0.01).
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from a parallel sample. As expected, appreciable omcB expression 
was not observed until 18 to 24 h p.i. in the untreated control, which 
correlates to the onset of EB re-differentiation for C. trachomatis. 
Alternatively, the expression of euo in the same samples increased 
during the earliest time-points measured and then decreased to 
near absent levels during the late stages of infection (Figure 7A). 
Culture with 100 µM DFO from the time of infection did not alter 
either of these transcriptional profiles, suggesting that a persistent 
phenotype could not be induced efficiently by this iron chelator 
when administered at the time of infection. In contrast, incuba-
tion with Bpdl caused the extended repression of omcB transcript 
expression throughout the entire time course. Concomitantly, 
expression of euo remained elevated until the late stages of infec-
tion. The altered expression of these two genes indicated that cul-
ture with Bpdl (100 µM), from the time of infection, elicited a 
persistent chlamydial phenotype.
We sought to validate the Bpdl model by monitoring its effects 
on the transcription of two previously reported chlamydial iron-
responsive genes, ahpC and devB (Dill et al., 2009), in parallel with 
untreated and DFO-treated cultures. When included immediately 
post-invasion, a 100-µM concentration of DFO, noticeable increases 
in the levels of devB transcript were only observed at 24 (2.6-fold) 
and 30 (2.5-fold) h p.i. (unpaired, two-tailed t-test; p = 0.0740, 
p = 0.0023, respectively), while no differential transcription of ahpC 
was observed (Figure 7B). In contrast, culture with Bpdl caused sta-
tistically significant elevation over the untreated control at multiple 
time-points of both ahpC and devB (Figure 7B), with a statistically 
significant increase observed as early as 6 h post-treatment for devB. 
Maximum differential expression occurred at 24 h p.i. for ahpC, 
and reached 3.1-fold over the untreated levels (p = 0.0008). For 
devB, maximum differential expression reached 5.6-fold at 30 h p.i. 
(p = 0.0009). Taken together, treatment with Bpdl caused a more 
robust induction ahpC and devB than treatment with DFO. Not 
only was the altered expression more pronounced, it also lasted 
longer, suggesting significant and sustained iron-deprivation.
We also analyzed the expression of ytgA. YtgA, a proposed peri-
plasmic iron-binding protein, was reported to be iron-responsive 
at the protein level upon long-term treatment with DFO (Miller 
et al., 2009), yet its differential expression at the transcript level 
has never been shown, and thus served as an excellent candidate to 
further evaluate the efficiency of iron starvation mediated by Bpdl. 
Using the Bpdl model, expression of ytgA was clearly elevated after 
24 and 30 h p.i. (unpaired, two-tailed t-test; p = 0.0083, p = 0.0433, 
respectively; Figure 7C), providing a mechanism for the elevated 
protein expression previously observed (Miller et al., 2009). Thus, 
the greater effectiveness of the new iron starvation method was 
validated by the discovery of ytgA being an iron-responsive gene 
at the level of transcription.
To ensure that the up-regulation of ahpC, devB, and ytgA were 
specific to iron-limitation, the expression of tyrP-1, which codes for 
an aromatic amino acid transporter, was monitored. Its transcript 
expression in C. pneumoniae was differentially expressed under 
persistence mediated by IFN-g treatment, but not iron-restriction 
(Timms et al., 2009). IFN-g is thought to induce expression of 
the host enzyme, indoleamine dioxygenase (IDO), which effec-
tively limits the available amount of tryptophan within the cell 
(Wood et al., 2004). Therefore its elevated expression under IFN-g 
 mediated persistence presumably functions to increase acquisition 
of the limited amino acid. Because Timms et al. (2009) reported 
that it was not differentially expressed under conditions of low-iron 
availability, its transcript expression was monitored to distinguish 
the effects of Bpdl-mediated iron starvation from general persist-
ence. As expected, transcription of tyrP1 was not altered under 
Bpdl treatment at any time-point tested (Figure 7C). The fact that 
this mid-stage gene was not differentially expressed under Bpdl-
mediated persistence indicated that the elevated transcription pub-
lished in this study was specific to iron-restriction. Taken together, 
the data indicate collectively that a single-dose Bpdl treatment is an 
efficient iron-restriction model for the growth of C. trachomatis, 
and is able to elicit a more uniform, and consequently, a more 
robust response from Chlamydiae than DFO under identical treat-
ment conditions.
DISCUSSION
We present a re-evaluation of the currently available iron starvation 
protocol for intracellular bacteria by directly comparing DFO and 
Bpdl for their abilities to induce iron starvation-related phenotypes 
in the obligate intracellular pathogen C. trachomatis. The goal was 
to identify an alternative means of starving Chlamydia of iron with 
minimal manipulations, such as pre-starving the host cell, or pre-
venting it from synthesizing proteins involved in iron acquisition. 
Our motivation for simplifying iron starvation of Chlamydia by 
excluding such manipulations was to minimize potential contribu-
tory factors that may confound data interpretation. To this end, 
we identified Bpdl to be a better iron chelator than DFO under 
single-treatment experimental conditions. In a number of crite-
ria, specifically IFU yield, aberrant RB formation, and transcrip-
tional modulation of previously reported persistence indicating 
genes, Bpdl was consistently more potent than DFO. Moreover, 
the increased differential transcription of iron-responsive genes, 
ahpC and devB, in the Bpdl protocol relative to the DFO starvation 
method validated the alternative iron starvation system. Finally, the 
Bpdl model allowed the novel observation that ytgA, which codes 
for an iron-binding periplasmic protein thought to be involved in 
iron acquisition/transport into Chlamydia, is iron-responsive at the 
transcript level. The use of this Bpdl model could allow additional 
insights into the global iron-restricted regulon of C. trachomatis.
Our study was initiated due to the inefficient ability of DFO to 
elicit a uniform, persistent phenotype of C. trachomatis for analysis 
of differential gene expression. We hypothesized that DFO, which 
is not membrane permeable and can only bind ferric iron, could 
only be efficient in the iron-restriction of the obligate intracel-
lular pathogen if the only chlamydial source of iron was the direct 
acquisition of ferric iron as it entered the host cell via the transfer-
rin pathway. On the other hand, if Chlamydia were able to acquire 
iron from another source, e.g., from the cytosolic labile iron pool 
or the slow recycling pathway (Ouellette and Carabeo, 2010), then 
use of DFO would require longer treatment to deplete intracel-
lular iron stores. In the literature, DFO has rarely been used with-
out auxiliary steps or methods for iron-restriction. For instance, 
the combination of DFO with cyclohexamide (which is a general 
eukaryotic protein synthesis inhibitor) has been employed to pre-
vent the host cell up-regulation of the transferrin iron-acquisition 
pathway (Raulston, 1997; Wehrl et al., 2004; Dill et al., 2009). Yet the 
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